151096-09-2 | 7-[(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

Packsize	Purity	Availability	Price	Discounted Price
250mg	98%	in stock	$14.00	$10.00
1g	98%	in stock	$41.00	$29.00
5g	98%	in stock	$74.00	$52.00
25g	98%	in stock	$203.00	$142.00
100g	98%	in stock	$496.00	$347.00
500g	98%	in stock	$2,004.00	$1,403.00

Description

• Catalog Number: AA76379
• Chemical Name: 7-[(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
• CAS Number: 151096-09-2
• Molecular Formula: C21H24FN3O4
• Molecular Weight: 401.4314
• MDL Number: MFCD04117996
• SMILES: COc1c(N2C[C@@H]3[C@H](C2)CCCN3)c(F)cc2c1n(cc(c2=O)C(=O)O)C1CC1

Computed Properties

• Complexity: 727
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 2
• Heavy Atom Count: 29
• Hydrogen Bond Acceptor Count: 8
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 4
• XLogP3: 0.6

Literature

• QT/QTc study conducted in Japanese adult healthy subjects: a novel xanthine oxidase inhibitor topiroxostat was not associated with QT prolongation.

  Journal of clinical pharmacology 20140401

• Bactericidal activity and mechanism of action of AZD5847, a novel oxazolidinone for treatment of tuberculosis.

  Antimicrobial agents and chemotherapy 20140101

• Methyl-thiazoles: a novel mode of inhibition with the potential to develop novel inhibitors targeting InhA in Mycobacterium tuberculosis.

  Journal of medicinal chemistry 20131114

• Assessment of clofazimine activity in a second-line regimen for tuberculosis in mice.

  American journal of respiratory and critical care medicine 20130901

• Synthesis, in vitro antimycobacterial and antibacterial evaluation of IMB-070593 derivatives containing a substituted benzyloxime moiety.

  Molecules (Basel, Switzerland) 20130328

• Synthesis of gatifloxacin derivatives and their biological activities against Mycobacterium leprae and Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry 20130215

• A liquid chromatography-tandem mass spectrometry assay for the determination of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, in human plasma and urine and its application to a single-dose pharmacokinetic study in healthy Chinese volunteers.

  Biomedical chromatography : BMC 20121101

• Development and validation of liquid chromatography-mass spectrometric method for simultaneous determination of moxifloxacin and ketorolac in rat plasma: application to pharmacokinetic study.

  Biomedical chromatography : BMC 20121101

• Emerging fluoroquinolone resistance in Streptococcus agalactiae in South Korea.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20121101

• Identification of a novel resistance mutation in parE that confers high-level resistance to moxifloxacin in Streptococcus pneumoniae.

  The Journal of antimicrobial chemotherapy 20121101

• Switch from intravenous to enteral moxifloxacin in critically ill patients: a pilot study.

  Scandinavian journal of infectious diseases 20121101

• 6-hydrogen-8-methylquinolones active against replicating and non-replicating Mycobacterium tuberculosis.

  Chemical biology & drug design 20121101

• Photodegradation of fluoroquinolones in surface water and antimicrobial activity of the photoproducts.

  Water research 20121101

• In vitro susceptibility of Mycobacterium bovis against moxifloxacin.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20121101

• [Current data and trends on the development of antibiotic resistance of Clostridium difficile].

  Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 20121101

• Primary resistance of Helicobacter pylori to levofloxacin and moxifloxacine in Iran.

  Internal and emergency medicine 20121001

• Shortening of the QT interval after food can be used to demonstrate assay sensitivity in thorough QT studies.

  Journal of clinical pharmacology 20121001

• Seasonality of Clostridium difficile infections in Southern Germany.

  Epidemiology and infection 20121001

• Fungal keratitis responsive to moxifloxacin monotherapy.

  Cornea 20121001

• Antibiotic susceptibility in prostate-derived Propionibacterium acnes isolates.

  APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 20121001

• Infectious keratitis after Boston type 1 keratoprosthesis implantation.

  Cornea 20121001

• Evaluation of the effects of bitopertin (RG1678) on cardiac repolarization: a thorough corrected QT study in healthy male volunteers.

  Clinical therapeutics 20121001

• Towards a new tuberculosis drug: pyridomycin - nature's isoniazid.

  EMBO molecular medicine 20121001

• Moxifloxacin in multidrug-resistant tuberculosis: is there any indication for therapeutic drug monitoring?

  The European respiratory journal 20121001

• The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment.

  American journal of respiratory and critical care medicine 20120915

• 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial.

  Lancet (London, England) 20120915

• Bupivacaine extended release liposome injection does not prolong QTc interval in a thorough QT/QTc study in healthy volunteers.

  Journal of clinical pharmacology 20120901

• Microcolonies in fluoroquinolone agar proportion susceptibility testing of Mycobacterium tuberculosis: an indicator of drug resistance.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20120901

• [The fate of 20 sea breams. Mycobacterium marinum infection].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20120901

• Negative electro-mechanical windows are required for drug-induced Torsades de Pointes in the anesthetized guinea pig.

  Journal of pharmacological and toxicological methods 20120901

• The role of the anaesthetised guinea-pig in the preclinical cardiac safety evaluation of drug candidate compounds.

  Toxicology and applied pharmacology 20120901

• Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD.

  Respiratory medicine 20120901

• Activity of JNJ-Q2 against Staphylococcus aureus isolated from patients with acute bacterial skin and skin-structure infection obtained during a Phase 2 clinical trial.

  Diagnostic microbiology and infectious disease 20120901

• Synthesis and in vitro antibacterial activity of gemifloxacin derivatives containing a substituted benzyloxime moiety.

  European journal of medicinal chemistry 20120901

• Effects of a supratherapeutic dose of investigational orally inhaled dihydroergotamine (MAP0004) on QT interval: a randomized, double-blind, active- and placebo-controlled crossover study in healthy volunteers.

  Clinical therapeutics 20120901

• [Spectrum and drug sensitivity of pathogenic bacteria in children with nephrotic syndrome complicated by urinary tract infection: an analysis of 97 cases].

  Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20120901

• [Helicobacter pylori-related diseases].

  Gastroenterologia y hepatologia 20120901

• In vivo metabolic investigation of moxifloxacin using liquid chromatography/electrospray ionization tandem mass spectrometry in combination with online hydrogen/deuterium exchange experiments.

  Rapid communications in mass spectrometry : RCM 20120830

• Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori.

  World journal of gastroenterology 20120828

• Characterization of the human QT interval: novel distribution-based assessment of the repolarization effects of moxifloxacin.

  Journal of clinical pharmacology 20120801

• A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects.

  International journal of cancer 20120801

• In vitro antichlamydial activity of garenoxacin against Chlamydia trachomatis.

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20120801

• Moxifloxacin punctum plug for sustained drug delivery.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120801

• Repeated supratherapeutic dosing of strontium ranelate over 15 days does not prolong QT(c) interval in healthy volunteers.

  British journal of clinical pharmacology 20120801

• Inhibitory activity of garenoxacin against DNA gyrase of Mycoplasma pneumoniae.

  The Journal of antimicrobial chemotherapy 20120801

• Changing trends in antimicrobial susceptibility of Streptococcus pneumoniae isolates in Taiwan, 2006-2007.

  Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20120801

• Anti-inflammatory effects of moxifloxacin on rat airway smooth muscle cells exposed to allergen: Inhibition of extracellular-signal-regulated kinase and nuclear factor-κB activation and of interleukin-8 and eotaxin synthesis.

  Respirology (Carlton, Vic.) 20120801

• A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging.

  The Journal of antimicrobial chemotherapy 20120801

• Antimicrobial susceptibility testing of Clostridium difficile using EUCAST epidemiological cut-off values and disk diffusion correlates.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20120801

• In vitro and in vivo activity of clofazimine against Mycobacterium tuberculosis persisters.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20120801

• Bilateral acute iris transillumination following systemic moxifloxacin for respiratory illness: report of two cases and review of the literature.

  Ocular immunology and inflammation 20120801

• Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives.

  Bioorganic & medicinal chemistry letters 20120801

• Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study.

  International journal of clinical pharmacology and therapeutics 20120801

• New drugs for the treatment of tuberculosis: hope and reality.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20120801

• [Sepsis. Update 2012].

  Deutsche medizinische Wochenschrift (1946) 20120801

• Herpes zoster ophthalmicus complicated by ipsilateral isolated Bell's palsy: a case report and review of the literature.

  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20120801

• [Abstracts of 8th Moxifloxacin Research Workshop. November 17-18, 2012. Leverkusen, Germany].

  Infection 20120801

• New drug combination for TB is tested in unique trial.

  BMJ (Clinical research ed.) 20120725

• Construction and functionalization of fused pyridine ring leading to novel compounds as potential antitubercular agents.

  Bioorganic & medicinal chemistry letters 20120715

• Ocular infections caused by non-tuberculous mycobacteria: update on epidemiology and management.

  Clinical & experimental ophthalmology 20120701

• Stenotrophomonas maltophilia in the respiratory tract of medical intensive care unit patients.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20120701

• Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.

  The European respiratory journal 20120701

• Comparison of moxifloxacin and levofloxacin in an epithelial disorder model using cultured rabbit corneal epithelial cell sheets.

  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20120701

• Role of mixed ion channel effects in the cardiovascular safety assessment of the novel anti-MRSA fluoroquinolone JNJ-Q2.

  British journal of pharmacology 20120701

• Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection.

  Ophthalmology 20120701

• Triprotic site-specific acid-base equilibria and related properties of fluoroquinolone antibacterials.

  Journal of pharmaceutical and biomedical analysis 20120701

• Induced osteoclastogenesis by fluoroquinolones in unstimulated and stimulated human osteoclast precursor cells.

  Bone 20120701

• Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense.

  Antimicrobial agents and chemotherapy 20120701

• Association between PCR ribotypes and antimicrobial susceptibility among Clostridium difficile isolates from healthcare-associated infections in South Korea.

  International journal of antimicrobial agents 20120701

• Laboratory diagnosis of Clostridium difficile associated diarrhoea and molecular characterization of clinical isolates.

  The new microbiologica 20120701

• Antimicrobial chemotherapy of Mycoplasma genitalium-positive non-gonococcal urethritis.

  Expert review of anti-infective therapy 20120701

• The evaluation of antimicrobial susceptibility of urine enterococci with the Vitek 2 automated system in eastern Turkey.

  The Southeast Asian journal of tropical medicine and public health 20120701

• Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial.

  JAMA 20120613

• Lack of significant effect of bilastine administered at therapeutic and supratherapeutic doses and concomitantly with ketoconazole on ventricular repolarization: results of a thorough QT study (TQTS) with QT-concentration analysis.

  Journal of clinical pharmacology 20120601

• Formulation and evaluation of micro hydrogel of Moxifloxacin hydrochloride.

  European journal of drug metabolism and pharmacokinetics 20120601

• Antimicrobial efficacies of several antibiotics against uterine cervicitis caused by Mycoplasma genitalium.

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20120601

• Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis.

  The European respiratory journal 20120601

• Safety of prophylactic intracameral moxifloxacin use in cataract surgery.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120601

• Early surgical debridement in the management of infectious scleritis after pterygium excision.

  Journal of ophthalmic inflammation and infection 20120601

• A single-dose placebo- and moxifloxacin-controlled study of the effects of temsirolimus on cardiac repolarization in healthy adults.

  Cancer chemotherapy and pharmacology 20120601

• Inter-individual variability in the pre-clinical drug cardiotoxic safety assessment--analysis of the age-cardiomyocytes electric capacitance dependence.

  Journal of cardiovascular translational research 20120601

• In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.

  Diagnostic microbiology and infectious disease 20120601

• Penetration of moxifloxacin into liver tissue.

  International journal of antimicrobial agents 20120601

• ESBL-positive Enterobacteria isolates in drinking water.

  Emerging infectious diseases 20120601

• LASIK interface-captured foreign bodies after mild traumatic corneal scratch without flap displacement.

  Korean journal of ophthalmology : KJO 20120601

• Moxifloxacin safety: an analysis of 14 years of clinical data.

  Drugs in R&D 20120601

• Besifloxacin ophthalmic suspension, 0.6%: a novel topical fluoroquinolone for bacterial conjunctivitis.

  Advances in therapy 20120601

• In vitro assessment of the cytotoxicity of six topical antibiotics to four cultured ocular surface cell lines.

  Biocontrol science 20120601

• Ciprofloxacin and the risk for cardiac arrhythmias: culprit delicti or watching bystander?

  Acta cardiologica 20120601

• Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120515

• Pharmacokinetics and repolarization effects of intravenous and transdermal granisetron.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20120515

• The electro-mechanical window in anaesthetized guinea pigs: a new marker in screening for Torsade de Pointes risk.

  British journal of pharmacology 20120501

• Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers.

  Cancer chemotherapy and pharmacology 20120501

• Multidrug-resistant North American pulsotype 2 Clostridium difficile was the predominant toxigenic hospital-acquired strain in the province of Manitoba, Canada, in 2006-2007.

  Journal of medical microbiology 20120501

• Activity of sitafloxacin against extracellular and intracellular Staphylococcus aureus in vitro and in vivo: comparison with levofloxacin and moxifloxacin.

  The Journal of antibiotics 20120501

• gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis.

  The Journal of antimicrobial chemotherapy 20120501

• Effects of bilastine on T-wave morphology and the QTc interval: a randomized, double-blind, placebo-controlled, thorough QTc study.

  Clinical drug investigation 20120501

• Tuberculosis: the drug development pipeline at a glance.

  European journal of medicinal chemistry 20120501

• Sensitivities of ciprofloxacin-resistant Mycobacterium tuberculosis clinical isolates to fluoroquinolones: role of mutant DNA gyrase subunits in drug resistance.

  International journal of antimicrobial agents 20120501

• Safety and efficacy of moxifloxacin-dexamethasone eyedrops as treatment for bacterial ocular infection associated with bacterial blepharitis.

  Advances in therapy 20120501

• More efficient ways of assessing treatments for neglected tropical diseases are required: innovative study designs, new endpoints, and markers of effects.

  PLoS neglected tropical diseases 20120501

• Drug use evaluation of moxifloxacin (avelox) using a hand-held electronic device at a canadian teaching hospital.

  P & T : a peer-reviewed journal for formulary management 20120501

• [Evaluation of bacterial colonization of the conjunctival sac in ranibizumab intravitreal injections treated patients].

  Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20120501

• Structure-based design of novel benzoxazinorifamycins with potent binding affinity to wild-type and rifampin-resistant mutant Mycobacterium tuberculosis RNA polymerases.

  Journal of medicinal chemistry 20120426

• Thorough QT/QTc study of ritonavir-boosted saquinavir following multiple-dose administration of therapeutic and supratherapeutic doses in healthy participants.

  Journal of clinical pharmacology 20120401

• Correlation between variable-number tandem-repeat-based genotypes and drug susceptibility in Mycobacterium avium isolates.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20120401

• Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India.

  The European respiratory journal 20120401

• Prophylactic effect of topical fluoroquinolones in a rabbit model of Staphylococcus aureus endophthalmitis.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120401

• Isolation and characterization of small qnrS1-carrying plasmids from imported seafood isolates of Salmonella enterica that are highly similar to plasmids of clinical isolates.

  FEMS immunology and medical microbiology 20120401

• Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU.

  Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20120401

• Antimicrobial resistance of Moraxella catarrhalis isolates in Taiwan.

  Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20120401

• In vivo antibacterial activity of chinfloxacin, a new fluoroquinolone antibiotic.

  The Journal of antimicrobial chemotherapy 20120401

• Characterization of vaginal lactobacilli in women after kidney transplantation.

  Anaerobe 20120401

• Activity of JNJ-Q2, a new fluoroquinolone, tested against contemporary pathogens isolated from patients with community-acquired bacterial pneumonia.

  International journal of antimicrobial agents 20120401

• Moxifloxacin versus placebo modeling of the QT interval.

  Journal of pharmacokinetics and pharmacodynamics 20120401

• Effect of a single supratherapeutic dose of dolutegravir on cardiac repolarization.

  Pharmacotherapy 20120401

• QT effect of semagacestat at therapeutic and supratherapeutic doses.

  International journal of clinical pharmacology and therapeutics 20120401

• Drug susceptibility of Mycobacterium tuberculosis Beijing genotype and association with MDR TB.

  Emerging infectious diseases 20120401

• Essentials for selecting antimicrobial therapy for intra-abdominal infections.

  Drugs 20120401

• Recent perspectives in the diagnosis and evidence-based treatment of Mycoplasma genitalium.

  Expert review of anti-infective therapy 20120401

• Comparison of corneal and aqueous humor penetration of moxifloxacin, gatifloxacin and levofloxacin during keratoplasty.

  Advances in therapy 20120401

• Update on the cardiac safety of moxifloxacin.

  Current drug safety 20120401

• Moxifloxacin-induced hypoglycemia in a non-diabetic patient.

  Current drug safety 20120401

• Trial tests new combination of drugs to treat tuberculosis.

  BMJ (Clinical research ed.) 20120320

• Reevaluation of moxifloxacin pharmacokinetics and their direct effect on the QT interval.

  Journal of clinical pharmacology 20120301

• Pyrazinamide-induced sideroblastic anemia.

  American journal of hematology 20120301

• Treatment failure in pneumonia: impact of antibiotic treatment and cost analysis.

  The European respiratory journal 20120301

• [Maculo-papular exanthem with acute renal failure. Drug-induced hypersensitivity syndrome].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20120301

• Nocardia scleritis-clinical presentation and management: a report of three cases and review of literature.

  Journal of ophthalmic inflammation and infection 20120301

• No evidence of QT prolongation with supratherapeutic doses of aleglitazar.

  Journal of cardiovascular pharmacology 20120301

• Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.

  International journal of antimicrobial agents 20120301

• Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2.

  European journal of medicinal chemistry 20120301

• Antimicrobial susceptibility of Stenotrophomonas maltophilia isolates from a Korean tertiary care hospital.

  Yonsei medical journal 20120301

• Moxifloxacin for tuberculosis.

  The Lancet. Infectious diseases 20120301

• Moxifloxacin for tuberculosis.

  The Lancet. Infectious diseases 20120301

• Use of clarithromycin and adverse cardiovascular events among older patients receiving donepezil: a population-based, nested case-control study.

  Drugs & aging 20120301

• [In vitro antibiotic susceptibility to fluoroquinolones].

  Archivos de la Sociedad Espanola de Oftalmologia 20120301

• Detection of QT prolongation using a novel electrocardiographic analysis algorithm applying intelligent automation: prospective blinded evaluation using the Cardiac Safety Research Consortium electrocardiographic database.

  American heart journal 20120301

• Group B streptococcus mycotic aneurysm of the abdominal aorta: report of a case and review of the literature.

  The Yale journal of biology and medicine 20120301

• PanACEA: a new approach to tuberculosis research.

  The Lancet. Infectious diseases 20120301

• Design and evaluation of moxifloxacin hydrochloride ocular inserts.

  Acta pharmaceutica (Zagreb, Croatia) 20120301

• Development and characterisation of thermo reversible mucoadhesive moxifloxacin hydrochloride in situ ophthalmic gel.

  Journal of pharmacy & bioallied sciences 20120301

• Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions.

  The Journal of infectious diseases 20120215

• Effect of trabectedin on the QT interval in patients with advanced solid tumor malignancies.

  Cancer chemotherapy and pharmacology 20120201

• Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study.

  British journal of clinical pharmacology 20120201

• The steroids for corneal ulcers trial: study design and baseline characteristics.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20120201

• Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).

  Archives of ophthalmology (Chicago, Ill. : 1960) 20120201

• Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120201

• Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitis.

  The Pediatric infectious disease journal 20120201

• In vitro pharmacodynamic evaluation of garenoxacin against quinolone-resistant Streptococcus pneumoniae.

  International journal of antimicrobial agents 20120201

• Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease.

  International journal of antimicrobial agents 20120201

• Occurrence and fate of quinolone and fluoroquinolone antibiotics in a municipal sewage treatment plant.

  Water research 20120201

• Spectrofluorimetric study of the interaction between europium(III) and moxifloxacin in micellar solution and its analytical application.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20120201

• Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine.

  The Journal of antimicrobial chemotherapy 20120201

• Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trial.

  International journal of antimicrobial agents 20120201

• Determination of photostability and photodegradation products of moxifloxacin in the presence of metal ions in solutions and solid phase. Kinetics and identification of photoproducts.

  Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 20120201

• Bilateral methicillin-resistant Staphylococcus aureus keratitis following hyperopic photorefractive surgery.

  International ophthalmology 20120201

• Role of moxifloxacin for the treatment of community-acquired [corrected] complicated intra-abdominal infections in Taiwan.

  Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20120201

• Moxifloxacin monotherapy for treatment of complicated intra-abdominal infections: a meta-analysis of randomised controlled trials.

  International journal of clinical practice 20120201

• Syndrome of inappropriate antidiuretic hormone associated with moxifloxacin.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120201

• Evaluation of gabapentin enacarbil on cardiac repolarization: a randomized, double-blind, placebo- and active-controlled, crossover thorough QT/QTc study in healthy adults.

  Clinical therapeutics 20120201

• [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].

  Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20120201

• Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20120201

• [Sensitivity surveillance of Streptococcus pneumoniae isolates for several antibacterial agents in Gifu and Aichi prefecture (2008-2009)].

  The Japanese journal of antibiotics 20120201

• Structure of Ddn, the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis involved in bioreductive activation of PA-824.

  Structure (London, England : 1993) 20120111

• Current role of community-acquired methicillin-resistant Staphylococcus aureus among children with skin and soft tissue infections.

  Pediatric reports 20120102

• Comparison of the IKr blockers moxifloxacin, dofetilide and E-4031 in five screening models of pro-arrhythmia reveals lack of specificity of isolated cardiomyocytes.

  British journal of pharmacology 20120101

• Optimal dose finding of garenoxacin based on population pharmacokinetics/pharmacodynamics and Monte Carlo simulation.

  European journal of clinical pharmacology 20120101

• Giant fornix syndrome: a case series.

  Ophthalmic plastic and reconstructive surgery 20120101

• Neither moxifloxacin nor cefuroxime produces significant attenuation of inflammatory mediator release in patients exposed to cardiopulmonary bypass: a randomized controlled trial.

  The Journal of antimicrobial chemotherapy 20120101

• Oral bioavailability of moxifloxacin after Roux-en-Y gastric bypass surgery.

  The Journal of antimicrobial chemotherapy 20120101

• Topical ophthalmic moxifloxacin elicits minimal or no selection of fluoroquinolone resistance among bacteria isolated from the skin, nose, and throat.

  Journal of pediatric ophthalmology and strabismus 20120101

• Synthesis and antibacterial activity of naphthyridone derivatives containing mono/difluoro-methyloxime pyrrolidine scaffolds.

  European journal of medicinal chemistry 20120101

• Synthesis of osteotropic hydroxybisphosphonate derivatives of fluoroquinolone antibacterials.

  European journal of medicinal chemistry 20120101

• Wild-type MIC distribution and epidemiological cut-off values in clinical Legionella pneumophila serogroup 1 isolates.

  Diagnostic microbiology and infectious disease 20120101

• Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment.

  Investigative ophthalmology & visual science 20120101

• Comparison of different techniques of cataract surgery in bacterial contamination of the anterior chamber in diabetic and non-diabetic population.

  Indian journal of ophthalmology 20120101

• Evaluation of bleb characteristics after implantation of the EX-PRESS™ glaucoma filtration device.

  Molecular vision 20120101

• Baseline predictors of sputum culture conversion in pulmonary tuberculosis: importance of cavities, smoking, time to detection and W-Beijing genotype.

  PloS one 20120101

• Successful treatment of Chlamydophila pneumoniae acute respiratory distress syndrome with extracorporeal membrane oxygenator: a case report and diagnostic review.

  Journal of medical case reports 20120101

• Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum.

  PLoS pathogens 20120101

• Autoluminescent Mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacy.

  PloS one 20120101

• Candida albicans isolates from the gut of critically ill patients respond to phosphate limitation by expressing filaments and a lethal phenotype.

  PloS one 20120101

• High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009-2010.

  Emerging infectious diseases 20120101

• Mycobacterium riyadhense pulmonary infection, France and Bahrain.

  Emerging infectious diseases 20120101

• Ocular medicines in children: the regulatory situation related to clinical research.

  BMC pediatrics 20120101

• Strategies for treating latent multiple-drug resistant tuberculosis: a decision analysis.

  PloS one 20120101

• Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study.

  PLoS neglected tropical diseases 20120101

• Results at seven years after the use of intracamerular cefazolin as an endophthalmitis prophylaxis in cataract surgery.

  BMC ophthalmology 20120101

• Evaluation of the levofloxacin release characters from a rabbit foldable capsular vitreous body.

  International journal of nanomedicine 20120101

• How 'humane' is your endpoint? Refining the science-driven approach for termination of animal studies of chronic infection.

  PLoS pathogens 20120101

• Descemet's stripping automated endothelial keratoplasty for congenital hereditary endothelial dystrophy.

  Clinical ophthalmology (Auckland, N.Z.) 20120101

• Staphylococcus aureus eye infections in two Indian hospitals: emergence of ST772 as a major clone.

  Clinical ophthalmology (Auckland, N.Z.) 20120101

• Clostridia in premature neonates' gut: incidence, antibiotic susceptibility, and perinatal determinants influencing colonization.

  PloS one 20120101

• Toward a New Gold Standard for Early Safety: Automated Temperature-Controlled hERG Test on the PatchLiner.

  Frontiers in pharmacology 20120101

• Adverse drug reactions in a complementary medicine hospital: a prospective, intensified surveillance study.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• Case series of mycobacterium abscessus infections associated with a trigger point injection and epidural block at a rural clinic.

  Epidemiology and health 20120101

• Chronic necrotizing pulmonary aspergillosis presenting as bilateral pleural effusion: a case report.

  Journal of medical case reports 20120101

• Post-traumatic endophthalmitis with retained intraocular foreign body - a case report with review of literature.

  Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH 20120101

• Trends in tropical medicine research in India.

  Indian journal of pharmacology 20120101

• Short-term visual outcomes of Boston keratoprosthesis type I in saudi arabia.

  Middle East African journal of ophthalmology 20120101

• Plasmid-Mediated Quinolone Resistance; Interactions between Human, Animal, and Environmental Ecologies.

  Frontiers in microbiology 20120101

• Mechanism of Honey Bacteriostatic Action Against MRSA and VRE Involves Hydroxyl Radicals Generated from Honey's Hydrogen Peroxide.

  Frontiers in microbiology 20120101

• Semiautomated QT interval measurement in electrocardiograms from a thorough QT study: comparison of the grouped and ungrouped superimposed median beat methods.

  Journal of electrocardiology 20120101

• Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions.

  Pharmacotherapy 20120101

• Simple and sensitive stability-indicating ion chromatography method for the determination of cyclopropylamine in nevirapine and moxifloxacin hydrochloride drug substances.

  Scientia pharmaceutica 20120101

• Streptococcus pneumoniae: susceptibility to penicillin and moxifloxacin.

  Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 20120101

• Rhodococcus bacteremia in cancer patients is mostly catheter related and associated with biofilm formation.

  PloS one 20120101

• Capsaicin protects mice from community-associated methicillin-resistant Staphylococcus aureus pneumonia.

  PloS one 20120101

• Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan.

  Substance abuse treatment, prevention, and policy 20120101

• Unilateral conjunctival ulcer due to Stenotrophomonas maltophilia infection.

  Indian journal of ophthalmology 20120101

• Short-term outcome of Boston Type 1 keratoprosthesis for bilateral limbal stem cell deficiency.

  Indian journal of ophthalmology 20120101

• Efficacy of directly observed treatment short-course intermittent regimen in spinal tuberculosis.

  Indian journal of orthopaedics 20120101

• Clostridium difficile genotypes other than ribotype 078 that are prevalent among human, animal and environmental isolates.

  BMC microbiology 20120101

• SCCmec Type IX Element in Methicillin Resistant Staphylococcusaureusspa Type t337 (CC9) Isolated from Pigs and Pork in Thailand.

  Frontiers in microbiology 20120101

• Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review.

  PloS one 20120101

• Multiple Pyogenic Liver Abscesses Caused by Eggerthella lenta Treated with Ertapenem: A Case Report.

  Case reports in medicine 20120101

• European ST80 community-associated methicillin-resistant Staphylococcus aureus orbital cellulitis in a neonate.

  BMC ophthalmology 20120101

• Interaction of avelox with bovine serum albumin and effect of the coexistent drugs on the reaction.

  International journal of analytical chemistry 20120101

• Bleb morphology and histology in a rabbit model of glaucoma filtration surgery using Ozurdex® or mitomycin-C.

  Molecular vision 20120101

• Inhibition of VEGF expression and corneal neovascularization by shRNA targeting HIF-1α in a mouse model of closed eye contact lens wear.

  Molecular vision 20120101

• Salmonella paratyphi neck abscess.

  Journal of global infectious diseases 20120101

• Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis.

  PloS one 20120101

• The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace.

  Frontiers in microbiology 20120101

• Rescue Therapy for Helicobacter pylori Infection 2012.

  Gastroenterology research and practice 20120101

• Initial experience with Descemet stripping automated endothelial keratoplasty in Saudi Arabia.

  Oman journal of ophthalmology 20120101

• High genetic diversity among community-associated Staphylococcus aureus in Europe: results from a multicenter study.

  PloS one 20120101

• Moxifloxacin (avelox) induced thrombotic thrombocytopenic purpura.

  Case reports in medicine 20120101

• High-performance liquid chromatography assay for moxifloxacin in brain tissue and plasma: validation in a pharmacokinetic study in a murine model of cerebral listeriosis.

  Journal of analytical methods in chemistry 20120101

• A case of endophthalmitis associated with limbal relaxing incision.

  Indian journal of ophthalmology 20120101

• Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infections.

  BMC infectious diseases 20120101

• Differential epigenetic compatibility of qnr antibiotic resistance determinants with the chromosome of Escherichia coli.

  PloS one 20120101

• Do β-defensins and other antimicrobial peptides play a role in neuroimmune function and neurodegeneration?

  TheScientificWorldJournal 20120101

• Necrotizing keratitis after laser refractive surgery in patients with inactive inflammatory bowel disease.

  Case reports in ophthalmology 20120101

• Acute retinal necrosis after Boston type I keratoprosthesis.

  Middle East African journal of ophthalmology 20120101

• Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome.

  PloS one 20120101

• Relationship between Gram negative enteric rods, Aggregatibacter actinomycetemcomitans, and clinical parameters in periodontal disease.

  Journal of Indian Society of Periodontology 20120101

• Cardiorenal syndrome: Resistant to diuretics, sensitive to ultraflitration.

  Journal of cardiovascular disease research 20120101

• Concomitant pulmonary tuberculosis in hospitalized healthcare-associated pneumonia in a tuberculosis endemic area: a multi-center retrospective study.

  PloS one 20120101

• Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence.

  PloS one 20120101

• Successful salvage therapy of Fusarium endophthalmitis secondary to keratitis: an interventional case series.

  Clinical ophthalmology (Auckland, N.Z.) 20120101

• Efficacy of a 'Rescue' Ciprofloxacin-Based Regimen for Eradication of Helicobacter pylori Infection after Treatment Failures.

  Gastroenterology research and practice 20120101

• Plectranthus amboinicus and Centella asiatica Cream for the Treatment of Diabetic Foot Ulcers.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• Discovery of a novel hsp65 genotype within Mycobacterium massiliense associated with the rough colony morphology.

  PloS one 20120101

• In vitro antibacterial activity of chinfloxacin, a new fluoroquinolone antibiotic.

  Chemotherapy 20120101

• Uncontrolled penile erection and increased sexual desire with intravenous moxifloxacin.

  Indian journal of pharmacology 20120101

• Safety of besifloxacin ophthalmic suspension 0.6% as a prophylactic antibiotic following routine cataract surgery: results of a prospective, parallel-group, investigator-masked study.

  Clinical ophthalmology (Auckland, N.Z.) 20120101

• Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer.

  Infectious agents and cancer 20120101

• Leukocytoclastic vasculitis induced by Mycoplasma pneumoniae infection.

  Acta dermatovenerologica Croatica : ADC 20120101

• New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations.

  PloS one 20120101

• Mass spectrometic study of speciation in aluminium-fluoroquinolone solutions.

  European journal of mass spectrometry (Chichester, England) 20120101

• Good penetration of moxifloxacin into human abscesses.

  Pharmacology 20120101

• The first case of cutaneous infection with Mycobacterium parascrofulaceum.

  Therapeutics and clinical risk management 20120101

• Stability indicating HPLC method for the simultaneous determination of moxifloxacin and prednisolone in pharmaceutical formulations.

  Chemistry Central journal 20120101

• Assessment of the sensitivity of detecting drug-induced QTc changes using subject-specific rate correction.

  Journal of electrocardiology 20120101

• New treatments for bacterial keratitis.

  Journal of ophthalmology 20120101

• [Microbiological monitoring in therapy of patients with iatrogenic esophageotracheal fistula].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20120101

• The Cardiac Safety Research Consortium ECG database.

  Journal of electrocardiology 20120101

• Radiological followup of the evolution of inflammatory process in sacroiliac joint with magnetic resonance imaging: a case with pyogenic sacroiliitis.

  Case reports in rheumatology 20120101

• Kinetic and thermodynamic studies of moxifloxacin hydrolysis in the presence and absence of metal ions in acidic solutions.

  Acta poloniae pharmaceutica 20120101

• [Assessment of susceptibility of strictly anaerobic bacteria originated from different sources to fluoroquinolones and other antimicrobial drugs].

  Medycyna doswiadczalna i mikrobiologia 20120101

• High quality draft genome sequence of Segniliparus rugosus CDC 945(T)= (ATCC BAA-974(T)).

  Standards in genomic sciences 20111231

• Modulation of the expression of ABC transporters in murine (J774) macrophages exposed to large concentrations of the fluoroquinolone antibiotic moxifloxacin.

  Toxicology 20111218

• Synthesis, characterization and antimicrobial investigation of some moxifloxacin metal complexes.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20111215

• Mycoplasma genitalium: should we treat and how?

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20111215

• [Development of subcutaneous nodules after mesotherapy].

  Enfermedades infecciosas y microbiologia clinica 20111201

• Stenotrophomonas maltophilia in cystic fibrosis: improved detection by the use of selective agar and evaluation of antimicrobial resistance.

  Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 20111201

• In vitro activity of ceftobiprole and seven other antimicrobial agents against invasive Streptococcus pneumoniae isolates in Spain.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20111201

• Treatment of experimental Bacillus cereus endophthalmitis using intravitreal moxifloxacin with or without dexamethasone.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20111201

• Antimicrobial resistance profiles of ocular and nasal flora in patients undergoing intravitreal injections.

  American journal of ophthalmology 20111201

• [Helicobacter pylori eradication therapy in Korea].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20111201

• [Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20111201

• Comparative in vitro activity of finafloxacin against staphylococci displaying normal and small colony variant phenotypes.

  The Journal of antimicrobial chemotherapy 20111201

• Surveillance of JNJ-Q2 activity tested against Staphylococcus aureus and beta-hemolytic streptococci as a component of the 2010 SENTRY Antimicrobial Surveillance Program.

  Diagnostic microbiology and infectious disease 20111201

• Synthesis and in-vitro antimycobacterial activity of fluoroquinolone derivatives containing a coumarin moiety.

  Archiv der Pharmazie 20111201

• Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20111201

• A novel hemotropic Mycoplasma (hemoplasma) in a patient with hemolytic anemia and pyrexia.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20111201

• Randomized trial on 14 versus 7 days of esomeprazole, moxifloxacin, and amoxicillin for second-line or rescue treatment of Helicobacter pylori infection.

  Helicobacter 20111201

• European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009).

  The Journal of antimicrobial chemotherapy 20111201

• Moxifloxacin relieves the persistent symptoms of lower urinary tract after cessation of ketamine abuse.

  Hong Kong medical journal = Xianggang yi xue za zhi 20111201

• [Diagnosis and treatment of atypical mycobacterial infections of the respiratory tract].

  Revue des maladies respiratoires 20111201

• In vitro comparison of the cytotoxic effects of clinically available ophthalmic solutions of fluoroquinolones on human keratocytes.

  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20111201

• Otomastoiditis with acute left facial nerve paralysis caused by Mycobacterium chelonae.

  Ear, nose, & throat journal 20111201

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• Simple and rapid liquid chromatography method for determination of moxifloxacin in saliva.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20111115

• Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010.

  International journal of antimicrobial agents 20111101

• A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections.

  The Journal of antimicrobial chemotherapy 20111101

• Exploiting bacterial DNA gyrase as a drug target: current state and perspectives.

  Applied microbiology and biotechnology 20111101

• Effect of nalmefene 20 and 80 mg on the corrected QT interval and T-wave morphology: a randomized, double-blind, parallel-group, placebo- and moxifloxacin-controlled, single-centre study.

  Clinical drug investigation 20111101

• Moxifloxacin as an alternative or additive therapy for treatment of pulmonary tuberculosis.

  The Annals of pharmacotherapy 20111101

• Alcaligenes xylosoxidans contact lens-related keratitis--a case report and literature review.

  Eye & contact lens 20111101

• Thorough QT/QTc study of tocilizumab after single-dose administration at therapeutic and supratherapeutic doses in healthy subjects.

  International journal of clinical pharmacology and therapeutics 20111101

• Vancomycin, ceftazidime, and moxifloxacin can be safely stored in single-use, polypropylene syringes.

  Retina (Philadelphia, Pa.) 20111101

• International spread of MDR TB from Tugela Ferry, South Africa.

  Emerging infectious diseases 20111101

• Mycobacterium indicus pranii as stand-alone or adjunct immunotherapeutic in treatment of experimental animal tuberculosis.

  The Indian journal of medical research 20111101

• 6-Benzyl-6,7-dihydro-5H-pyrrolo-[3,4-b]pyridine-5,7-dione.

  Acta crystallographica. Section E, Structure reports online 20111101

• Determination of quinolone residues in infant and young children powdered milk combining solid-phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry.

  Journal of chromatography. A 20111021

• Synthesis and structure-activity relationships of novel substituted 8-amino, 8-thio, and 1,8-pyrazole congeners of antitubercular rifamycin S and rifampin.

  Bioorganic & medicinal chemistry letters 20111015

• Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience.

  The European respiratory journal 20111001

• Tuberculous hepatic abscess appearing after liver transplantation in a patient with human immunodeficiency virus and hepatitis B and C virus co-infection.

  Transplant infectious disease : an official journal of the Transplantation Society 20111001

• Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999-2006.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20111001

• Life-threatening disseminated tuberculosis as a complication of TNF-α blockade in an adolescent.

  European journal of pediatrics 20111001

• Isoniazid-resistant intracranial tuberculoma treated with a combination of moxifloxacin and first-line anti-tuberculosis medication.

  Journal of medical microbiology 20111001

• Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patients.

  The Journal of antimicrobial chemotherapy 20111001

• Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model.

  The Journal of antimicrobial chemotherapy 20111001

• Multidrug resistance in European Clostridium difficile clinical isolates.

  The Journal of antimicrobial chemotherapy 20111001

• Pre-clinical studies of a new quinolone (UB-8902) against Acinetobacter baumannii resistant to ciprofloxacin.

  International journal of antimicrobial agents 20111001

• Mooren's-type ulceration associated with severe hidradenitis suppurativa: a case report and literature review.

  Ocular immunology and inflammation 20111001

• Microbiology at first visit of moderate-to-severe diabetic foot infection with antimicrobial activity and a survey of quinolone monotherapy.

  Diabetes research and clinical practice 20111001

• Bilateral microbial keratitis in highly active antiretroviral therapy-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a case series.

  Ocular immunology and inflammation 20111001

• Efficacy and safety of moxifloxacin for community-acquired bacterial pneumonia based on pharmacokinetic analysis.

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20111001

• Ophthalmic antibiotic use and multidrug-resistant staphylococcus epidermidis: a controlled, longitudinal study.

  Ophthalmology 20111001

• Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review.

  Drug safety 20111001

• Primary antibiotic resistance of Helicobacter pylori isolated from Beijing children.

  Helicobacter 20111001

• A thorough QT study to evaluate the effects of singledose exenatide 10 μg on cardiac repolarization in healthy subjects.

  International journal of clinical pharmacology and therapeutics 20111001

• Chronic rhinosinusitis: therapeutic efficacy of anti-inflammatory and antibiotic approaches.

  Allergy, asthma & immunology research 20111001

• A case of Stenotrophomonas maltophilia keratitis effectively treated with moxifloxacin.

  Korean journal of ophthalmology : KJO 20111001

• Bilateral acute iris transillumination.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20111001

• Prevalence, enumeration, and antimicrobial agent resistance of Clostridium difficile in cattle at harvest in the United States.

  Journal of food protection 20111001

• Prevalence of plasmid-mediated quinolone resistance and its association with extended-spectrum beta-lactamase and AmpC beta-lactamase in Enterobacteriaceae.

  The Korean journal of laboratory medicine 20111001

• Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital.

  Journal of Korean medical science 20111001

• The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile.

  PLoS pathogens 20111001

• Moxifloxacinium chloride monohydrate.

  Acta crystallographica. Section E, Structure reports online 20111001

• Moxifloxacin-Gelrite in situ ophthalmic gelling system against photodynamic therapy for treatment of bacterial corneal inflammation.

  Archives of pharmacal research 20111001

• [Helicobacter pylori-related diseases: dyspepsia, ulcers and gastric cancer].

  Gastroenterologia y hepatologia 20111001

• Aqueous humour penetration of moxifloxocin and gatifloxacin eye drops in different dosing regimens before phacoemulsification surgery.

  The British journal of ophthalmology 20110901

• Antibiotic therapy for acute Q fever in The Netherlands in 2007 and 2008 and its relation to hospitalization.

  Epidemiology and infection 20110901

• [Microbiological analysis in contact lens-associated keratits].

  Klinische Monatsblatter fur Augenheilkunde 20110901

• A supratherapeutic dose of the Janus kinase inhibitor tasocitinib (CP-690,550) does not prolong QTc interval in healthy participants.

  Journal of clinical pharmacology 20110901

• Antibiotic susceptibility of cocultures in polymicrobial infections such as peri-implantitis or periodontitis: an in vitro model.

  Journal of periodontology 20110901

• Bacteriological findings and antimicrobial resistance in odontogenic and non-odontogenic chronic maxillary sinusitis.

  Journal of medical microbiology 20110901

• PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates.

  The Journal of antimicrobial chemotherapy 20110901

• In vitro and in vivo antibacterial activities of garenoxacin against group G Streptococcus dysgalactiae subsp. equisimilis.

  International journal of antimicrobial agents 20110901

• Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy.

  Expert opinion on drug metabolism & toxicology 20110901

• Cellular accumulation of fluoroquinolones is not predictive of their intracellular activity: studies with gemifloxacin, moxifloxacin and ciprofloxacin in a pharmacokinetic/pharmacodynamic model of uninfected and infected macrophages.

  International journal of antimicrobial agents 20110901

• The use of beat-to-beat electrocardiogram analysis to distinguish QT/QTc interval changes caused by moxifloxacin from those caused by vardenafil.

  Clinical pharmacology and therapeutics 20110901

• Moxifloxacin-dependent Torsades de Pointes.

  Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20110901

• Single-agent, broad-spectrum fluoroquinolones for the outpatient treatment of low-risk febrile neutropenia.

  The Annals of pharmacotherapy 20110901

• Tattoo-associated Mycobacterium haemophilum skin infection in immunocompetent adult, 2009.

  Emerging infectious diseases 20110901

• Hepatotoxicity in the treatment of tuberculosis using moxifloxacin-containing regimens.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20110901

• The activity of several newer antimicrobials against logarithmically multiplying M. leprae in mice.

  Leprosy review 20110901

• Evaluation of the effect of dapagliflozin on cardiac repolarization: a thorough QT/QTc study.

  Diabetes therapy : research, treatment and education of diabetes and related disorders 20110901

• [The effect of moxifloxacin on apoptosis of airway smooth muscle cells and mitochondria membrane potential].

  Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20110901

• Oxidized multi-walled carbon nanotubes for the dispersive solid-phase extraction of quinolone antibiotics from water samples using capillary electrophoresis and large volume sample stacking with polarity switching.

  Journal of chromatography. A 20110805

• Bacteraemia caused by Weissella confusa at a university hospital in Taiwan, 1997-2007.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20110801

• In vitro activity of multiple antibiotic combinations against Nocardia: relationship with a short-term treatment strategy in heart transplant recipients with pulmonary nocardiosis.

  Transplant infectious disease : an official journal of the Transplantation Society 20110801

• Population pharmacokinetic and concentration--QTc models for moxifloxacin: pooled analysis of 20 thorough QT studies.

  Journal of clinical pharmacology 20110801

• Assessing the ecotoxicologic hazards of a pandemic influenza medical response.

  Environmental health perspectives 20110801

• Multi-drug resistant Bacteroides fragilis recovered from blood and severe leg wounds caused by an improvised explosive device (IED) in Afghanistan.

  Anaerobe 20110801

• Characterization and antimicrobial susceptibility of Clostridium difficile strains isolated from adult patients with diarrhoea hospitalized in two university hospitals in Poland, 2004-2006.

  Journal of medical microbiology 20110801

• Susceptibility of hamsters to infection by historic and epidemic BI Clostridium difficile strains during daily administration of three fluoroquinolones.

  Anaerobe 20110801

• Effect of gatifloxacin against Mycoplasma genitalium-related urethritis: an open clinical trial.

  Sexually transmitted infections 20110801

• Low rate of fluoroquinolone resistance in Mycobacterium tuberculosis isolates from northern Tanzania.

  The Journal of antimicrobial chemotherapy 20110801

• Synthesis and in-vitro antibacterial activity of 7-(3-aminopyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivatives.

  Archiv der Pharmazie 20110801

• Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009.

  Anaerobe 20110801

• Synthesis and evaluation of 1-cyclopropyl-2-thioalkyl-8-methoxy fluoroquinolones.

  Bioorganic & medicinal chemistry letters 20110801

• Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: a pilot study.

  AJR. American journal of roentgenology 20110801

• [Current value of quinolones in Helicobacter pylori therapy].

  Zeitschrift fur Gastroenterologie 20110801

• The TB Alliance: overcoming challenges to chart the future course of TB drug development.

  Future medicinal chemistry 20110801

• Risk factors of postoperative pneumonia after lung cancer surgery.

  Journal of Korean medical science 20110801

• Contact-lens-related corneal ulcer caused by Klebsiella pneumoniae.

  Clinics (Sao Paulo, Brazil) 20110801

• Prevalence of and Risk Factors for Levofloxacin-Resistant E. coli Isolated from Outpatients with Urinary Tract Infection.

  Korean journal of urology 20110801

• Clarithromycin and amikacin vs. clarithromycin and moxifloxacin for the treatment of post-acupuncture cutaneous infections due to Mycobacterium abscessus: a prospective observational study.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20110701

• Creation of a knowledge management system for QT analyses.

  Journal of clinical pharmacology 20110701

• Interface blood after descemet stripping automated endothelial keratoplasty.

  Cornea 20110701

• The DPP-4 inhibitor linagliptin does not prolong the QT interval at therapeutic and supratherapeutic doses.

  British journal of clinical pharmacology 20110701

• T-wave morphology abnormalities in benign, potent, and arrhythmogenic I(kr) inhibition.

  Heart rhythm 20110701

• Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections.

  Ophthalmology 20110701

• Mycobacterium tuberculosis and cholinesterase inhibitors from Voacanga globosa.

  European journal of medicinal chemistry 20110701

• Supra-therapeutic doses of roflumilast have no effect on cardiac repolarization in healthy subjects.

  Expert opinion on drug safety 20110701

• Hepatic safety of antibiotics used in primary care.

  The Journal of antimicrobial chemotherapy 20110701

• Thorough QT study of the effects of vildagliptin, a dipeptidyl peptidase IV inhibitor, on cardiac repolarization and conduction in healthy volunteers.

  Current medical research and opinion 20110701

• Microbiological efficacy of a new ophthalmic formulation of moxifloxacin dosed twice-daily for bacterial conjunctivitis.

  Advances in therapy 20110701

• Interaction study of moxifloxacin and lomefloxacin with co-administered drugs.

  Pakistan journal of pharmaceutical sciences 20110701

• A placebo- and active-controlled assessment of 6- and 50-mg oral doxepin on cardiac repolarization in healthy volunteers: a thorough QT evaluation.

  Clinical therapeutics 20110701

• Effect of topical immunomodulatory interleukin 1 receptor antagonist therapy on corneal healing in New Zealand white rabbits (Oryctolagus cunniculus) after photorefractive keratectomy.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20110701

• Emergence of Clostridium difficile ribotype 027 in Korea.

  The Korean journal of laboratory medicine 20110701

• [The effectiveness of intraocular delivery of 5-fluoroquinolones for prophylaxis of intraocular infection].

  Voenno-meditsinskii zhurnal 20110701

• Extensively drug-resistant tuberculosis: New Zealand's first case and the challenges of management in a low-prevalence country.

  The Medical journal of Australia 20110606

• Effect of number of replicate electrocardiograms recorded at each time point in a thorough QT study on sample size and study cost.

  Journal of clinical pharmacology 20110601

• Aclidinium bromide, a long-acting antimuscarinic, does not affect QT interval in healthy subjects.

  Journal of clinical pharmacology 20110601

• Incidence, occurrence rate, and characteristics of suture-related corneal infections after penetrating keratoplasty.

  Cornea 20110601

• Clinical and histopathologic features of fluoroquinolone-induced liver injury.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20110601

• Facile transformation of Biginelli pyrimidin-2(1H)-ones to pyrimidines. In vitro evaluation as inhibitors of Mycobacterium tuberculosis and modulators of cytostatic activity.

  European journal of medicinal chemistry 20110601

• Preventing endophthalmitis after cataract surgeries.

  The British journal of ophthalmology 20110601

• Fatal Pseudomonas aeruginosa pneumonia in a previously healthy woman was most likely associated with a contaminated hot tub.

  Infection 20110601

• Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin.

  International journal of antimicrobial agents 20110601

• Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-4-amino-4-methylpiperidin-1-yl) fluoroquinolone derivatives.

  European journal of medicinal chemistry 20110601

• Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance.

  European journal of gastroenterology & hepatology 20110601

• Limited-sampling strategies for therapeutic drug monitoring of moxifloxacin in patients with tuberculosis.

  Therapeutic drug monitoring 20110601

• A review of the epidemiology, diagnosis and evidence-based management of Mycoplasma genitalium.

  Sexual health 20110601

• Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application.

  Journal of cataract and refractive surgery 20110601

• Conventional Epi-LASIK and lamellar epithelial debridement in myopic patients with dermatologic keloids.

  Korean journal of ophthalmology : KJO 20110601

• Diagnosis and management of community-acquired pneumonia in adults.

  American family physician 20110601

• Intravenous moxifloxacin. Even more harmful than the oral form.

  Prescrire international 20110601

• Retrospective comparison of levofloxacin and moxifloxacin on multidrug-resistant tuberculosis treatment outcomes.

  The Korean journal of internal medicine 20110601

• Evidence-based guidelines for empirical therapy of neutropenic fever in Korea.

  The Korean journal of internal medicine 20110601

• Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies.

  PLoS medicine 20110601

• Thrombocytopenia, INR prolongation and fall in fibrinogen under daptomycin.

  Journal of chemotherapy (Florence, Italy) 20110601

• Binary toxin and death after Clostridium difficile infection.

  Emerging infectious diseases 20110601

• High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteremia.

  Emerging infectious diseases 20110601

• [Activity of macrolides and fluoroquinolones against intracellular Legionella pneumophila].

  Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20110601

• Molecular epidemiology of clostridium difficile in a tertiary medical center in Israel: emergence of the polymerase chain reaction ribotype 027.

  The Israel Medical Association journal : IMAJ 20110601

• [Tuberculous meningitis: tips for diagnosis and proposals for treatment].

  Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 20110601

• Immunoasssay chromatographic antigen test for rapid diagnosis of Group A beta hemolytic Streptococcus pharyngitis in children: A cross/ sectional study.

  Iranian journal of microbiology 20110601

• Exploration of the activity of 7-pyrrolidino-8-methoxyisothiazoloquinolones against methicillin-resistant Staphylococcus aureus (MRSA).

  Journal of medicinal chemistry 20110512

• Selenophene-containing inhibitors of type IIA bacterial topoisomerases.

  Journal of medicinal chemistry 20110512

• Mycobacterium avium ssp. hominissuis biofilm is composed of distinct phenotypes and influenced by the presence of antimicrobials.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20110501

• Effects of levofloxacin, moxifloxacin and prulifloxacin on murine gut colonization by Candida albicans.

  Medical mycology 20110501

• Healthcare-associated bacteraemia caused by Leuconostoc species at a university hospital in Taiwan between 1995 and 2008.

  The Journal of hospital infection 20110501

• Modelling biphasic killing of fluoroquinolones: guiding optimal dosing regimen design.

  The Journal of antimicrobial chemotherapy 20110501

• Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110501

• Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110501

• Effect of efflux pump inhibitors on drug susceptibility of ofloxacin resistant Mycobacterium tuberculosis isolates.

  The Indian journal of medical research 20110501

• Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women.

  PLoS pathogens 20110501

• Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients.

  British journal of cancer 20110426

• Synthesis and biological evaluation of tetracyclic thienopyridones as antibacterial and antitumor agents.

  Bioorganic & medicinal chemistry 20110415

• Molecular epidemiology and susceptibility profiles of Clostridium difficile in New Zealand, 2009.

  The New Zealand medical journal 20110415

• A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer.

  Cancer chemotherapy and pharmacology 20110401

• Effects of antibiotics on Chlamydia trachomatis viability as determined by real-time quantitative PCR.

  Journal of medical microbiology 20110401

• IL-5 release of CD4+ non-effector lymphocytes is increased in COPD--modulating effects of moxifloxacin and dexamethasone.

  International immunopharmacology 20110401

• Radiosynthesis and biological evaluation of the (99m)Tc-tricarbonyl moxifloxacin dithiocarbamate complex as a potential Staphylococcus aureus infection radiotracer.

  Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20110401

• Impact of pH on bacterial growth and activity of recent fluoroquinolones in pooled urine.

  Research in microbiology 20110401

• The epidemiology of Clostridium difficile in Scotland.

  The Journal of infection 20110401

• A rare case of peripartum endogenous bacterial endophthalmitis.

  International ophthalmology 20110401

• Comparative in vitro and in vivo antimicrobial activities of sitafloxacin, gatifloxacin and moxifloxacin against Mycobacterium avium.

  International journal of antimicrobial agents 20110401

• Novel thiolactone-isatin hybrids as potential antimalarial and antitubercular agents.

  Bioorganic & medicinal chemistry letters 20110401

• Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community.

  The Journal of antimicrobial chemotherapy 20110401

• In vitro time-kill experiments with besifloxacin, moxifloxacin and gatifloxacin in the absence and presence of benzalkonium chloride.

  The Journal of antimicrobial chemotherapy 20110401

• Moxifloxacin-containing triple therapy versus bismuth-containing quadruple therapy for second-line treatment of Helicobacter pylori infection: a meta-analysis.

  Helicobacter 20110401

• Fluoroquinolone use is not associated with the change in imipenem susceptibility of Pseudomonas aeruginosa in 25 hospitals.

  Advances in therapy 20110401

• Rational use of moxifloxacin for tuberculosis treatment.

  The Lancet. Infectious diseases 20110401

• Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20110401

• Mycobacterium bolletii/Mycobacterium massiliense furunculosis associated with pedicure footbaths: a report of 3 cases.

  Archives of dermatology 20110401

• [Regional difference of antibiotic resistance of helicobacter pylori strains in Korea].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20110401

• Pharmacokinetic/pharmacodynamic-based treatment of disseminated Mycobacterium avium.

  Future microbiology 20110401

• Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin.

  Journal of chemotherapy (Florence, Italy) 20110401

• Evaluation of the effect of bacterial efflux pumps on the antibacterial activity of the novel fluoroquinolone besifloxacin.

  Journal of chemotherapy (Florence, Italy) 20110401

• Comparison of the chromatographic behavior of levofloxacin, ciprofloxacin and moxifloxacin on various HPLC phases.

  Die Pharmazie 20110401

• [Comparative evaluation of e-test and disk diffusion methods for susceptibility testing of Nocardia species].

  Mikrobiyoloji bulteni 20110401

• Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis.

  Investigative ophthalmology & visual science 20110325

• Synthesis and in vitro antibacterial activity of 7-(3-amino-6,7-dihydro-2-methyl-2H-pyrazolo[4,3-c] pyridin-5(4H)-yl)fluoroquinolone derivatives.

  Molecules (Basel, Switzerland) 20110322

• [Practical ECG problems in the elderly patient. Case number 16. Moxifloxacin-associated QT interval prolongation].

  Revue medicale suisse 20110316

• Synthesis, characterization and anti-tumor activity of moxifloxacin-copper complexes against breast cancer cell lines.

  Bioorganic & medicinal chemistry letters 20110315

• High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions.

  Analytical chemistry 20110315

• Geographical clustering of cases of infection with moxifloxacin-resistant Clostridium difficile PCR-ribotypes 012, 017 and 046 in Sweden, 2008 and 2009.

  Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20110310

• Enterococcus gallinarum meningitis: a case report and literature review.

  Journal of infection in developing countries 20110304

• Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20110301

• Perioperative moxifloxacin treatment in rats subjected to deep hypothermic circulatory arrest: reduction in cerebral inflammation but without improvement in cognitive performance.

  The Journal of thoracic and cardiovascular surgery 20110301

• Antimicrobial resistance profile of Staphylococcus aureus isolated from clinical samples and foods of animal origin.

  Foodborne pathogens and disease 20110301

• Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, levofloxacin and amoxicillin/clavulanic acid.

  The Journal of antimicrobial chemotherapy 20110301

• Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpoint.

  The Journal of antimicrobial chemotherapy 20110301

• Moxifloxacin monotherapy versus ß-lactam mono- or combination therapy in hospitalized patients with community-acquired pneumonia.

  The Journal of infection 20110301

• Moxifloxacin and pyrazinamide susceptibility testing in a complex case of multidrug-resistant tuberculosis.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20110301

• Tear, cornea, and aqueous humor concentrations of ciprofloxacin and moxifloxacin after topical ocular application in ophthalmologically normal horses.

  American journal of veterinary research 20110301

• Epidemiology of Mycobacterium bovis disease in humans, The Netherlands, 1993-2007.

  Emerging infectious diseases 20110301

• Molecular epidemiology of Mycobacterium tuberculosis, Buenos Aires, Argentina.

  Emerging infectious diseases 20110301

• New drugs for tuberculosis treatment.

  Enfermedades infecciosas y microbiologia clinica 20110301

• Torticollis in mice intravenously infected with Mycobacterium tuberculosis.

  Journal of the American Association for Laboratory Animal Science : JAALAS 20110301

• Recent developments in treatment of latent tuberculosis infection.

  The Indian journal of medical research 20110301

• Should quinolones come first in Helicobacter pylori therapy?

  Therapeutic advances in gastroenterology 20110301

• Enzymatic quorum quenching increases antibiotic susceptibility of multidrug resistant Pseudomonas aeruginosa.

  Iranian journal of microbiology 20110301

• Detection of cross-infection associated to a Brazilian PCR-ribotype of Clostridium difficile in a university hospital in Rio de Janeiro, Brazil.

  Antonie van Leeuwenhoek 20110201

• In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones.

  Allergy 20110201

• Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort.

  European journal of clinical pharmacology 20110201

• Response of Gardnerella vaginalis biofilm to 5 days of moxifloxacin treatment.

  FEMS immunology and medical microbiology 20110201

• Characterization of toxin genes and antimicrobial susceptibility of Staphylococcus aureus isolates from Louisiana retail meats.

  Foodborne pathogens and disease 20110201

• Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa.

  Dermatology (Basel, Switzerland) 20110201

• Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolated from the eye.

  Current eye research 20110201

• Year in review in Intensive Care Medicine 2010: II. Pneumonia and infections, cardiovascular and haemodynamics, organization, education, haematology, nutrition, ethics and miscellanea.

  Intensive care medicine 20110201

• Moxifloxacin-tetracycline-lansoprazole triple therapy for first-line treatment of Helicobacter pylori infection: a prospective study.

  Helicobacter 20110201

• Segniliparus rugosus-associated bronchiolitis in California sea lion.

  Emerging infectious diseases 20110201

• Surface layer protein A variant of Clostridium difficile PCR-ribotype 027.

  Emerging infectious diseases 20110201

• Clinical effectiveness and safety of gemifloxacin versus cefpodoxime in acute exacerbation of chronic bronchitis: A randomized, controlled trial.

  Indian journal of pharmacology 20110201

• Severe isoniazid related sideroblastic anemia.

  Hematology reports 20110113

• Susceptibility of rapidly growing mycobacteria isolated from cats and dogs, to ciprofloxacin, enrofloxacin and moxifloxacin.

  Veterinary microbiology 20110110

• Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis.

  Investigative ophthalmology & visual science 20110105

• Inter-α inhibitor proteins: a novel therapeutic strategy for experimental anthrax infection.

  Shock (Augusta, Ga.) 20110101

• Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear Infirmary.

  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20110101

• Low prevalence of fluoroquinolone resistant strains and resistance precursor strains in Streptococcus pneumoniae from patients with community-acquired pneumonia despite high fluoroquinolone usage.

  International journal of medical microbiology : IJMM 20110101

• Epidemiology of Streptococcus pneumoniae and Staphylococcus aureus colonization in healthy Venezuelan children.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20110101

• Status epilepticus attributed to moxifloxacin in an adolescent patient with spina bifida occulta.

  European journal of clinical pharmacology 20110101

• Efficacy and safety of adjunctive local moxifloxacin delivery in the treatment of periodontitis.

  Journal of periodontology 20110101

• Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis.

  Cornea 20110101

• What's in a Name? Can Mullein Weed Beat TB Where Modern Drugs Are Failing?

  Evidence-based complementary and alternative medicine : eCAM 20110101

• Effect of fluoroquinolones on the expression of matrix metalloproteinase in debrided cornea of rats.

  Toxicology mechanisms and methods 20110101

• Modulation of Salmonella gene expression by subinhibitory concentrations of quinolones.

  The Journal of antibiotics 20110101

• Reduced levofloxacin susceptibility in clinical respiratory isolates of Haemophilus influenzae is not yet associated with mutations in the DNA gyrase and topoisomerase II genes in Korea.

  Yonsei medical journal 20110101

• Moxifloxacin 0.5% ophthalmic solution: in bacterial conjunctivitis.

  Drugs 20110101

• Effects of multistrain probiotic-containing yogurt on second-line triple therapy for Helicobacter pylori infection.

  Journal of gastroenterology and hepatology 20110101

• Relevance of aqueous humor concentrations of fluoroquinolones.

  Journal of cataract and refractive surgery 20110101

• Treatment outcome and mortality among patients with multidrug-resistant tuberculosis in tuberculosis hospitals of the public sector.

  Journal of Korean medical science 20110101

• WSES consensus conference: Guidelines for first-line management of intra-abdominal infections.

  World journal of emergency surgery : WJES 20110101

• Treatment of disseminated mycobacterial infection with high-dose IFN-γ in a patient with IL-12Rβ1 deficiency.

  Clinical & developmental immunology 20110101

• Comparison of 5 methods of QT interval measurements on electrocardiograms from a thorough QT/QTc study: effect on assay sensitivity and categorical outliers.

  Journal of electrocardiology 20110101

• Eosinophilic pneumonia associated with daptomycin: a case report and a review of the literature.

  Journal of medical case reports 20110101

• Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in mice.

  PLoS neglected tropical diseases 20110101

• Highly automated QT measurement techniques in 7 thorough QT studies implemented under ICH E14 guidelines.

  Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20110101

• A novel approach to pharmacodynamic assessment of antimicrobial agents: new insights to dosing regimen design.

  PLoS computational biology 20110101

• Development and implementation of a performance improvement project in adult intensive care units: overview of the Improving Medicine Through Pathway Assessment of Critical Therapy in Hospital-Acquired Pneumonia (IMPACT-HAP) study.

  Critical care (London, England) 20110101

• Animal models of bacterial keratitis.

  Journal of biomedicine & biotechnology 20110101

• 'The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women'.

  BMC infectious diseases 20110101

• Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial.

  Trials 20110101

• Canadian clinical practice guidelines for acute and chronic rhinosinusitis.

  Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20110101

• Vitreous and aqueous penetration of orally and topically administered moxifloxacin.

  Ophthalmic research 20110101

• [Highlights of the Congress of the National Infectious Disease Medicine Days 2010].

  Medecine et maladies infectieuses 20110101

• Hematoma and abscess formation caused by Mycoplasma hominis following cesarean section.

  International journal of women's health 20110101

• Tuberculous meningitis in Denmark: a review of 50 cases.

  BMC infectious diseases 20110101

• A Comprehensive review of abdominal infections.

  World journal of emergency surgery : WJES 20110101

• Acute endophthalmitis following 23-gauge sutureless transconjunctival vitrectomy.

  Indian journal of ophthalmology 20110101

• A spatial approach for the epidemiology of antibiotic use and resistance in community-based studies: the emergence of urban clusters of Escherichia coli quinolone resistance in Sao Paulo, Brasil.

  International journal of health geographics 20110101

• Long-term potency, sterility, and stability of vancomycin, ceftazidime, and moxifloxacin for treatment of bacterial endophthalmitis.

  Retina (Philadelphia, Pa.) 20110101

• Efficacy and tolerability of a combined gatifloxacin plus prednisolone formulation for topical prophylaxis after LASIK.

  Clinical ophthalmology (Auckland, N.Z.) 20110101

• Development of novel in silico model to predict corneal permeability for congeneric drugs: a QSPR approach.

  Journal of biomedicine & biotechnology 20110101

• Laboratory animal models for brucellosis research.

  Journal of biomedicine & biotechnology 20110101

• Severe pneumococcal pneumonia: impact of new quinolones on prognosis.

  BMC infectious diseases 20110101

• Sterilizing activity of second-line regimens containing TMC207 in a murine model of tuberculosis.

  PloS one 20110101

• Pharmacokinetic-pharmacodynamic modelling of the effect of Moxifloxacin on QTc prolongation in telemetered cynomolgus monkeys.

  Journal of pharmacological and toxicological methods 20110101

• Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi.

  PloS one 20110101

• Decline in Clostridium difficile-associated disease rates in Singapore public hospitals, 2006 to 2008.

  BMC research notes 20110101

• Transfer kinetics from colloidal drug carriers and liposomes to biomembrane models: DSC studies.

  Journal of pharmacy & bioallied sciences 20110101

• Generic antibiotic industries: Challenges and implied strategies with regulatory perspectives.

  Journal of pharmacy & bioallied sciences 20110101

• Association of mutation patterns in gyrA/B genes and ofloxacin resistance levels in Mycobacterium tuberculosis isolates from East China in 2009.

  BMC infectious diseases 20110101

• Location of intra- and extracellular M. tuberculosis populations in lungs of mice and guinea pigs during disease progression and after drug treatment.

  PloS one 20110101

• Antimicrobial susceptibilities of Brucella isolates from various clinical specimens.

  International journal of medical sciences 20110101

• Legionnaires' disease with facial nerve palsy.

  Case reports in medicine 20110101

• Antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from Artemisia absinthium against gram-positive pathogenic bacteria.

  PloS one 20110101

• Antimicrobial treatment of 'complicated' intra-abdominal infections and the new IDSA guidelines ? a commentary and an alternative European approach according to clinical definitions.

  European journal of medical research 20110101

• 2009 H1N1 influenza and experience in three critical care units.

  International journal of medical sciences 20110101

• First report of molecular detection of fluoroquinolone resistance-associated gyrA mutations in multidrug-resistant clinical Mycobacterium tuberculosis isolates in Kuwait.

  BMC research notes 20110101

• Geographic differences in time to culture conversion in liquid media: Tuberculosis Trials Consortium study 28. Culture conversion is delayed in Africa.

  PloS one 20110101

• Urinary elimination of coproporphyrins is dependent on ABCC2 polymorphisms and represents a potential biomarker of MRP2 activity in humans.

  Journal of biomedicine & biotechnology 20110101

• Antibiotic resistance and molecular epidemiology of Staphylococcus aureus in Nigeria.

  BMC microbiology 20110101

• Characteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experience.

  PloS one 20110101

• Fusidic acid resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in a Taiwanese hospital.

  BMC microbiology 20110101

• A Case Of Staphylococcus lugdunensis Related Pyomyoma Occurring after Cesarean Section.

  Journal of global infectious diseases 20110101

• Pulmonary strongyloidiasis associated CD3+ large granular lymphocytosis.

  Annals of thoracic medicine 20110101

• SCEDOSPORIUM INFECTION IN A PATIENT WITH ANTI-TNFα THERAPY.

  Indian journal of dermatology 20110101

• Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis.

  Clinical ophthalmology (Auckland, N.Z.) 20110101

• Size and usage patterns of private TB drug markets in the high burden countries.

  PloS one 20110101

• Clinical characteristics and therapeutic outcomes of nosocomial super-infection in adult bacterial meningitis.

  BMC infectious diseases 20110101

• Persistent neutrophilic meningitis in an immunocompetent patient after basilar skull fracture: case report.

  BMC infectious diseases 20110101

• [Beta-lactamases of clinical isolates of Enterobacteriaceae family].

  Mikrobiolohichnyi zhurnal (Kiev, Ukraine : 1993) 20110101

• The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.

  Clinical drug investigation 20110101

• Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study.

  BMC pulmonary medicine 20110101

• Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: retrospective analysis of three medical/pharmacy claims databases.

  BMC ophthalmology 20110101

• Intravenous moxifloxacin in routine hospital treatment of respiratory tract infections in China: results of a multicenter, noninterventional study.

  International journal of general medicine 20110101

• Potential role of tigecycline in the treatment of community-acquired bacterial pneumonia.

  Infection and drug resistance 20110101

• Survival of civilian and prisoner drug-sensitive, multi- and extensive drug- resistant tuberculosis cohorts prospectively followed in Russia.

  PloS one 20110101

• Evaluation of direct inoculation of the BD PHOENIX system from positive BACTEC blood cultures for both Gram-positive cocci and Gram-negative rods.

  BMC microbiology 20110101

• Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence.

  BMC microbiology 20110101

• Unnecessary use of fluoroquinolone antibiotics in hospitalized patients.

  BMC infectious diseases 20110101

• Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex for first and second line drugs by broth dilution in a microtiter plate format.

  Journal of visualized experiments : JoVE 20110101

• A clinical pathway for community-acquired pneumonia: an observational cohort study.

  BMC infectious diseases 20110101

• Effect of administration of moxifloxacin plus rifampin against Mycobacterium tuberculosis for 7 of 7 days versus 5 of 7 days in an in vitro pharmacodynamic system.

  mBio 20110101

• Update and critical appraisal of the use of topical azithromycin ophthalmic 1% (AzaSite) solution in the treatment of ocular infections.

  Clinical ophthalmology (Auckland, N.Z.) 20110101

• A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology.

  International journal of chronic obstructive pulmonary disease 20110101

• The thorough QT study: let's be precise.

  Cardiology journal 20110101

• Improving the precision of QT measurements.

  Cardiology journal 20110101

• Efficacy and tolerability of a combined moxifloxacin/dexamethasone formulation for topical prophylaxis in phacoemulsification: an open-label single-arm clinical trial.

  Journal of ophthalmology 20110101

• Potential economic viability of two proposed rifapentine-based regimens for treatment of latent tuberculosis infection.

  PloS one 20110101

• Influence of a probiotic soy product on fecal microbiota and its association with cardiovascular risk factors in an animal model.

  Lipids in health and disease 20110101

• Clostridium difficile-associated diarrhea in radiooncology: an underestimated problem for the feasibility of the radiooncological treatment?

  Radiation oncology (London, England) 20110101

• Prevalence of aac(6')-Ib-cr plasmid-mediated and chromosome-encoded fluoroquinolone resistance in Enterobacteriaceae in Italy.

  Gut pathogens 20110101

• Is C. Pneumoniae research in peril?

  Frontiers in microbiology 20110101

• Fluoroquinolones, the cornerstone of treatment of drug-resistant tuberculosis: a pharmacokinetic and pharmacodynamic approach.

  Current pharmaceutical design 20110101

• In vitro and in vivo modeling of tuberculosis drugs and its impact on optimization of doses and regimens.

  Current pharmaceutical design 20110101

• Outcome of in-the-bag implanted square-edge polymethyl methacrylate intraocular lenses with and without primary posterior capsulotomy in pediatric traumatic cataract.

  Indian journal of ophthalmology 20110101

• Visual perception changes and optical stability after intracorneal ring segment implantation: comparison between 3 months and 1 year after surgery.

  Clinical ophthalmology (Auckland, N.Z.) 20110101

• Single intravitreal ranibizumab for myopic choroidal neovascularization.

  Clinical ophthalmology (Auckland, N.Z.) 20110101

• Cataract surgery in a patient with amyotrophic lateral sclerosis: a case report.

  Case reports in ophthalmology 20110101

• Treatment of tuberculosis in a region with high drug resistance: outcomes, drug resistance amplification and re-infection.

  PloS one 20110101

• Tuberculosis chemotherapy in the 21 century: Back to the basics.

  Lung India : official organ of Indian Chest Society 20110101

• New therapeutic approach for latent tuberculosis infection.

  Lung India : official organ of Indian Chest Society 20110101

• Cross sensitivity between ciprofloxacin and levofloxacin for an immediate hypersensitivity reaction.

  Journal of pharmacology & pharmacotherapeutics 20110101

• A toxin-antitoxin module in Bacillus subtilis can both mitigate and amplify effects of lethal stress.

  PloS one 20110101

• Treatment of drug-resistant tuberculosis.

  Infection and drug resistance 20110101

• Moxifloxacin-induced delirium with hallucinations.

  Psychosomatics 20110101

• Clostridium difficile Infection and Inflammatory Bowel Disease: A Review.

  Gastroenterology research and practice 20110101

• Rare occurrence of methicillin-resistant Staphylococcus aureus CC130 with a novel mecA homologue in humans in Germany.

  PloS one 20110101

• Clonal population of Mycobacterium tuberculosis strains reside within multiple lung cavities.

  PloS one 20110101

• Internalization of Staphylococcus aureus in lymphocytes induces oxidative stress and DNA fragmentation: possible ameliorative role of nanoconjugated vancomycin.

  Oxidative medicine and cellular longevity 20110101

• Molecular detection of fluoroquinolone-resistance in multi-drug resistant tuberculosis in Cambodia suggests low association with XDR phenotypes.

  BMC infectious diseases 20110101

• The chicken cornea as a model of wound healing and neuronal re-innervation.

  Molecular vision 20110101

• Topoisomerase mutations that are associated with high-level resistance to earlier fluoroquinolones in Staphylococcus aureus have less effect on the antibacterial activity of besifloxacin.

  Chemotherapy 20110101

• Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations.

  International journal of chronic obstructive pulmonary disease 20110101

• Rhodococcus equi infection after reduction mammaplasty in an immunocompetent patient.

  Revista do Instituto de Medicina Tropical de Sao Paulo 20110101

• The National Formulary of India 2010: Thorough and extensive revision of the preprint version needed.

  Journal of pharmacology & pharmacotherapeutics 20110101

• Pharmacodynamic evaluation of commonly prescribed oral antibiotics against respiratory bacterial pathogens.

  BMC infectious diseases 20110101

• Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes.

  Clinical ophthalmology (Auckland, N.Z.) 20110101

• Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: etiology of bacterial conjunctivitis and antibacterial susceptibility profile.

  Clinical ophthalmology (Auckland, N.Z.) 20110101

• Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK.

  Clinical ophthalmology (Auckland, N.Z.) 20110101

• Hypervirulent Clostridium difficile PCR-ribotypes exhibit resistance to widely used disinfectants.

  PloS one 20110101

• Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy.

  Drug, healthcare and patient safety 20110101

• Ertapenem for treatment of osteomyelitis: a case series.

  BMC research notes 20110101

• Mycobacterium genavense as a cause of subacute pneumonia in patients with severe cellular immunodeficiency.

  BMC infectious diseases 20110101

• Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis.

  PloS one 20110101

• Paraneoplastic syndrome mimicking adult-onset Still's disease caused by advanced lung cancer: a case report.

  BMC cancer 20110101

• Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal.

  HIV/AIDS (Auckland, N.Z.) 20110101

• Molecular and immunological characterization of Staphylococcus aureus in pediatric atopic dermatitis: implications for prophylaxis and clinical management.

  Clinical & developmental immunology 20110101

• Computer aided screening and evaluation of herbal therapeutics against MRSA infections.

  Bioinformation 20110101

• Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India.

  PloS one 20110101

• Completeness and timeliness of tuberculosis notification in Taiwan.

  BMC public health 20110101

• Transient peripheral edema following displaced corneal graft after descemet stripping automated endothelial keratoplasty (DSAEK): case presentation.

  BMC ophthalmology 20110101

• Docking studies on novel analogues of 8 methoxy fluoroquinolones against GyrA mutants of Mycobacterium tuberculosis.

  BMC structural biology 20110101

• QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications.

  Cardiology 20110101

• Characterization of Abcc4 gene amplification in stepwise-selected mouse J774 macrophages resistant to the topoisomerase II inhibitor ciprofloxacin.

  PloS one 20110101

• 'Ten Commandments' for the Appropriate use of Antibiotics by the Practicing Physician in an Outpatient Setting.

  Frontiers in microbiology 20110101

• Discovery of novel MDR-Mycobacterium tuberculosis inhibitor by new FRIGATE computational screen.

  PloS one 20110101

• Impact of sub-inhibitory antibiotics on fibronectin-mediated host cell adhesion and invasion by Staphylococcus aureus.

  BMC microbiology 20110101

• Different cellular effects of four anti-inflammatory eye drops on human corneal epithelial cells: independent in active components.

  Molecular vision 20110101

• Surveillance of broad-spectrum antibiotic prescription in Singaporean hospitals: a 5-year longitudinal study.

  PloS one 20110101

• Influenza A/H1N1 septic shock in a patient with systemic lupus erythematosus. A case report.

  BMC infectious diseases 20110101

• In the quest of drugs for bad bugs: are newer fluoroquinolones any better?

  Journal of laboratory physicians 20110101

• Development and validation of spectrophotometric, atomic absorption and kinetic methods for determination of moxifloxacin hydrochloride.

  Analytical chemistry insights 20110101

• Oxidative stress induced by fluoroquinolones on treatment for complicated urinary tract infections in Indian patients.

  Journal of young pharmacists : JYP 20110101

• Treatment of acute pelvic inflammatory disease.

  Infectious diseases in obstetrics and gynecology 20110101

• Modulation of biofilm of strains isolated from patients with chronic obstructive pulmonary disease by levofloxacin, moxifloxacin, ciprofloxacin, amoxicillin/clavulanic acid and ceftriaxone.

  International journal of immunopathology and pharmacology 20110101

• Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease.

  Infectious diseases in obstetrics and gynecology 20110101

• Investigation of parameters highlighting drug induced small changes of the T-wave's morphology for drug safety studies.

  Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 20110101

• Drug-resistant tuberculosis: emerging treatment options.

  Clinical pharmacology : advances and applications 20110101

• Factors affecting the cost effectiveness of antibiotics.

  Chemotherapy research and practice 20110101

• Antibiotic Combinations with Daptomycin for Treatment of Staphylococcus aureus Infections.

  Chemotherapy research and practice 20110101

• [Present and future in the use of anti-tubercular drugs].

  Pneumologia (Bucharest, Romania) 20110101

• [Crystalline keratopathy: an infrequent corneal infection produced by the Streptococcus mitis group].

  Revista Argentina de microbiologia 20110101

• Tuberculous meningitis: diagnosis and treatment overview.

  Tuberculosis research and treatment 20110101

• Traumatic Endophthalmitis due to Cellulosimicrobium cellulans.

  Case reports in ophthalmological medicine 20110101

• Inhibition of DNA gyrase by levofloxacin and related fluorine-containing heterocyclic compounds.

  Acta naturae 20110101

• Mycobacterial brain tuberculomas due to Bacille Calmette-Guérin intravesical chemotherapy for bladder cancer: A case report and literature review.

  The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 20110101

• High performance liquid chromatography assay with ultraviolet detection for moxifloxacin: validation and application to a pharmacokinetic study in Chinese volunteers.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20101215

• Drugs in development for tuberculosis.

  Drugs 20101203

• Aspergillus keratitis in vernal shield ulcer--a case report and review.

  International ophthalmology 20101201

• Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20101201

• Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections.

  Ophthalmology 20101201

• MLVA typing and antibiotic susceptibility of Brucella human isolates from Liaoning, China.

  Transactions of the Royal Society of Tropical Medicine and Hygiene 20101201

• Antimicrobial susceptibility and heteroresistance in Chinese Clostridium difficile strains.

  Anaerobe 20101201

• Conjunctival concentrations of a new ophthalmic solution formulation of moxifloxacin 0.5% in cataract surgery patients.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20101201

• Antibacterial activity of finafloxacin under different pH conditions against isogenic strains of Escherichia coli expressing combinations of defined mechanisms of fluoroquinolone resistance.

  The Journal of antimicrobial chemotherapy 20101201

• In vitro susceptibility of Actinobaculum schaalii to 12 antimicrobial agents and molecular analysis of fluoroquinolone resistance.

  The Journal of antimicrobial chemotherapy 20101201

• Can intraocular lenses deliver antibiotics intracamerally?

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20101201

• Penetration and effectiveness of prophylactic fluoroquinolones in experimental methicillin-sensitive or methicillin-resistant Staphylococcus aureus anterior chamber infections.

  Journal of cataract and refractive surgery 20101201

• Moxifloxacin and cholesterol combined treatment of pneumococcal keratitis.

  Current eye research 20101201

• Half-century-old TB drugs get a facelift in new cocktails.

  Nature medicine 20101201

• Novel technologies: A weapon against tuberculosis.

  Indian journal of pharmacology 20101201

• [Chinfloxacin hydrochloride inhibits HERG potassium channel at open state].

  Yao xue xue bao = Acta pharmaceutica Sinica 20101201

• [In vitro activity of sitafloxacin against clinical isolates in 2009].

  The Japanese journal of antibiotics 20101201

• Fatal cases associated with pandemic influenza A (H1N1) reported in Greece.

  PLoS currents 20101109

• Single therapeutic and supratherapeutic doses of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, do not prolong the QTcF interval in healthy volunteers.

  Journal of clinical pharmacology 20101101

• Pharmacokinetics and pharmacodynamics of three moxifloxacin dosage forms: implications for blinding in active-controlled cardiac repolarization studies.

  Journal of clinical pharmacology 20101101

• High resistance against clindamycin, metronidazole and amoxicillin in Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans isolates of periodontal disease.

  Medicina oral, patologia oral y cirugia bucal 20101101

• Comparative antimicrobial susceptibility of biofilm versus planktonic forms of Salmonella enterica strains isolated from children with gastroenteritis.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20101101

• In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20101101

• Comparison of the effects of fourth-generation fluoroquinolones on epithelial healing after photorefractive keratectomy.

  Cornea 20101101

• Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study.

  BJOG : an international journal of obstetrics and gynaecology 20101101

• Pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor during and after the approved dosing regimens.

  American journal of ophthalmology 20101101

• Impact of different empirical antibiotic treatment regimens for community-acquired pneumonia on the emergence of Clostridium difficile.

  The Journal of antimicrobial chemotherapy 20101101

• German multicentre survey of the antibiotic susceptibility of Bacteroides fragilis group and Prevotella species isolated from intra-abdominal infections: results from the PRISMA study.

  The Journal of antimicrobial chemotherapy 20101101

• Complicated skin and soft tissue infection.

  The Journal of antimicrobial chemotherapy 20101101

• Presumed corneal stromal graft rejection after deep anterior lamellar keratoplasty in a patient with systemic lupus erythematosis.

  Eye & contact lens 20101101

• Two pediatric cases of multidrug-resistant tuberculosis treated with linezolid and moxifloxacin.

  Pediatrics 20101101

• Mycobacterium heckeshornense infection in HIV-infected patient.

  Emerging infectious diseases 20101101

• Fluoroquinolones in the management of community-acquired pneumonia in primary care.

  Expert review of anti-infective therapy 20101101

• Current medical management of diabetic foot infections.

  Expert review of anti-infective therapy 20101101

• All-oral antibiotic treatment for buruli ulcer: a report of four patients.

  PLoS neglected tropical diseases 20101101

• Synthesis of non-purine analogs of 6-aryl-9-benzylpurines, and their antimycobacterial activities. Compounds modified in the imidazole ring.

  Bioorganic & medicinal chemistry 20101015

• [Use of moxifloxacin in tuberculosis regimen in a French teaching hospital].

  Medecine et maladies infectieuses 20101001

• Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20101001

• Short-course fluoroquinolone therapy in exacerbations of chronic bronchitis and COPD.

  Respiratory medicine 20101001

• Clinical update on the use of moxifloxacin in the treatment of community-acquired complicated intraabdominal infections.

  Surgical infections 20101001

• Practice patterns for antibiotic de-escalation in culture-negative healthcare-associated pneumonia.

  Infection 20101001

• Post-antibiotic effect (PAE) of moxifloxacin in multidrug-resistant Stenotrophomonas maltophilia.

  International journal of antimicrobial agents 20101001

• Thorough cardiac QTc interval conductance assessment of a novel oral tranexamic acid treatment for heavy menstrual bleeding.

  Expert opinion on pharmacotherapy 20101001

• Fluoroquinolones induce the expression of patA and patB, which encode ABC efflux pumps in Streptococcus pneumoniae.

  The Journal of antimicrobial chemotherapy 20101001

• Comparative antibiotic failure rates in the treatment of community-acquired pneumonia: Results from a claims analysis.

  Advances in therapy 20101001

• Evaluation of the effects of AZD3480 on cardiac repolarization: a thorough QT/QTc study using moxifloxacin as a positive control.

  Clinical pharmacology and therapeutics 20101001

• Efficacy of moxifloxacin compared to teicoplanin in the treatment of implant-related chronic osteomyelitis in rats.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20101001

• Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20101001

• Single-dose ticagrelor does not prolong the QT interval in healthy subjects.

  International journal of clinical pharmacology and therapeutics 20101001

• A thorough QT/QTc study of multiple doses of tapentadol immediate release in healthy subjects.

  International journal of clinical pharmacology and therapeutics 20101001

• Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of Clostridium difficile isolated from 12 hospitals in South Korea.

  The Korean journal of laboratory medicine 20101001

• Accurate detection of drug-induced delayed ventricular repolarization with a suitable correction formula in Langendorff guinea pig heart.

  The Journal of toxicological sciences 20101001

• Clostridium difficile-associated diarrhea in a tertiary care medical center.

  Proceedings (Baylor University. Medical Center) 20101001

• A case of Pantoea endophthalmitis.

  Korean journal of ophthalmology : KJO 20101001

• [A case of cerebral abscess due to methicillin-resistant Staphylococcus aureus which is treated with linezolid + rifampin combination].

  Mikrobiyoloji bulteni 20101001

• [A case of spinal osteomyelitis due to Mycobacterium intracellulare with pulmonary Mycobacterium avium complex].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20101001

• Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing.

  Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20101001

• The evolution of Helicobacter pylori antibiotics resistance over 10 years in Beijing, China.

  Helicobacter 20101001

• Advantages of azithromycin over erythromycin in improving the gastric emptying half-time in adult patients with gastroparesis.

  Journal of neurogastroenterology and motility 20101001

• [The role of moxifloxacin in the prophylaxis of post-surgical endophthalmitis].

  Archivos de la Sociedad Espanola de Oftalmologia 20101001

• [Antimicrobial susceptibility, capsular serotypes and clonal relationship of invasive streptococcus pneumoniae isolates in adult population of the Bio-Bio region, Chile. 2005-2006].

  Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 20101001

• Ninety-seven Years Old Hispanic Male With Mantle Cell Lymphoma.

  Journal of clinical medicine research 20101001

• Endophthalmitis caused by Stenotrophomonas maltophilia.

  Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 20100922

• An adaptable HPLC method for the analysis of frequently used antibiotics in ocular samples.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100915

• Moxifloxacin in the treatment of acute bacterial rhinosinusitis: results of a multicenter, non-interventional study.

  Acta oto-laryngologica 20100901

• Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates.

  International journal of antimicrobial agents 20100901

• Artifactual measurement of low serum HDL-cholesterol due to paraproteinemia.

  Clinical research in cardiology : official journal of the German Cardiac Society 20100901

• Antimicrobial activity of DW286 against Streptococcus pneumoniae.

  International journal of antimicrobial agents 20100901

• Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones.

  International journal of antimicrobial agents 20100901

• Aqueous penetration of moxifloxacin 0.5% ophthalmic solution and besifloxacin 0.6% ophthalmic suspension in cataract surgery patients.

  Journal of cataract and refractive surgery 20100901

• Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones.

  Journal of cataract and refractive surgery 20100901

• Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy.

  Drug safety 20100901

• Cerebrospinal fluid concentrations of antituberculosis agents in adults and children.

  Tuberculosis (Edinburgh, Scotland) 20100901

• Acute cervical lymphadenitis caused by Mycobacterium florentinum.

  Emerging infectious diseases 20100901

• Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance.

  Nature structural & molecular biology 20100901

• Evaluation of MGIT 960 and the colorimetric-based method for tuberculosis drug susceptibility testing.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20100901

• Anterior chamber and vitreous concordance in endophthalmitis: implications for prophylaxis.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20100901

• Cytotoxicity of topical medications used for infection and inflammation control after cataract surgery in cultured corneal endothelial cells.

  Biocontrol science 20100901

• Comparison of the influence of intracameral gentamicin, gatifloxacin, and moxifloxacin on the corneal endothelium in a rabbit model.

  Japanese journal of ophthalmology 20100901

• Thermoreversible mucoadhesive ophthalmic in situ hydrogel: Design and optimization using a combination of polymers.

  Acta pharmaceutica (Zagreb, Croatia) 20100901

• Sensitivity pattern of methicillin resistant Staphylococcus aureus isolated from patients admitted in a tertiary care hospital of Pakistan.

  Iranian journal of microbiology 20100901

• Synthesis and biological evaluation of tetracyclic fluoroquinolones as antibacterial and anticancer agents.

  Bioorganic & medicinal chemistry 20100815

• In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993-2007 in Sweden.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20100801

• [Intracameral moxifloxacin: a safe option for endophthalmitis prophylaxis? In vitro safety profile for intraocular application].

  Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20100801

• Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20100801

• Pharmacokinetics and bioavailability of moxifloxacin in buffalo calves.

  Research in veterinary science 20100801

• Experimental pulmonary infection and colonization of Haemophilus influenzae in emphysematous hamsters.

  Pulmonary pharmacology & therapeutics 20100801

• An in vitro investigation of synergy or antagonism between antimicrobial combinations against isolates from bacterial keratitis.

  Investigative ophthalmology & visual science 20100801

• Colonisation of fluoroquinolone-resistant Haemophilus influenzae among nursing home residents in southern Taiwan.

  The Journal of hospital infection 20100801

• Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin.

  Eye (London, England) 20100801

• Maternal and fetal blood levels of moxifloxacin, levofloxacin, cefepime and cefoperazone.

  International journal of antimicrobial agents 20100801

• Oritavancin, a new lipoglycopeptide antibiotic: results from a thorough QT study.

  Journal of clinical pharmacology 20100801

• Synthesis and in vitro antimycobacterial activity of balofloxacin ethylene isatin derivatives.

  European journal of medicinal chemistry 20100801

• In vitro antituberculosis activities of ACH-702, a novel isothiazoloquinolone, against quinolone-susceptible and quinolone-resistant isolates.

  Antimicrobial agents and chemotherapy 20100801

• Lack of effect of dalcetrapib on QT interval in healthy subjects following multiple dosing.

  European journal of clinical pharmacology 20100801

• Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.

  The Journal of antimicrobial chemotherapy 20100801

• Antibiotic resistance of subgingival species in chronic periodontitis patients.

  Journal of periodontal research 20100801

• New antituberculous drugs in development.

  Current HIV/AIDS reports 20100801

• Moxifloxacin enhances etoposide-induced cytotoxic, apoptotic and anti-topoisomerase II effects in a human colon carcinoma cell line.

  International journal of oncology 20100801

• Electrochemical determination of gatifloxacin, moxifloxacin and sparfloxacin fluoroquinolonic antibiotics on glassy carbon electrode in pharmaceutical formulations.

  Drug testing and analysis 20100801

• A single-dose, crossover, placebo- and moxifloxacin-controlled study to assess the effects of neratinib (HKI-272) on cardiac repolarization in healthy adult subjects.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100801

• Doxycycline failure in lymphogranuloma venereum.

  Sexually transmitted infections 20100801

• Severe corneal changes following intravitreal injection of bevacizumab.

  Ocular immunology and inflammation 20100801

• [Questionnaire surveying nephrologists on drug dose adjustment in patients with impaired kidney function].

  Wiener klinische Wochenschrift 20100801

• Pharmacodynamics of moxifloxacin versus vancomycin against biofilms of methicillin-resistant Staphylococcus aureus and epidermidis in an in vitro model.

  Journal of chemotherapy (Florence, Italy) 20100801

• Clinical efficacy of moxifloxacin versus comparator therapies for community-acquired pneumonia caused by Legionella spp.

  Journal of chemotherapy (Florence, Italy) 20100801

• Safety of moxifloxacin and voriconazole in corneal storage media on porcine corneal endothelial cells.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100801

• Two cases of corneal ulcer due to methicillin-resistant Staphylococcus aureus in high risk groups.

  Korean journal of ophthalmology : KJO 20100801

• Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile.

  PLoS pathogens 20100801

• [Mutant prevention concentrations of garenoxacin against Streptococcus pneumoniae isolates from otorhinolaryngological infections].

  The Japanese journal of antibiotics 20100801

• Mayamycin, a cytotoxic polyketide from a Streptomyces strain isolated from the marine sponge Halichondria panicea.

  Journal of natural products 20100723

• Identification of Qnr and AAC(6')-1b-cr plasmid-mediated fluoroquinolone resistance determinants in multidrug-resistant Enterobacter spp. isolated from extraintestinal infections in companion animals.

  Veterinary microbiology 20100714

• [R207910 (TMC207): a new antibiotic for the treatment of tuberculosis].

  Medecine et maladies infectieuses 20100701

• Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis.

  Journal of medical microbiology 20100701

• Moxifloxacin monotherapy versus beta-lactam-based standard therapy for community-acquired pneumonia: a meta-analysis of randomised controlled trials.

  International journal of antimicrobial agents 20100701

• Comparison of pharmacokinetic profiles of moxifloxacin in Caesarean versus non-pregnant sectioned women by fully validated HPLC with fluorescence detection.

  Combinatorial chemistry & high throughput screening 20100701

• Bactericidal activity of besifloxacin against staphylococci, Streptococcus pneumoniae and Haemophilus influenzae.

  The Journal of antimicrobial chemotherapy 20100701

• Covariate analysis of QTc and T-wave morphology: new possibilities in the evaluation of drugs that affect cardiac repolarization.

  Clinical pharmacology and therapeutics 20100701

• Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.

  Cornea 20100701

• Spontaneous subconjunctival abscess because of Haemophilus influenzae.

  Cornea 20100701

• Methicillin-resistant Staphylococcus aureus in wound cultures recovered from a combat support hospital in Iraq.

  The Journal of trauma 20100701

• Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis.

  Wiener klinische Wochenschrift 20100701

• Eltrombopag does not affect cardiac repolarization: results from a definitive QTc study in healthy subjects.

  British journal of clinical pharmacology 20100701

• Treatment of Drug-resistant Pneumococcal Meningitis.

  Current infectious disease reports 20100701

• From 6-aminoquinolone antibacterials to 6-amino-7-thiopyranopyridinylquinolone ethyl esters as inhibitors of Staphylococcus aureus multidrug efflux pumps.

  Journal of medicinal chemistry 20100610

• Fungal keratitis associated with ocular rosacea.

  International ophthalmology 20100601

• A severely symptomatic case of anaerobic chronic bacterial prostatitis successfully resolved with moxifloxacin therapy.

  Anaerobe 20100601

• Pharmacokinetics, plasma protein binding and bioavailability of moxifloxacin in Muscovy ducks after different routes of administration.

  Research in veterinary science 20100601

• Pharmacokinetics of moxifloxacin in patients with severe sepsis or septic shock.

  Intensive care medicine 20100601

• In vitro activities of DC-159a, a novel fluoroquinolone, against Mycobacterium species.

  Antimicrobial agents and chemotherapy 20100601

• Update on antithrombotic therapy for stroke prevention in atrial fibrillation.

  Current treatment options in cardiovascular medicine 20100601

• Causes of infection after earthquake, China, 2008.

  Emerging infectious diseases 20100601

• Comparative efficacy of besifloxacin and other fluoroquinolones in a prophylaxis model of penicillin-resistant Streptococcus pneumoniae rabbit endophthalmitis.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100601

• Maternal blood and amniotic fluid levels of moxifloxacin, levofloxacin and cefixime.

  The journal of obstetrics and gynaecology research 20100601

• Tsukamurella: an emerging opportunistic ocular pathogen.

  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20100601

• Antimicrobial susceptibility and multiplex PCR screening of AmpC genes from isolates of Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens.

  Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20100601

• Intensive care of a weils disease with multiorgan failure.

  Journal of clinical medicine research 20100601

• Direct detection and serogroup characterization of Neisseria meningitidis from outbreak of meningococcal meningitis in Delhi.

  Iranian journal of microbiology 20100601

• Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study.

  Lancet (London, England) 20100522

• Polypyrrole solid phase microextraction: A new approach to rapid sample preparation for the monitoring of antibiotic drugs.

  Analytica chimica acta 20100514

• Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strains.

  World journal of gastroenterology 20100514

• Comparison of fluoroquinolones: cytotoxicity on human corneal epithelial cells.

  Eye (London, England) 20100501

• A comparison of culture-positive and culture-negative health-care-associated pneumonia.

  Chest 20100501

• Minimum inhibitory concentrations of standard and novel antimicrobials for isolates from bacterial keratitis.

  Investigative ophthalmology & visual science 20100501

• Ultra high-pressure liquid chromatographic assay of moxifloxacin in rabbit aqueous humor after topical instillation of moxifloxacin nanoparticles.

  Journal of pharmaceutical and biomedical analysis 20100501

• Absence of pharmacokinetic interference of moxifloxacin on cyclosporine and tacrolimus in kidney transplant recipients.

  Journal of clinical pharmacology 20100501

• Effects of the selective alpha 1a-adrenoceptor antagonist silodosin on ECGs of healthy men in a randomized, double-blind, placebo- and moxifloxacin-controlled study.

  Clinical pharmacology and therapeutics 20100501

• Sewage sludge and liquid pig manure as possible sources of antibiotic resistant bacteria.

  Environmental research 20100501

• Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data.

  The Journal of antimicrobial chemotherapy 20100501

• The relationship between inpatient fluoroquinolone use and Clostridium difficile-associated diarrhea.

  The Annals of pharmacotherapy 20100501

• Statistical characteristics of moxifloxacin-induced QTc effect.

  Journal of biopharmaceutical statistics 20100501

• Statistical consideration in testing for assay sensitivity in a 'thorough' QT study.

  Journal of biopharmaceutical statistics 20100501

• Revisit the combination validation test of Tsong et al. for thorough QT/QTc clinical trials.

  Journal of biopharmaceutical statistics 20100501

• Response to letter to the editor: Statistical issues of QT prolongation assessment based on linear concentration modeling by Yi Tsong et al.

  Journal of biopharmaceutical statistics 20100501

• Levofloxacin-induced Achilles tendinitis in a young adult in the absence of predisposing conditions.

  Yonsei medical journal 20100501

• Multihospital outbreak of Clostridium difficile infection, Cleveland, Ohio, USA.

  Emerging infectious diseases 20100501

• Thorough QT study of the effect of fesoterodine on cardiac repolarization.

  International journal of clinical pharmacology and therapeutics 20100501

• Moxifloxacin five-day therapy versus placebo in acute bacterial rhinosinusitis.

  The Laryngoscope 20100501

• Aqueous humor and plasma concentrations of ciprofloxacin and moxifloxacin following topical ocular administration in ophthalmologically normal horses.

  American journal of veterinary research 20100501

• Oral moxifloxacin and topical amikacin for Mycobacterium abscessus keratitis after laser in situ keratomileusis.

  Journal of cataract and refractive surgery 20100501

• Comparing the effectiveness of moxifloxacin and povidone-iodine with povidone-iodine alone.

  Journal of cataract and refractive surgery 20100501

• Inguinal panniculitis in a young Tasmanian devil (Sarcophilus harrisii) caused by Mycobacterium mageritense.

  Australian veterinary journal 20100501

• Municipal wastewater effluents as a source of listerial pathogens in the aquatic milieu of the Eastern Cape Province of South Africa: a concern of public health importance.

  International journal of environmental research and public health 20100501

• [Susceptibility test of the Mycobacterium avium complex to sixteen anti-infective agents].

  Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20100501

• Synthesis and antitubercular evaluation of new fluoroquinolone derivatives coupled with carbohydrates.

  Carbohydrate research 20100419

• Moxifloxacin increases anti-tumor and anti-angiogenic activity of irinotecan in human xenograft tumors.

  Biochemical pharmacology 20100415

• 10th survey of antimicrobial resistance in noninvasive clinical isolates of Streptococcus pneumoniae collected in Belgium during winter 2007-2008.

  Pathologie-biologie 20100401

• Bacterial contamination of the vitreous cavity associated with transconjunctival 25-gauge microincision vitrectomy surgery.

  Ophthalmology 20100401

• Effects of milnacipran on cardiac repolarization in healthy participants.

  Journal of clinical pharmacology 20100401

• A novel Listeria monocytogenes-based DNA delivery system for cancer gene therapy.

  Human gene therapy 20100401

• Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig.

  The Journal of antimicrobial chemotherapy 20100401

• Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials.

  Paediatric drugs 20100401

• [Efficacy of moxifloxacin in treating bacterial conjunctivitis: a meta-analysis].

  Journal francais d'ophtalmologie 20100401

• Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates.

  Diagnostic microbiology and infectious disease 20100401

• Immediate hypersensitivity to moxifloxacin with tolerance to ciprofloxacin: report of three cases and review of the literature.

  The Annals of pharmacotherapy 20100401

• Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System.

  Drug safety 20100401

• Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100401

• Antimicrobial susceptibility of Moraxella catarrhalis isolated from children in Kalgoorlie-Boulder, Western Australia.

  Pathology 20100401

• Fluoroquinolone resistance and Clostridium difficile, Germany.

  Emerging infectious diseases 20100401

• Hypervirulent Clostridium difficile strains in hospitalized patients, Canada.

  Emerging infectious diseases 20100401

• Novel Corynebacterium diphtheriae in domestic cats.

  Emerging infectious diseases 20100401

• Clostridium difficile in ground meat, France.

  Emerging infectious diseases 20100401

• Update on the management of antibiotic allergy.

  Allergy, asthma & immunology research 20100401

• Red eye, blurry vision, and cough.

  The Journal of family practice 20100401

• Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteers.

  British journal of clinical pharmacology 20100401

• No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a 'thorough QT/QTc study' performed according to ICH guidelines.

  British journal of clinical pharmacology 20100401

• Determination of moxifloxacin in human plasma, plasma ultrafiltrate, and cerebrospinal fluid by a rapid and simple liquid chromatography- tandem mass spectrometry method.

  Journal of analytical toxicology 20100401

• High prevalence of Fluoroquinolone- and Methicillin-resistant Staphylococcus pseudintermedius isolates from canine pyoderma and otitis externa in veterinary teaching hospital.

  Journal of microbiology and biotechnology 20100401

• [Antimicrobial activity of oral quinolones against clinical isolates of Bifidobacterium group and Clostridium difficile].

  The Japanese journal of antibiotics 20100401

• Clostridium difficile in raw products of animal origin.

  International journal of food microbiology 20100331

• [Fatal acute hepatitis and cholestasis associated with liver disease].

  Medicina clinica 20100320

• Update in tuberculosis 2009.

  American journal of respiratory and critical care medicine 20100315

• Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?

  The European respiratory journal 20100301

• Changes in antibiotic susceptibility and ribotypes in Clostridium difficile isolates from southern Scotland, 1979-2004.

  Journal of medical microbiology 20100301

• Effects of moxifloxacin and clinafloxacin on murine limb buds cultured in regular and in magnesium-deficient medium.

  Archives of toxicology 20100301

• Contribution of reactive oxygen species to pathways of quinolone-mediated bacterial cell death.

  The Journal of antimicrobial chemotherapy 20100301

• Safety considerations of fluoroquinolones in the elderly: an update.

  Drugs & aging 20100301

• A comparison of treatment outcomes for moxifloxacin versus ofloxacin/metronidazole for first-line treatment of uncomplicated non-gonococcal pelvic inflammatory disease.

  International journal of STD & AIDS 20100301

• [Treatment of critically ill influenza A H1N1 patients in plateau region].

  Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue 20100301

• Besifloxacin: a topical fluoroquinolone for the treatment of bacterial conjunctivitis.

  Clinical therapeutics 20100301

• Disseminated systemic Nocardia farcinica infection complicating alefacept and infliximab therapy in a patient with severe psoriasis.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20100201

• Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20100201

• Acute granulomatous acanthamoeba encephalitis in an immunocompetent patient.

  Neurocritical care 20100201

• Synthesis and evaluation of (99m)Tc-moxifloxacin, a potential infection specific imaging agent.

  Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20100201

• Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin.

  Current medical research and opinion 20100201

• Beauveria keratitis and biopesticides: case histories and a random amplification of polymorphic DNA comparison.

  Cornea 20100201

• Synthesis, antimalarial and antitubercular activity of acetylenic chalcones.

  Bioorganic & medicinal chemistry letters 20100201

• Activity of various drugs alone or in combination against Mycobacterium fortuitum.

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20100201

• Investigating an airborne tularemia outbreak, Germany.

  Emerging infectious diseases 20100201

• Disseminated Mycobacterium kansasii infection associated with skin lesions: a case report and comprehensive review of the literature.

  Journal of Korean medical science 20100201

• Simultaneous scrofuloderma and intracranial tuberculomas: a rare presentation of systemic tuberculosis.

  The Australasian journal of dermatology 20100201

• Antimicrobial susceptibility of moxifloxacin against gram-negative enteric rods from colombian patients with chronic periodontitis.

  Journal of periodontology 20100201

• [Antibiotic susceptibility of blood-borne Streptococcus pneumoniae and efficacy assessment of respiratory quinolones using Monte Carlo simulation].

  The Japanese journal of antibiotics 20100201

• Exposure-response modeling and clinical trial simulation of the effect of tolterodine on QT intervals in healthy volunteers.

  Drug discoveries & therapeutics 20100201

• [Efficacy of second-line treatment based on moxifloxacin triple therapy for Helicobacter pylori infection].

  Zhonghua yi xue za zhi 20100112

• [Efficacy of moxifloxacin-based triple therapy to eradicate Helicobacter pylori infection].

  Zhonghua yi xue za zhi 20100112

• In vitro elution of moxifloxacin from cancellous bone allografts.

  Journal of biomedical materials research. Part A 20100101

• Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South India.

  Eye (London, England) 20100101

• Use of a mydriatic cocktail with a wick for preoperative mydriasis in cataract surgery: a prospective randomised controlled trial.

  Eye (London, England) 20100101

• Oral moxifloxacin for outpatient treatment of low-risk, febrile neutropenic patients.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20100101

• Moxifloxacin associated vanishing bile duct syndrome.

  Journal of clinical gastroenterology 20100101

• Dexrazoxane protects the heart from acute doxorubicin-induced QT prolongation: a key role for I(Ks).

  British journal of pharmacology 20100101

• Subinhibitory concentrations of moxifloxacin decrease adhesion and biofilm formation of Stenotrophomonas maltophilia from cystic fibrosis.

  Journal of medical microbiology 20100101

• In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.

  Antimicrobial agents and chemotherapy 20100101

• Determination of the mutant selection window for clindamycin, doxycycline, linezolid, moxifloxacin and trimethoprim/sulfamethoxazole against community-associated meticillin-resistant Staphylococcus aureus (MRSA).

  International journal of antimicrobial agents 20100101

• The use of baseline covariates in crossover studies.

  Biostatistics (Oxford, England) 20100101

• In vitro susceptibility of bacterial keratitis isolates to fourth-generation fluoroquinolones.

  European journal of ophthalmology 20100101

• Neglected diseases caused by bacterial infections.

  Current medicinal chemistry 20100101

• Effects of prulifloxacin on cardiac repolarization in healthy subjects: a randomized, crossover, double-blind versus placebo, moxifloxacin-controlled study.

  Clinical drug investigation 20100101

• Thorough QT Studies: Questions and Quandaries.

  Drug safety 20100101

• Adding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosis.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20100101

• [On the way to shortening tuberculosis treatments: clinical trials of the Unitat d' Investagació en Tuberculosi de Barcelona supported by the Centers for Disease Control and Prevention].

  Gaceta sanitaria 20100101

• A single supratherapeutic dose of rolofylline does not prolong the QTcF interval in healthy volunteers.

  American journal of therapeutics 20100101

• Besifloxacin ophthalmic suspension 0.6%.

  Drugs 20100101

• Skin lesion caused by ST398 and ST1 MRSA, Spain.

  Emerging infectious diseases 20100101

• Sequential bilateral lung resection in a patient with Mycobacterium abscessus lung disease refractory to medical treatment.

  Yonsei medical journal 20100101

• Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100101

• Characterization of the quinolone resistant determining regions in clinical isolates of pneumococci collected in Canada.

  Annals of clinical microbiology and antimicrobials 20100101

• Systemic anaphylaxis caused by moxifloxacin.

  Allergologia et immunopathologia 20100101

• Sensitivity of common marmosets to detect drug-induced QT interval prolongation: moxifloxacin case study.

  Journal of pharmacological and toxicological methods 20100101

• Saudi guidelines for testing and treatment of latent tuberculosis infection.

  Annals of Saudi medicine 20100101

• Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.

  Respiratory research 20100101

• Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits.

  Canadian journal of microbiology 20100101

• Characteristics of ambulatory anticoagulant adverse drug events: a descriptive study.

  Thrombosis journal 20100101

• Kinetics of kill of bacterial conjunctivitis isolates with moxifloxacin, a fluoroquinolone, compared with the aminoglycosides tobramycin and gentamicin.

  Clinical ophthalmology (Auckland, N.Z.) 20100101

• Comparison of fluoroquinolone kinetics of kill in susceptible and resistant gram-positive conjunctival pathogens.

  Advances in therapy 20100101

• Association between gefitinib and hemorrhagic cystitis and severely contracted bladder: a case report.

  BMC urology 20100101

• Pharmacokinetics and bioavailability of moxifloxacin in calves following different routes of administrations.

  Chemotherapy 20100101

• Intracellular persisting Staphylococcus aureus is the major pathogen in recurrent tonsillitis.

  PloS one 20100101

• Kikuchi Fujimoto disease associated with cryptogenic organizing pneumonia: case report and literature review.

  BMC infectious diseases 20100101

• Methicillin-resistant Staphylococcus epidermidis isolation from the vitrectomy specimen four hours after initial treatment with vancomycin and ceftazidime.

  Clinical ophthalmology (Auckland, N.Z.) 20100101

• A focus on intra-abdominal infections.

  World journal of emergency surgery : WJES 20100101

• Continuation treatment of major depressive disorder: is there a case for duloxetine?

  Drug design, development and therapy 20100101

• Antibiotic treatment of exacerbations of COPD in general practice: long-term impact on health-related quality of life.

  International journal of chronic obstructive pulmonary disease 20100101

• Moxifloxacin does not alter ciclosporin pharmacokinetics in transplant patients: a multiple-dose, uncontrolled, single-centre study.

  Clinical drug investigation 20100101

• Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives.

  Clinical ophthalmology (Auckland, N.Z.) 20100101

• Suture-related keratitis following cataract surgery caused by methicillin-resistant Staphylococcus aureus.

  Clinical ophthalmology (Auckland, N.Z.) 20100101

• Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial.

  Annals of clinical microbiology and antimicrobials 20100101

• In vitro selection of resistance in Escherichia coli and Klebsiella spp. at in vivo fluoroquinolone concentrations.

  BMC microbiology 20100101

• Dysglycemias in pregnancy: from diagnosis to treatment. Brazilian consensus statement.

  Diabetology & metabolic syndrome 20100101

• Prulifloxacin ECG study.

  Clinical drug investigation 20100101

• [In vitro synergistic effect of moxifloxacin and amphotericin B combination against Candida strains].

  Mikrobiyoloji bulteni 20100101

• Legionnaires' disease mimicking swine influenza (H1N1) pneumonia during the 'herald wave' of the pandemic.

  Heart & lung : the journal of critical care 20100101

• The comparison of clinical outcomes of endophthalmitis from fluoroquinolone-resistant and susceptible bacteria.

  Clinical ophthalmology (Auckland, N.Z.) 20100101

• Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitis.

  Clinical ophthalmology (Auckland, N.Z.) 20100101

• Intracameral vancomycin following cataract surgery: An eleven-year study.

  Clinical ophthalmology (Auckland, N.Z.) 20100101

• Concentrations of besifloxacin, gatifloxacin, and moxifloxacin in human conjunctiva after topical ocular administration.

  Clinical ophthalmology (Auckland, N.Z.) 20100101

• Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease.

  Respiratory research 20100101

• Pharmacokinetics of Linezolid and Ertapenem in experimental parapneumonic pleural effusion.

  Journal of inflammation (London, England) 20100101

• Pulmonary impairment after tuberculosis and its contribution to TB burden.

  BMC public health 20100101

• Real-time visualization of photochemically induced fluorescence of 8-halogenated quinolones: lomefloxacin, clinafloxacin and Bay3118 in live human HaCaT keratinocytes.

  Photochemistry and photobiology 20100101

• Metaplastic ossification in the cartilage of the bronchus of a patient with chronic multi-drug resistant tuberculosis: a case report.

  Journal of medical case reports 20100101

• Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis.

  PloS one 20100101

• Disparities of care for African-Americans and Caucasians with community-acquired pneumonia: a retrospective cohort study.

  BMC health services research 20100101

• Effectiveness, tolerability and safety of azithromycin 1% in DuraSite for acute bacterial conjunctivitis.

  Patient preference and adherence 20100101

• Left thoracotomy surgical approach for chronic instrumentation in dogs and monkeys providing high-quality electrocardiogram signals.

  Journal of pharmacological and toxicological methods 20100101

• Bile and gallbladder tissue concentrations of moxifloxacin in patients with acute cholecystitis.

  The Annals of pharmacotherapy 20100101

• Comparative in-vitro efficacy of fluoroquinolones against Streptococcus pneumoniae recovered from bacterial keratitis as determined by E-test.

  Indian journal of pathology & microbiology 20100101

• [Prevalence of Clostridium difficile in the gastrointestinal tract of hospitalized children under two years of age].

  Medycyna doswiadczalna i mikrobiologia 20100101

• Evaluation of in vitro activities of tigecycline and various antibiotics against Brucella spp.

  Polish journal of microbiology 20100101

• Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study.

  Clinical drug investigation 20100101

• Cardiovascular safety assessments in the conscious telemetered dog: utilisation of super-intervals to enhance statistical power.

  Journal of pharmacological and toxicological methods 20100101

• Acute onset lactobacillus endophthalmitis after trabeculectomy: a case report.

  Journal of medical case reports 20100101

• Structural basis of gate-DNA breakage and resealing by type II topoisomerases.

  PloS one 20100101

• Clostridium difficile and the disease it causes.

  Methods in molecular biology (Clifton, N.J.) 20100101

• Systemic Capillary Leak Syndrome associated with hypovolemic shock and compartment syndrome. Use of transpulmonary thermodilution technique for volume management.

  Scandinavian journal of trauma, resuscitation and emergency medicine 20100101

• Mycoplasma pneumonia: Clinical features and management.

  Lung India : official organ of Indian Chest Society 20100101

• Antibiotic susceptibility pattern of rapidly growing mycobacteria.

  Journal of postgraduate medicine 20100101

• Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort study.

  PloS one 20100101

• Safety and tolerability of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis: data from six clinical and phase I safety studies.

  Clinical drug investigation 20100101

• Sphingosine kinase-1 is required for toll mediated beta-defensin 2 induction in human oral keratinocytes.

  PloS one 20100101

• Identification and antimicrobial resistance of Enterococcus spp. isolated from surface water.

  Water science and technology : a journal of the International Association on Water Pollution Research 20100101

• Chordoma in the lateral medullary cistern in a patient with tuberous sclerosis: A case report and review of the literature.

  Surgical neurology international 20100101

• A new approach for the discovery of antibiotics by targeting non-multiplying bacteria: a novel topical antibiotic for staphylococcal infections.

  PloS one 20100101

• Voriconazole-refractory fungal infection of phacoemulsification tunnel.

  Indian journal of ophthalmology 20100101

• Azithromycin in DuraSite for the treatment of blepharitis.

  Clinical ophthalmology (Auckland, N.Z.) 20100101

• CASE REPORT Febrile Ulceronecrotic Mucha-Habermann Disease.

  Eplasty 20100101

• Intravitreal Ampicillin Sodium for Antibiotic-Resistant Endophthalmitis: Streptococcus uberis First Human Intraocular Infection Report.

  Journal of ophthalmology 20100101

• Biopsy proven acute interstitial nephritis after treatment with moxifloxacin.

  BMC nephrology 20100101

• The combination of rifampin plus moxifloxacin is synergistic for suppression of resistance but antagonistic for cell kill of Mycobacterium tuberculosis as determined in a hollow-fiber infection model.

  mBio 20100101

• Structural insights into the quinolone resistance mechanism of Mycobacterium tuberculosis DNA gyrase.

  PloS one 20100101

• Sequential introduction of single room isolation and hand hygiene campaign in the control of methicillin-resistant Staphylococcus aureus in intensive care unit.

  BMC infectious diseases 20100101

• Paroxysmal autonomic instability with dystonia in a patient with tuberculous meningitis: a case report.

  Journal of medical case reports 20100101

• The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis.

  PloS one 20100101

• Greatest International ANtiinfective Trial (GIANT) with moxifloxacin in the treatment of acute exacerbation of chronic bronchitis: subanalysis of Chinese data of a global, multicenter, noninterventional study.

  Clinical epidemiology 20100101

• [Adverse drug reactions in multidrug-resistant tuberculosis].

  Medicina 20100101

• Cytotoxicity of five fluoroquinolone and two nonsteroidal anti-inflammatory benzalkonium chloride-free ophthalmic solutions in four corneoconjunctival cell lines.

  Clinical ophthalmology (Auckland, N.Z.) 20100101

• Low endotoxin release from Escherichia coli and Bacteroides fragilis during exposure to moxifloxacin.

  Chemotherapy 20100101

• Quinolone and cephalosporin resistance in enteric Fever.

  Journal of global infectious diseases 20100101

• Fatal spontaneous rectus sheath hematoma in a patient with cirrhosis.

  Journal of emergencies, trauma, and shock 20100101

• Immune thrombocytopenia in a challenging case of disseminated tuberculosis: a case report and review of the literature.

  Case reports in medicine 20100101

• Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro.

  International journal of biological sciences 20100101

• Serial interferon-gamma release assays during treatment of active tuberculosis in young adults.

  BMC infectious diseases 20100101

• Etiology and antibacterial susceptibility pattern of community-acquired bacterial ocular infections in a tertiary eye care hospital in south India.

  Indian journal of ophthalmology 20100101

• Visual Performance of Tecnis ZM900 Diffractive Multifocal IOL after 2500 Implants: A 3-Year Followup.

  Journal of ophthalmology 20100101

• Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis.

  Clinical ophthalmology (Auckland, N.Z.) 20100101

• Profile of temsirolimus in the treatment of advanced renal cell carcinoma.

  OncoTargets and therapy 20100101

• Disposition kinetics of levofloxacin in sheep after intravenous and intramuscular administration.

  Veterinary medicine international 20100101

• Fluoroquinolone antibacterial eye drops: effects on normal human corneal epithelium, stroma, and endothelium.

  Clinical ophthalmology (Auckland, N.Z.) 20100101

• Acanthamoeba and Stenotrophomonas maltophilia keratitis with fungal keratitis in the contralateral eye.

  Clinical ophthalmology (Auckland, N.Z.) 20100101

• MRSA and cataract surgery - reflections for practice.

  Clinical ophthalmology (Auckland, N.Z.) 20100101

• Three-year multicenter surveillance of community-acquired Listeria monocytogenes meningitis in adults.

  BMC infectious diseases 20100101

• Mycoplasma hominis necrotizing pleuropneumonia in a previously healthy adolescent.

  BMC infectious diseases 20100101

• Two Legionnaires' disease cases associated with industrial waste water treatment plants: a case report.

  BMC infectious diseases 20100101

• New approaches in the diagnosis and treatment of latent tuberculosis infection.

  Respiratory research 20100101

• Protection Afforded by Fluoroquinolones in Animal Models of Respiratory Infections with Bacillus anthracis, Yersinia pestis, and Francisella tularensis.

  The open microbiology journal 20100101

• A protocol for the retina surgeon's safe initial intravitreal injections.

  Clinical ophthalmology (Auckland, N.Z.) 20100101

• A role for spleen monocytes in post-ischemic brain inflammation and injury.

  Journal of neuroinflammation 20100101

• Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin.

  European journal of medical research 20100101

• Advances in the prevention, management, and treatment of community-acquired pneumonia.

  F1000 medicine reports 20100101

• [Staphylococcus aureus: new and old antimicrobial agents].

  Revista Argentina de microbiologia 20100101

• Bacterial conjunctivitis.

  Clinical ophthalmology (Auckland, N.Z.) 20100101

• Methicillin resistance of Staphylococcus species among health care and nonhealth care workers undergoing cataract surgery.

  Clinical ophthalmology (Auckland, N.Z.) 20100101

• [Research regarding extended-spectrum beta-lactamases produced by enterobacteria strains].

  Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20100101

• Antibiotic Treatment of Dogs and Cats during Pregnancy.

  Veterinary medicine international 20100101

• Allergy to quinolones: low cross-reactivity to levofloxacin.

  Journal of investigational allergology & clinical immunology 20100101

• MRSA: treating people with infection.

  BMJ clinical evidence 20100101

• Leprosy therapy, past and present: can we hope to eliminate it?

  Indian journal of dermatology 20100101

• Role of telavancin in treatment of skin and skin structure infections.

  Clinical, cosmetic and investigational dermatology 20100101

• A rare case of toxic epidermal necrolysis with unexpected Fever resulting from dengue virus.

  Case reports in dermatology 20100101

• Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial.

  Infection and drug resistance 20100101

• The use of anti-tuberculosis therapy for latent TB infection.

  Infection and drug resistance 20100101

• Evaluation of surrogate animal models of melioidosis.

  Frontiers in microbiology 20100101

• Characterization and evaluation of the directly observed treatment for tuberculosis in Santiago de Compostela (1996-2006).

  Risk management and healthcare policy 20100101

• Enhancement of the antimalarial activity of ciprofloxacin using a double prodrug/bioorganometallic approach.

  Journal of medicinal chemistry 20091224

• [Moxifloxacin and hepatic toxicity].

  Gastroenterologia y hepatologia 20091201

• Assessment of changes in the epidemiology of Clostridium difficile isolated from diarrheal patients in Hungary.

  Anaerobe 20091201

• Clinical, microbiological profile and treatment outcome of ocular infections caused by Achromobacter xylosoxidans.

  Cornea 20091201

• In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20091201

• Emerging prevalence of microsporidial keratitis in Singapore: epidemiology, clinical features, and management.

  Ophthalmology 20091201

• Phenotypic changes in ciprofloxacin-resistant Staphylococcus aureus.

  Research in microbiology 20091201

• Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea.

  Anaerobe 20091201

• Lack of electrocardiographic effect of dexlansoprazole MR, a novel modified-release formulation of the proton pump inhibitor dexlansoprazole, in healthy participants.

  Journal of clinical pharmacology 20091201

• In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.

  The Journal of antimicrobial chemotherapy 20091201

• Absence of effect of telbivudine on cardiac repolarization: results of a thorough QT/QTc study in healthy participants.

  Journal of clinical pharmacology 20091201

• Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin.

  Eye (London, England) 20091201

• Validation of a MLC method with fluorescence detection for the determination of quinolones in urine samples by direct injection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20091201

• Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study.

  Therapeutic advances in respiratory disease 20091201

• Future treatment options for Gram-positive infections--looking ahead.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20091201

• Assessment of the cardiac safety of fampridine-SR sustained-release tablets in a thorough QT/QTc evaluation at therapeutic and supratherapeutic doses in healthy individuals.

  Expert opinion on investigational drugs 20091201

• Preoperative topical moxifloxacin 0.5% and povidone-iodine 5.0% versus povidone-iodine 5.0% alone to reduce bacterial colonization in the conjunctival sac.

  Journal of cataract and refractive surgery 20091201

• Re: Association between moxifloxacin ophthalmic solution and fungal infection in patients with corneal ulcers and microbial keratitis.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20091201

• Effect of cefuroxime and moxifloxacin on Staphylococcus epidermidis adherence to intraocular lenses.

  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20091201

• Disseminated multiorgan MDR-TB resistant to virtually all first-line drugs.

  European respiratory review : an official journal of the European Respiratory Society 20091201

• Electrocardiographic characterization of the QTc interval in patients with advanced solid tumors: pharmacokinetic- pharmacodynamic evaluation of sunitinib.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20091115

• Comparison of manual and automated measurements of the QT interval in healthy volunteers: an analysis of five thorough QT studies.

  Clinical pharmacology and therapeutics 20091101

• Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD.

  The European respiratory journal 20091101

• Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type I diabetic rats.

  Experimental eye research 20091101

• In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs.

  International journal of antimicrobial agents 20091101

• Efficacy of moxifloxacin or gatifloxacin as prophylaxis against experimental murine Brucella melitensis infection.

  International journal of antimicrobial agents 20091101

• Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections.

  International journal of antimicrobial agents 20091101

• Tissue penetration of moxifloxacin into human gallbladder wall in patients with biliary tract infections.

  The Journal of antimicrobial chemotherapy 20091101

• Absence of QTc prolongation in a thorough QT study with subcutaneous liraglutide, a once-daily human GLP-1 analog for treatment of type 2 diabetes.

  Journal of clinical pharmacology 20091101

• Flucloxacillin, still the empirical choice for putative Staphylococcus aureus infections in intensive care units in the Netherlands.

  The Journal of antimicrobial chemotherapy 20091101

• Abuse of antibiotic prophylaxis in third molar surgeries.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20091101

• Predicting the complicated neutropenic fever in the emergency department.

  Emergency medicine journal : EMJ 20091101

• Buruli ulcer in United Kingdom tourist returning from Latin America.

  Emerging infectious diseases 20091101

• Moxifloxacin-induced drug hypersensitivity syndrome with features of toxic epidermal necrolysis.

  Journal of drugs in dermatology : JDD 20091101

• Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes.

  Journal of medicinal chemistry 20091022

• Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery.

  Ophthalmology 20091001

• Evidence for moxifloxacin in community-acquired pneumonia: the impact of pharmaco-economic considerations on guidelines.

  Current medical research and opinion 20091001

• Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile.

  The Journal of hospital infection 20091001

• Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20091001

• Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis.

  Cornea 20091001

• Design, synthesis and biological evaluations of novel 7-[3-(1-aminocycloalkyl)pyrrolidin-1-yl]-6-desfluoro-8-methoxyquinolones with potent antibacterial activity against multi-drug resistant Gram-positive bacteria.

  Bioorganic & medicinal chemistry 20091001

• Besifloxacin, a new ophthalmic fluoroquinolone for the treatment of bacterial conjunctivitis.

  Expert opinion on pharmacotherapy 20091001

• Moxifloxacin-containing triple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate.

  Helicobacter 20091001

• Should moxifloxacin be substituted for isoniazid as a first-line antituberculosis drug?

  American journal of respiratory and critical care medicine 20091001

• [Active drugs against Mycobacterium tuberculosis].

  Enfermedades infecciosas y microbiologia clinica 20091001

• Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections.

  Infection 20091001

• One-day application of topical moxifloxacin 0.5% to select for fluoroquinolone-resistant coagulase-negative Staphylococcus.

  Journal of cataract and refractive surgery 20091001

• A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease.

  International journal of STD & AIDS 20091001

• Community-associated methicillin-resistant Staphylococcus aureus, Iowa, USA.

  Emerging infectious diseases 20091001

• Moxifloxacin: new indication. Inadequate restriction of indications in ENT and respiratory infections.

  Prescrire international 20091001

• Moxifloxacin: new indication. Do not use in gynaecological infections or other conditions.

  Prescrire international 20091001

• [Factors effecting the duration of hospitalization and mortality in patients with community-acquired pneumonia].

  Mikrobiyoloji bulteni 20091001

• Antibiotic therapy in elderly patients with acute exacerbation of chronic bronchitis.

  Expert review of respiratory medicine 20091001

• Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis.

  American journal of respiratory and critical care medicine 20090915

• Optimization of separation and determination of moxifloxacin and its related substances by RP-HPLC.

  Journal of pharmaceutical and biomedical analysis 20090908

• Fluoroquinolone-resistant Brucella melitensis mutants obtained in vitro.

  International journal of antimicrobial agents 20090901

• Antibacterial activity of lipophilic fluoroquinolone derivatives.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20090901

• Efficacy of fluoroquinolones against pathogenic oral bacteria.

  Mini reviews in medicinal chemistry 20090901

• Pharmacodynamics of moxifloxacin against a high inoculum of Escherichia coli in an in vitro infection model.

  The Journal of antimicrobial chemotherapy 20090901

• Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.

  Current medical research and opinion 20090901

• Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.

  Ophthalmology 20090901

• Susceptibility and bactericidal activity of 8 oral quinolones against conventional-fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.

  Diagnostic microbiology and infectious disease 20090901

• Kill rates of preserved and preservative-free topical 8-methoxy fluoroquinolones against various strains of Staphylococcus.

  Journal of cataract and refractive surgery 20090901

• Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent persons.

  Emerging infectious diseases 20090901

• [Methicillin resistant Staphyloccus aureus infection: a case report and literature review].

  Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20090901

• Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis.

  American journal of respiratory and critical care medicine 20090815

• Susceptibility of clinical isolates of frequently encountered bacterial species to tigecycline one year after the introduction of this new class of antibiotics: results of the second multicentre surveillance trial in Germany (G-TEST II, 2007).

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20090801

• Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.

  American journal of respiratory and critical care medicine 20090801

• Selective role of sulfotransferase 2A1 (SULT2A1) in the N-sulfoconjugation of quinolone drugs in humans.

  Drug metabolism and disposition: the biological fate of chemicals 20090801

• Evaluation of the mutant selection window for fluoroquinolones against Neisseria gonorrhoeae.

  The Journal of antimicrobial chemotherapy 20090801

• Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila.

  The Journal of antimicrobial chemotherapy 20090801

• Prospective randomized comparison of 1-day and 3-day application of topical 0.5% moxifloxacin in eliminating preoperative conjunctival bacteria.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090801

• Comparison of semiautomated and fully automated methods for QT measurement during a thorough QT/QTc study: variability and sample size considerations.

  Journal of clinical pharmacology 20090801

• 7-((4-Substituted)piperazin-1-yl) derivatives of ciprofloxacin: synthesis and in vitro biological evaluation as potential antitumor agents.

  Bioorganic & medicinal chemistry 20090801

• A thorough QTc study to assess the effect of sitagliptin, a DPP4 inhibitor, on ventricular repolarization in healthy subjects.

  Journal of clinical pharmacology 20090801

• Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects.

  Anesthesia and analgesia 20090801

• Benzalkonium chloride enhances antibacterial activity of gatifloxacin and reduces its propensity to select for fluoroquinolone-resistant strains.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090801

• Moxifloxacin-induced QT prolongation and torsades: an uncommon effect of a common drug.

  The American journal of the medical sciences 20090801

• 10 years' experience with the pneumococcal quinolone moxifloxacin.

  Expert review of anti-infective therapy 20090801

• Prognostic factors and clinical features of non-typhoid Salmonella bacteremia in adults.

  Journal of the Chinese Medical Association : JCMA 20090801

• Aqueous humor penetration of fourth-generation fluoroquinolone ophthalmic solutions given by multiple administration in a rabbit model.

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20090801

• Quinolones: action and resistance updated.

  Current topics in medicinal chemistry 20090801

• Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance.

  Current cardiology reviews 20090801

• Acyclovir-induced renal failure in an obese patient.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20090715

• Separation of fluoroquinolones in acidic buffer by capillary electrophoresis with contactless conductivity detection.

  Journal of chromatography. A 20090703

• In vitro selection of fluoroquinolone resistance in Brucella melitensis.

  International journal of antimicrobial agents 20090701

• Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types.

  Diagnostic microbiology and infectious disease 20090701

• Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species.

  The Journal of antimicrobial chemotherapy 20090701

• Haemolytic anaemia following rituximab treatment in a patient with pemphigus vulgaris.

  The British journal of dermatology 20090701

• Drug discovery using chemical systems biology: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis.

  PLoS computational biology 20090701

• Correction for QT/RR hysteresis in the assessment of drug-induced QTc changes--cardiac safety of gadobutrol.

  Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20090701

• [Successful treatment of Legionella pneumonia with moxifloxacin in a hemodialysis patient].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20090701

• Treatment of multidrug-resistant and extensively drug-resistant tuberculosis: current status and future prospects.

  Expert review of clinical pharmacology 20090701

• Spontaneous anterior lens capsular dehiscence causing lens particle glaucoma.

  Yonsei medical journal 20090630

• Moxifloxacin versus ethambutol in initial tuberculosis treatment.

  Lancet (London, England) 20090627

• Moxifloxacin versus ethambutol in initial tuberculosis treatment.

  Lancet (London, England) 20090627

• Levofloxacin 0.5% ophthalmic solution: a review of its use in the treatment of external ocular infections and in intraocular surgery.

  Drugs 20090618

• Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of moxifloxacin in sheep.

  Veterinary journal (London, England : 1997) 20090601

• Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance.

  The Journal of antimicrobial chemotherapy 20090601

• Association between moxifloxacin ophthalmic solution and fungal infection in patients with corneal ulcers and microbial keratitis.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090601

• Pharmacokinetic, pharmacodynamic, and electrocardiographic effects of dapoxetine and moxifloxacin compared with placebo in healthy adult male subjects.

  Journal of clinical pharmacology 20090601

• Antibiotic susceptibility of conjunctival bacterial isolates from refractive surgery patients.

  Ophthalmology 20090601

• Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090601

• Late-onset laser in situ keratomileusis-related corneal ulcer--a case series.

  Cornea 20090601

• Intracameral moxifloxacin: in vitro safety on human ocular cells.

  Cornea 20090601

• Simultaneous determination of bisoprolol and hydrochlorothiazide in human plasma by HPLC coupled with tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090601

• Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases.

  Nature structural & molecular biology 20090601

• Electrocardiographic QTc changes due to moxifloxacin infusion.

  Journal of clinical pharmacology 20090601

• Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain.

  Emerging infectious diseases 20090601

• The first case of antibiotic-associated colitis by Clostridium difficile PCR ribotype 027 in Korea.

  Journal of Korean medical science 20090601

• [A case of primary pulmonary nocardiosis with multiple pulmonary nodules successfully treated with moxifloxacin].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20090601

• Rapid killing of M. leprae by moxifloxacin in two patients with lepromatous leprosy.

  Leprosy review 20090601

• [Antibacterial activity of quinolones against various clinically isolated strains and evaluation of efficacy based on the pharmacokinetics/pharmacodynamics theory].

  The Japanese journal of antibiotics 20090601

• Propofol infusion syndrome: case report and literature review.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20090515

• [First Danish case of Clostridium difficile ribotype 027].

  Ugeskrift for laeger 20090504

• Trimethoprim/sulfamethoxazole resistance in urinary tract infections.

  The Journal of emergency medicine 20090501

• Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria.

  The Journal of antimicrobial chemotherapy 20090501

• Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.

  The Journal of antimicrobial chemotherapy 20090501

• Period correction of the QTc of moxifloxacin with multiple predose baseline ECGs is the least variable of 4 methods tested.

  Journal of clinical pharmacology 20090501

• Antimicrobial ambiguine isonitriles from the cyanobacterium Fischerella ambigua.

  Journal of natural products 20090501

• Cross-border dissemination of methicillin-resistant Staphylococcus aureus, Euregio Meuse-Rhin region.

  Emerging infectious diseases 20090501

• Methicillin-Resistant Staphylococcus aureus ST398 from human patients, upper Austria.

  Emerging infectious diseases 20090501

• Possible seasonality of Clostridium difficile in retail meat, Canada.

  Emerging infectious diseases 20090501

• Clostridium difficile in ready-to-eat salads, Scotland.

  Emerging infectious diseases 20090501

• Clostridium difficile in retail meat products, USA, 2007.

  Emerging infectious diseases 20090501

• Effect of subconjunctival bevacizumab on primary pterygium.

  Cornea 20090501

• Deferasirox does not induce QT/QTc-prolongation in healthy subjects.

  International journal of clinical pharmacology and therapeutics 20090501

• Severe and symptomatic hyponatraemia after moxifloxacin intake.

  The Netherlands journal of medicine 20090501

• Outbreak of Clostridium difficile 027 infection in Vienna, Austria 2008-2009.

  Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20090430

• Outbreak of Clostridium difficile 027 in North Zealand, Denmark, 2008-2009.

  Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20090423

• Simple and rapid liquid chromatography method for determination of moxifloxacin in plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090415

• Antibiotic susceptibility of thermo-tolerant Escherichia coli 2 isolated from drinking water of Khairpur City, Sindh, Pakistan.

  Pakistan journal of biological sciences : PJBS 20090415

• Measurement and regulation of cardiac ventricular repolarization: from the QT interval to repolarization morphology.

  Philosophical transactions. Series A, Mathematical, physical, and engineering sciences 20090413

• 'My foot hurts': a flare of rheumatoid arthritis?

  The Medical journal of Australia 20090406

• Fourth-generation fluoroquinolones in tuberculosis.

  Lancet (London, England) 20090404

• Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.

  Lancet (London, England) 20090404

• [Nosocomial urinary tract infections in the geriatric hospital - pathogen spectrum and resistancies].

  Zeitschrift fur Gerontologie und Geriatrie 20090401

• Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes.

  International journal of antimicrobial agents 20090401

• Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a synthetic carrier of calcium sulphate (Stimulan) releasing moxifloxacin.

  International journal of antimicrobial agents 20090401

• Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype and revertant strains.

  Antimicrobial agents and chemotherapy 20090401

• In vitro selection of resistance in Streptococcus pneumoniae at in vivo fluoroquinolone concentrations.

  The Journal of antimicrobial chemotherapy 20090401

• The mitochondria targeted antioxidant MitoQ protects against fluoroquinolone-induced oxidative stress and mitochondrial membrane damage in human Achilles tendon cells.

  Free radical research 20090401

• Pharmacokinetics of fluoroquinolones in critical care patients: A bio-analytical HPLC method for the simultaneous quantification of ofloxacin, ciprofloxacin and moxifloxacin in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090401

• Stability of extemporaneously prepared moxifloxacin oral suspensions.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20090401

• Segniliparus rugosus infection, Australia.

  Emerging infectious diseases 20090401

• Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.

  Advances in therapy 20090401

• Bactericidal activity of moxifloxacin on exponential and stationary phase cultures of Mycobacterium tuberculosis.

  Journal of chemotherapy (Florence, Italy) 20090401

• Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study).

  Journal of chemotherapy (Florence, Italy) 20090401

• [Severe bacterial keratitis and activity of fluoroquinolones].

  Journal francais d'ophtalmologie 20090401

• [Antimicrobial susceptibility surveillance of recent isolates from otorhinolaryngological infections to garenoxacin and other antimicrobial drugs].

  The Japanese journal of antibiotics 20090401

• The insulinotropic effect of fluoroquinolones.

  Biochemical pharmacology 20090315

• Mycobacterium chelonae infection in a tattoo site.

  The Medical journal of Australia 20090302

• In vitro antibiotic susceptibility of preoperative normal conjunctival bacteria.

  Eye (London, England) 20090301

• Antimicrobial susceptibility of anaerobic bacteria in Belgium as determined by E-test methodology.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20090301

• Enhanced distribution of fourth-generation fluoroquinolones in prostatic tissue.

  International journal of antimicrobial agents 20090301

• Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli.

  The Journal of antimicrobial chemotherapy 20090301

• High doses of levofloxacin vs moxifloxacin against staphylococcal experimental foreign-body infection: the effect of higher MIC-related pharmacokinetic parameters on efficacy.

  The Journal of infection 20090301

• Effects of standard and supratherapeutic doses of nelfinavir on cardiac repolarization: a thorough QT study.

  Journal of clinical pharmacology 20090301

• Susceptibility comparisons of normal preoperative conjunctival bacteria to fluoroquinolones.

  Journal of cataract and refractive surgery 20090301

• Exploration of the African green monkey as a preclinical pharmacokinetic model: oral pharmacokinetic parameters and drug-drug interactions.

  Xenobiotica; the fate of foreign compounds in biological systems 20090301

• Topical and oral voriconazole in the treatment of fungal keratitis.

  Korean journal of ophthalmology : KJO 20090301

• Pharmacokinetics and tissue residues of moxifloxacin in broiler chickens.

  British poultry science 20090301

• Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial.

  Neuroscience 20090206

• Corticosteroids for bacterial corneal ulcers.

  The British journal of ophthalmology 20090201

• Pharmacokinetics of intravenously administered moxifloxacin in eye compartments: an experimental study.

  International journal of antimicrobial agents 20090201

• Spectrofluorimetric determination of fluoroquinolones in pharmaceutical preparations.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20090201

• In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum.

  The Journal of antimicrobial chemotherapy 20090201

• Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV.

  Therapeutic drug monitoring 20090201

• Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus.

  The Journal of antimicrobial chemotherapy 20090201

• Patients' perception of recovery after third molar surgery following postoperative treatment with moxifloxacin versus amoxicillin and clavulanic acid: a randomized, double-blind, controlled study.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090201

• Fluorescence quenching as a tool to investigate quinolone antibiotic interactions with bacterial protein OmpF.

  The Journal of membrane biology 20090201

• Fluoroquinolones and postoperative endophthalmitis.

  Journal of cataract and refractive surgery 20090201

• Fluoroquinolones and postoperative endophthalmitis.

  Journal of cataract and refractive surgery 20090201

• Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan.

  Helicobacter 20090201

• Influence of type and neutralisation capacity of antacids on dissolution rate of ciprofloxacin and moxifloxacin from tablets.

  Bosnian journal of basic medical sciences 20090201

• Emergence of pristinamycin resistance in India.

  Indian journal of pharmacology 20090201

• Treatment of extensively drug-resistant tuberculosis.

  Lancet (London, England) 20090103

• Clinical and microbiological efficacy of moxifloxacin versus amoxicillin/clavulanic acid in severe odontogenic abscesses: a pilot study.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20090101

• Successful treatment with moxifloxacin of experimental aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).

  International journal of antimicrobial agents 20090101

• Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).

  International journal of antimicrobial agents 20090101

• Community acquired Clostridium difficile infection due to a moxifloxacin susceptible ribotype 027 strain.

  Scandinavian journal of infectious diseases 20090101

• A once-weekly R207910-containing regimen exceeds activity of the standard daily regimen in murine tuberculosis.

  American journal of respiratory and critical care medicine 20090101

• Activity of antibiotics against Fusarium and Aspergillus.

  The British journal of ophthalmology 20090101

• Cerebrospinal fluid of patients administered moxifloxacin modulates the secretion of cytokines from human monocytes.

  Diagnostic microbiology and infectious disease 20090101

• Severe pseudomembranous colitis after moxifloxacin use: a case series.

  The Annals of pharmacotherapy 20090101

• The resistance patterns of normal ocular bacterial flora to 4 fluoroquinolone antibiotics.

  Cornea 20090101

• Nocardial infection in Crete, Greece: review of fifteen cases from 2003 to 2007.

  Scandinavian journal of infectious diseases 20090101

• Clonal multidrug-resistant Corynebacterium striatum strains, Italy.

  Emerging infectious diseases 20090101

• Buruli ulcer in long-term traveler to Senegal.

  Emerging infectious diseases 20090101

• Automated QT measurement and application to detection of moxifloxacin-induced changes.

  Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20090101

• ECG evaluation of ventricular properties: the importance of cardiac cycle length.

  Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20090101

• Automated QT analysis that learns from cardiologist annotations.

  Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20090101

• Methicillin-resistant Staphylococcus aureus (MRSA) strain ST398 is present in midwestern U.S. swine and swine workers.

  PloS one 20090101

• Screening for sterilizing activity of antibiotic combinations in an acid model of rapidly growing mycobacteria during the stationary phase of growth.

  Chemotherapy 20090101

• Transmission of MDR and XDR tuberculosis in Shanghai, China.

  PloS one 20090101

• Corneal collagen cross-linking with riboflavin and ultraviolet - a light for keratoconus: results in Indian eyes.

  Indian journal of ophthalmology 20090101

• Emergence of respiratory Streptococcus agalactiae isolates in cystic fibrosis patients.

  PloS one 20090101

• T-SPOT.TB responses during treatment of pulmonary tuberculosis.

  BMC infectious diseases 20090101

• Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial.

  Wiener klinische Wochenschrift 20090101

• Acute generalized exanthematous pustulosis following oral treatment with moxifloxacine.

  European journal of dermatology : EJD 20090101

• Aspergillus iris granuloma: a case report with review of literature.

  Survey of ophthalmology 20090101

• Penetration of moxifloxacin into rat mandibular bone and soft tissue.

  Acta odontologica Scandinavica 20090101

• Personal and societal health quality lost to tuberculosis.

  PloS one 20090101

• Defining the role of macrophages in local moxifloxacin tissue concentrations using biopsy data and whole-body physiologically based pharmacokinetic modelling.

  Clinical pharmacokinetics 20090101

• Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in two university hospitals in Istanbul, Turkey.

  Chemotherapy 20090101

• Extensively drug resistance (XDR) tb is not always fatal.

  The Indian journal of tuberculosis 20090101

• Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes.

  Drug safety 20090101

• Validation of the normal, freely moving Göttingen minipig for pharmacological safety testing.

  Journal of pharmacological and toxicological methods 20090101

• How beta-lactam antibiotics enter bacteria: a dialogue with the porins.

  PloS one 20090101

• Efficacy of amoxycillin versus amoxycillin/clavulanate in acute exacerbations of chronic pulmonary obstructive disease in primary care.

  International journal of chronic obstructive pulmonary disease 20090101

• Ten years of antibiotic consumption in ambulatory care: trends in prescribing practice and antibiotic resistance in Austria.

  BMC infectious diseases 20090101

• Occurrence of HSV-1-induced pneumonitis in patients under standard immunosuppressive therapy for rheumatic, vasculitic, and connective tissue disease.

  BMC pulmonary medicine 20090101

• [Conjunctivitis due to Achromobacter xylosoxidans: case report].

  Arquivos brasileiros de oftalmologia 20090101

• Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis.

  Ophthalmic research 20090101

• [New indications for novel fluoroquinolones: moxifloxacin in the treatment of nosocomial infections].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20090101

• [Pharmacodynamics of antibiotics in CSF: principles and consequences (predictive factors of efficacy)].

  Medecine et maladies infectieuses 20090101

• Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?

  Critical care (London, England) 20090101

• Delineating bacteriostatic and bactericidal targets in mycobacteria using IPTG inducible antisense expression.

  PloS one 20090101

• Genetic relatedness and molecular characterization of multidrug resistant Acinetobacter baumannii isolated in central Ohio, USA.

  Annals of clinical microbiology and antimicrobials 20090101

• Conjugative IncFI plasmids carrying CTX-M-15 among Escherichia coli ESBL producing isolates at a University hospital in Germany.

  BMC infectious diseases 20090101

• Scleral ulceration after vitreoretinal surgery.

  Indian journal of ophthalmology 20090101

• Bacterial thymidine kinase as a non-invasive imaging reporter for Mycobacterium tuberculosis in live animals.

  PloS one 20090101

• The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.

  American journal of therapeutics 20090101

• [Study of efficacy of modern fluoroquinolones against agent of glanders in experiments in vivo].

  Zhurnal mikrobiologii, epidemiologii, i immunobiologii 20090101

• Risk factors for nasopharyngeal carriage of drug-resistant Streptococcus pneumoniae: data from a nation-wide surveillance study in Greece.

  BMC infectious diseases 20090101

• Actinomyces species: A danish survey on human infections and microbiological characteristics.

  The open microbiology journal 20090101

• Intracameral dexamethasone reduces inflammation on the first postoperative day after cataract surgery in eyes with and without glaucoma.

  Clinical ophthalmology (Auckland, N.Z.) 20090101

• Gemifloxacin use in the treatment of acute bacterial exacerbation of chronic bronchitis.

  International journal of chronic obstructive pulmonary disease 20090101

• Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus.

  BMC microbiology 20090101

• Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days).

  BMC infectious diseases 20090101

• Comparative analysis of length of stay, total costs, and treatment success between intravenous moxifloxacin 400 mg and levofloxacin 750 mg among hospitalized patients with community-acquired pneumonia.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20090101

• Outer membrane porin M35 of Moraxella catarrhalis mediates susceptibility to aminopenicillins.

  BMC microbiology 20090101

• Mycoplasma pneumoniae community-acquired pneumonia (CAP) in the elderly: Diagnostic significance of acute thrombocytosis.

  Heart & lung : the journal of critical care 20090101

• Pharmacokinetics of moxifloxacin in patients undergoing continuous ambulatory peritoneal dialysis.

  Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20090101

• Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium.

  Genome biology 20090101

• Anti-inflammatory effects of antibacterials on human Bronchial epithelial cells.

  Respiratory research 20090101

• Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics.

  Clinical ophthalmology (Auckland, N.Z.) 20090101

• Drugs associated with more suicidal ideations are also associated with more suicide attempts.

  PloS one 20090101

• Safety profile of Coartem: the evidence base.

  Malaria journal 20090101

• Ofloxacin induced leucopenia in complicated falciparum malaria: a case report.

  Cases journal 20090101

• Moxifloxacin induced fatal hepatotoxicity in a 72-year-old man: a case report.

  Cases journal 20090101

• Empiric antibiotic therapy in acute uncomplicated urinary tract infections and fluoroquinolone resistance: a prospective observational study.

  Annals of clinical microbiology and antimicrobials 20090101

• Intracameral recombinant tissue plasminogen activator for refractory glaucoma secondary to a fungal corneal abscess.

  The open ophthalmology journal 20090101

• Intraocular penetration of sequentially instilled topical moxifloxacin, gatifloxacin, and levofloxacin.

  Clinical ophthalmology (Auckland, N.Z.) 20090101

• Mycobacterium marinum Hand Infection in a 'Sushi Chef'.

  Eplasty 20090101

• Non-specific interstitial pneumonia as the initial presentation of biphenotypic acute leukemia: a case report.

  Cases journal 20090101

• New antibiotics: optimal use in current clinical practice.

  International journal of antimicrobial agents 20090101

• Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States.

  BMC ophthalmology 20090101

• C. pneumoniae community-acquired pneumonia (CAP) in mimicking Mycoplasma pneumoniae meningoencephalitis complicated by asthma.

  Heart & lung : the journal of critical care 20090101

• Fesoterodine for the treatment of urinary incontinence and overactive bladder.

  Therapeutics and clinical risk management 20090101

• The treatment of diabetic foot infections: focus on ertapenem.

  Vascular health and risk management 20090101

• Managing human bites.

  Journal of emergencies, trauma, and shock 20090101

• Moxifloxacin-based triple therapy versus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection: a meta-analysis of randomized controlled trials.

  Internal medicine (Tokyo, Japan) 20090101

• The Differential Gene Expression Pattern of Mycobacterium tuberculosis in Response to Capreomycin and PA-824 versus First-Line TB Drugs Reveals Stress- and PE/PPE-Related Drug Targets.

  International journal of microbiology 20090101

• Clonal dissemination of the multi-drug resistant Salmonella enterica serovar Braenderup, but not the serovar Bareilly, of prevalent serogroup C1 Salmonella from Taiwan.

  BMC microbiology 20090101

• Effect of the novel influenza A (H1N1) virus in the human immune system.

  PloS one 20090101

• [Efficacy of levofloxacin, lomefloxacin and moxifloxacin vs. other fluoroquinolones in experimental plague due to FI+ and FI- strains of Yersinia pestis in Albino mice].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20090101

• Anaerobic bacteria as a cause of mycotic aneurysm of the aorta: microbiology and antimicrobial therapy.

  Current cardiology reviews 20090101

• Lemierre's syndrome, reemergence of a forgotten disease: a case report.

  Cases journal 20090101

• Increasing resistance to quinolones: A four-year prospective study of urinary tract infection pathogens.

  International journal of general medicine 20090101

• Prevention of acute chemotherapy-induced nausea and vomiting: the role of palonosetron.

  Cancer management and research 20090101

• Palonosetron for the prevention of chemotherapy-induced nausea and vomiting: approval and efficacy.

  Cancer management and research 20090101

• Dosing Recommendations for Continuous Venovenous Hemodiafiltration with AN69 Filter Membranes and Prismaflex Dialyzers.

  The Canadian journal of hospital pharmacy 20090101

• Trace analysis of quinolone and fluoroquinolone antibiotics from wastewaters by liquid chromatography-electrospray tandem mass spectrometry.

  Journal of chromatography. A 20081219

• Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany.

  Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20081204

• Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20081202

• Moxifloxacine plus amoxicillin and ranitidine bismuth citrate or esomeprazole triple therapies for Helicobacter pylori infection.

  Digestive diseases and sciences 20081201

• Epidemiology of Clostridium difficile-associated disease at University Hospital Basel including molecular characterisation of the isolates 2006-2007.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20081201

• Penicillin compared with other advanced broad spectrum antibiotics regarding antibacterial activity against oral pathogens isolated from odontogenic abscesses.

  Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20081201

• In vitro elution of moxifloxacin and fusidic acid by a synthetic crystallic semihydrate form of calcium sulphate (Stimulan).

  International journal of antimicrobial agents 20081201

• Interpretive categorical accuracy of fluoroquinolone reference broth microdilution MIC results when testing Streptococcus pneumoniae: selection of a surrogate testing agent.

  Diagnostic microbiology and infectious disease 20081201

• Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20081201

• Comparison of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens- and non-contact lens-related keratitis.

  Journal of medical microbiology 20081201

• Determination of the inhibitory potential of 6 fluoroquinolones on CYP1A2 and CYP2C9 in human liver microsomes.

  Acta pharmacologica Sinica 20081201

• Calculation of AQCmax: comparison of five ophthalmic fluoroquinolone solutions*.

  Current medical research and opinion 20081201

• A comparison of fluoroquinolone penetration into human conjunctival tissue.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20081201

• Gas-forming parotid abscess in a diabetic patient: an unusual complication of Salmonella enteritidis bacteremia.

  The American journal of the medical sciences 20081201

• An update on invasive pneumococcal antibiotic resistance in Turkey, 2008.

  Journal of chemotherapy (Florence, Italy) 20081201

• Use of azithromycin in the treatment of acute exacerbations of COPD.

  International journal of chronic obstructive pulmonary disease 20081201

• Effects of treatment with antimicrobial agents on the human colonic microflora.

  Therapeutics and clinical risk management 20081201

• Duloxetine in the treatment of generalized anxiety disorder.

  Neuropsychiatric disease and treatment 20081201

• Extensively drug-resistant tuberculosis.

  The New England journal of medicine 20081127

• Linking bisphosphonates to the free amino groups in fluoroquinolones: preparation of osteotropic prodrugs for the prevention of osteomyelitis.

  Journal of medicinal chemistry 20081113

• Disposition kinetics of moxifloxacin in lactating ewes.

  Veterinary journal (London, England : 1997) 20081101

• Thorough QT/QTc study in patients with advanced Parkinson's disease: cardiac safety of rotigotine.

  Clinical pharmacology and therapeutics 20081101

• Development and validation of a HPLC method for simultaneous quantitation of gatifloxacin, sparfloxacin and moxifloxacin using levofloxacin as internal standard in human plasma: application to a clinical pharmacokinetic study.

  Biomedical chromatography : BMC 20081101

• [Severe febrile illness with renal impairment after travel to Southeast Asia].

  Der Internist 20081101

• Disseminated salmonellosis in a patient treated with temozolomide.

  The Journal of infection 20081101

• Isoniazid or moxifloxacin in rifapentine-based regimens for experimental tuberculosis?

  American journal of respiratory and critical care medicine 20081101

• Emerging therapies for the treatment of Helicobacter pylori infections.

  The Annals of pharmacotherapy 20081101

• Bacteremia caused by Mycobacterium wolinskyi.

  Emerging infectious diseases 20081101

• [Traumatic Endophthalmitis Prevention Trial (TEPT)].

  Klinische Monatsblatter fur Augenheilkunde 20081101

• Contamination of chicken meat with Salmonella enterica Serovar Haardt with nalidixic acid resistance and reduced fluoroquinolone susceptibility.

  Journal of microbiology and biotechnology 20081101

• Anti-inflammatory effects of besifloxacin, a novel fluoroquinolone, in primary human corneal epithelial cells.

  Current eye research 20081101

• [A severe side effect of antitubercular therapy: pyrazinamide induced thrombocytopenia].

  Revue des maladies respiratoires 20081101

• Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers.

  Clinical therapeutics 20081101

• Ethyl 1-cyclo-propyl-6,7-difluoro-8-meth-oxy-4-oxo-1,4-dihydro-quinoline-3-carboxyl-ate.

  Acta crystallographica. Section E, Structure reports online 20081101

• Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007-08.

  Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20081009

• Facilitated permeation of antibiotics across membrane channels--interaction of the quinolone moxifloxacin with the OmpF channel.

  Journal of the American Chemical Society 20081008

• Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease.

  Sexually transmitted infections 20081001

• An intrinsic pattern of reduced susceptibility to fluoroquinolones in pediatric isolates of Streptococcus pyogenes.

  Diagnostic microbiology and infectious disease 20081001

• Eikenella corrodens as a causative agent for neonatal conjunctivitis.

  Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 20081001

• Comparison of the effects of fourth-generation fluoroquinolones on corneal re-epithelialization in rabbit eyes.

  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20081001

• Successful treatment of post-neurosurgical intracranial Mycoplasma hominis infection using gatifloxacin.

  The Journal of infection 20081001

• Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20081001

• Surveillance study of the susceptibility of Haemophilus influenzae to various antibacterial agents in Europe and Canada.

  Current medical research and opinion 20081001

• Mycoplasma hominis meningitis in a neonate: case report and review.

  The Journal of infection 20081001

• Antimicrobial activity of acrylic intraocular lenses soaked in fourth generation fluoroquinolones.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20081001

• Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study.

  International journal of STD & AIDS 20081001

• Moxifloxacin as an adjunctive antibiotic in the treatment of severe chronic periodontitis.

  Journal of periodontology 20081001

• Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy.

  Advances in therapy 20081001

• Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis.

  Therapeutics and clinical risk management 20081001

• The effect of moxifloxacin on QTc and implications for the design of thorough QT studies.

  Clinical pharmacology and therapeutics 20081001

• Recent Advances in Multi-Drug-Resistant Tuberculosis and RNTCP.

  Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine 20081001

• Pharmacogenomics.

  Indian journal of pharmacology 20081001

• Moxifloxacin monotherapy in severe pneumonia: do we really need it?

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080915

• Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20080901

• Single- and multiple-dose pharmacokinetics of intravenous moxifloxacin in patients with severe hepatic impairment.

  The Journal of antimicrobial chemotherapy 20080901

• Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes.

  The Journal of antimicrobial chemotherapy 20080901

• Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects.

  British journal of clinical pharmacology 20080901

• Acute bacterial maxillary sinusitis: time to symptom resolution and return to normal activities with moxifloxacin.

  International journal of clinical practice 20080901

• Mechanism of binding of fluoroquinolones to the quinolone resistance-determining region of DNA gyrase: towards an understanding of the molecular basis of quinolone resistance.

  Chembiochem : a European journal of chemical biology 20080901

• Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery.

  Journal of cataract and refractive surgery 20080901

• Third- and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years.

  Journal of cataract and refractive surgery 20080901

• Effect of nepafenac sodium 0.1% on delayed corneal epithelial healing and haze after photorefractive keratectomy: retrospective comparative study.

  Journal of cataract and refractive surgery 20080901

• Evaluation of toxicity of commercial ophthalmic fluoroquinolone antibiotics as assessed on immortalized corneal and conjunctival epithelial cells.

  Cornea 20080901

• [In vitro generation of mutants of Klebsiella pneumoniae following exposure to fluorquinolones. Relationship with the presence of extended spectrum betalactamases].

  Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20080901

• Therapeutic effect of a novel oxazolidinone, DA-7867, in BALB/c mice infected with Nocardia brasiliensis.

  PLoS neglected tropical diseases 20080901

• Biofilm formation is not necessary for development of quinolone-resistant 'persister' cells in an attached Staphylococcus epidermidis population.

  The International journal of artificial organs 20080901

• Antimicrobial activity among multidrug-resistant Streptococcus pneumoniae isolated in the United States, 2001-2005.

  Postgraduate medicine 20080901

• Decline in the prevalence of pandemic clones Spain23F-1 and Spain9V-3 among US fluoroquinolone-resistant Streptococcus pneumoniae TRUST Surveillance isolates since 2001.

  Postgraduate medicine 20080901

• Role of macrolide therapy in chronic obstructive pulmonary disease.

  International journal of chronic obstructive pulmonary disease 20080901

• Delayed epithelial ingrowth caused by viral conjunctivitis after LASIK.

  Yonsei medical journal 20080830

• [Novel side effects of moxifloxacin: making a balanced decision again].

  Nederlands tijdschrift voor geneeskunde 20080823

• Penetration and accumulation of moxifloxacin in uterine tissue.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20080801

• Doxycycline or moxifloxacin for the management of community-acquired pneumonia in the UK?

  International journal of antimicrobial agents 20080801

• A case of fungal keratitis: a clinical and in vivo confocal microscopy assessment.

  Contact lens & anterior eye : the journal of the British Contact Lens Association 20080801

• Effect of brivaracetam on cardiac repolarisation--a thorough QT study.

  Current medical research and opinion 20080801

• Literature-based evaluation of four 'hard endpoint' models for assessing drug-induced torsades de pointes liability.

  British journal of pharmacology 20080801

• Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin.

  Journal of cataract and refractive surgery 20080801

• Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 2: residual conjunctival flora.

  Journal of cataract and refractive surgery 20080801

• Prospective comparison of topical moxifloxacin in eliminating conjunctival bacterial flora following a one-day or one-hour application.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20080801

• Moxifloxacin as the likely cause of drug-induced linear immunoglobulin A bullous dermatosis.

  Journal of drugs in dermatology : JDD 20080801

• Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20080801

• [Pseudomonas aeruginosa keratitis associated with the use of last generation contact lens made of silicone hydrogel: case report].

  Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 20080801

• [Synthesis and antibacterial activity of 7-(3-amino-4-alkoxyimino-1 -piperidyl) -quinolones].

  Yao xue xue bao = Acta pharmaceutica Sinica 20080801

• New compounds in the management of venous thromboembolism after orthopedic surgery: focus on rivaroxaban.

  Vascular health and risk management 20080801

• Moxifloxacin: update and perspectives after 8 years of usage.

  Expert review of respiratory medicine 20080801

• Intravesical treatments of bladder cancer: review.

  Pharmaceutical research 20080701

• Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece.

  The Journal of antimicrobial chemotherapy 20080701

• Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae.

  The Journal of antimicrobial chemotherapy 20080701

• Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells.

  American journal of physiology. Lung cellular and molecular physiology 20080701

• Effects of aliskiren, a direct Renin inhibitor, on cardiac repolarization and conduction in healthy subjects.

  Journal of clinical pharmacology 20080701

• In vitro synergism of beta-lactams with ciprofloxacin and moxifloxacin against genetically distinct multidrug-resistant isolates of Pseudomonas aeruginosa.

  International journal of antimicrobial agents 20080701

• Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins.

  The Journal of infection 20080701

• A pharmacoeconomic review of the management of respiratory tract infections with moxifloxacin.

  Expert opinion on pharmacotherapy 20080701

• Moxifloxacin: a respiratory fluoroquinolone.

  Expert opinion on pharmacotherapy 20080701

• Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery.

  Journal of cataract and refractive surgery 20080701

• Report of a case of Streptococcus agalactiae mycotic aneurysm and review of the literature.

  International journal of surgical pathology 20080701

• Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei.

  Emerging infectious diseases 20080701

• Toxinotype V Clostridium difficile in humans and food animals.

  Emerging infectious diseases 20080701

• A significant interaction between moxifloxacin and warfarin in a patient with a mitral bioprosthetic valve.

  Heart and vessels 20080701

• Antimicrobial susceptibility of Streptococcus pneumoniae in the oropharynx of healthy preschool children and identification of risk factors.

  Japanese journal of infectious diseases 20080701

• Pharmacokinetics of moxifloxacin in non-inflamed cerebrospinal fluid of humans: implication for a bactericidal effect.

  The Journal of antimicrobial chemotherapy 20080601

• Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates.

  American journal of ophthalmology 20080601

• Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic fibroblasts).

  The Journal of antimicrobial chemotherapy 20080601

• Raltegravir thorough QT/QTc study: a single supratherapeutic dose of raltegravir does not prolong the QTcF interval.

  Journal of clinical pharmacology 20080601

• Etravirine has no effect on QT and corrected QT interval in HIV-negative volunteers.

  The Annals of pharmacotherapy 20080601

• Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolones.

  The British journal of ophthalmology 20080601

• Genomes of model organisms: know thy tools.

  Environmental microbiology 20080601

• Characterization of clinical Clostridium difficile isolates by PCR ribotyping and detection of toxin genes in Austria, 2006-2007.

  Journal of medical microbiology 20080601

• Antibiotics involved in Clostridium difficile-associated disease increase colonization factor gene expression.

  Journal of medical microbiology 20080601

• Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe.

  Journal of medical microbiology 20080601

• Moxifloxacin for bacterial keratitis.

  Ophthalmology 20080601

• Acute streptococcal myopericarditis mimicking myocardial infarction.

  The American journal of emergency medicine 20080601

• Extensively drug-resistant tuberculosis, Lesotho.

  Emerging infectious diseases 20080601

• Mycobacterium peregrinum: bactericidal activity of antibiotics alone and in combination.

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20080601

• [Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci].

  Biomedica : revista del Instituto Nacional de Salud 20080601

• Prevalence of antimicrobial resistances in Streptococcus pneumoniae in Australia, 2005: report from the Australian Group on Antimicrobial Resistance.

  Communicable diseases intelligence quarterly report 20080601

• Efficacy and tolerability of a fixed-dose moxifloxacin - dexamethasone formulation for topical prophylaxis in LASIK: a comparative, double-masked clinical trial.

  Clinical ophthalmology (Auckland, N.Z.) 20080601

• Potential bias in ophthalmic pharmaceutical clinical trials.

  Clinical ophthalmology (Auckland, N.Z.) 20080601

• In vitro activity of moxifloxacin and piperacillin/sulbactam against pathogens of acute cholangitis.

  World journal of gastroenterology 20080528

• Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080515

• Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes.

  The Journal of antimicrobial chemotherapy 20080501

• Determination of moxifloxacin anaerobic susceptibility breakpoints according to the Clinical and Laboratory Standards Institute guidelines.

  Diagnostic microbiology and infectious disease 20080501

• A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial.

  Current medical research and opinion 20080501

• Interactions between warfarin and three commonly prescribed fluoroquinolones.

  The Annals of pharmacotherapy 20080501

• Multidrug-resistant viridans streptococcus (MDRVS) osteomyelitis of the mandible successfully treated with moxifloxacin.

  Southern medical journal 20080501

• Primary Nocardia farcinica brain abscess with secondary meningitis and ventriculitis in an immunocompetent patient, successfully treated with moxifloxacin.

  Acta neurochirurgica 20080501

• Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given in different concentrations in a wick before cataract surgery.

  Journal of cataract and refractive surgery 20080501

• Microbial cultures of the microkeratome blade immediately after flap construction in laser in situ keratomileusis.

  Journal of cataract and refractive surgery 20080501

• Prevention of endophthalmitis by collagen shields presoaked in fourth-generation fluoroquinolones versus by topical prophylaxis.

  Journal of cataract and refractive surgery 20080501

• Minimising moxifloxacin resistance with tuberculosis.

  The Lancet. Infectious diseases 20080501

• Comparison of the effect of intracameral moxifloxacin, levofloxacin and cefazolin on rabbit corneal endothelial cells.

  Clinical & experimental ophthalmology 20080501

• Characterization of the interactions between fluoroquinolone antibiotics and lipids: a multitechnique approach.

  Biophysical journal 20080415

• Atomic absorption spectroscopic, conductometric and colorimetric methods for determination of some fluoroquinolone antibacterials using ammonium reineckate.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20080401

• Infectious scleritis after retinal surgery.

  American journal of ophthalmology 20080401

• Effect of single doses of maraviroc on the QT/QTc interval in healthy subjects.

  British journal of clinical pharmacology 20080401

• Moxifloxacin-associated neutropenia in a cirrhotic elderly woman with lower extremity cellulitis.

  The Annals of pharmacotherapy 20080401

• Virulence characteristics of community-associated Staphylococcus aureus and in vitro activities of moxifloxacin alone and in combination against community-associated and healthcare-associated meticillin-resistant and -susceptible S. aureus.

  Journal of medical microbiology 20080401

• Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.

  Cornea 20080401

• [Fluoroquinolones and Gram-negative bacteria: antimicrobial activity and mechanisms of resistance].

  Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20080401

• Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20080325

• Quinolones as enhancers of camptothecin-induced cytotoxic and anti-topoisomerase I effects.

  Biochemical pharmacology 20080315

• The epidemiology and treatment of infections in cancer patients.

  International journal of antimicrobial agents 20080301

• Frequency of 1st- and 2nd-step topoisomerase mutations in Streptococcus pneumoniae following levofloxacin and moxifloxacin exposure.

  Diagnostic microbiology and infectious disease 20080301

• Deep infection of a total knee implant as a complication of disseminated pneumococcal sepsis. A case report and review of literature.

  The Knee 20080301

• Does in vitro susceptibility predict clinical outcome in bacterial keratitis?

  American journal of ophthalmology 20080301

• Plasma protein binding of fluoroquinolones affects antimicrobial activity.

  The Journal of antimicrobial chemotherapy 20080301

• A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium.

  Current medical research and opinion 20080301

• Moxifloxacin versus ampicillin + gentamicin in the therapy of experimental Listeria monocytogenes meningitis.

  The Journal of antimicrobial chemotherapy 20080301

• Haemophilus influenzae type-b and non-b-type invasive diseases in urban children (<5years) of Bangladesh: implications for therapy and vaccination.

  The Journal of infection 20080301

• In vitro safety of intravitreal moxifloxacin for endophthalmitis treatment.

  Journal of cataract and refractive surgery 20080301

• Phlyctenular keratoconjunctivitis in a patient with Staphylococcal blepharitis and ocular rosacea.

  Optometry (St. Louis, Mo.) 20080301

• Experience of Comamonas acidovorans keratitis with delayed onset and treatment response in immunocompromised cornea.

  Korean journal of ophthalmology : KJO 20080301

• In vitro susceptibilities of bacterial isolates from conjunctival flora to gatifloxacin, levofloxacin, tosufloxacin, and moxifloxacin.

  Eye & contact lens 20080301

• Vitreal penetration of oral moxifloxacin in humans.

  Retina (Philadelphia, Pa.) 20080301

• A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.

  Current medical research and opinion 20080301

• [Diagnosis and treatment of acute rhinosinusitis: second consensus].

  Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20080301

• Moxifloxacin.

  Tuberculosis (Edinburgh, Scotland) 20080301

• Optimizing antibiotic selection in treating COPD exacerbations.

  International journal of chronic obstructive pulmonary disease 20080301

• Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections.

  Clinical ophthalmology (Auckland, N.Z.) 20080301

• Fluoroquinolones compared to 1% azithromycin in DuraSite for bacterial conjunctivitis.

  Clinical ophthalmology (Auckland, N.Z.) 20080301

• Response to correspondence from Lichtenstein and Granet Re: Fluoroquinolones compared to 1% azithromycin in DuraSite for bacterial conjunctivitis.

  Clinical ophthalmology (Auckland, N.Z.) 20080301

• Influence of bacterial resistances on the efficiency of antibiotic treatments for community-acquired pneumonia.

  The European journal of health economics : HEPAC : health economics in prevention and care 20080201

• Chitosan microspheres for intrapulmonary administration of moxifloxacin: interaction with biomembrane models and in vitro permeation studies.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20080201

• In vitro pharmacodynamics of moxifloxacin versus levofloxacin against 4 strains of Streptococcus pneumoniae: 1 wild type, 2 first-step parC mutants, and 1 pump mutant.

  Diagnostic microbiology and infectious disease 20080201

• Serum bactericidal activities of moxifloxacin and levofloxacin against aerobic and anaerobic intra-abdominal pathogens.

  Anaerobe 20080201

• In vitro activity of fluoroquinolones against clinical isolates of Nocardia identified by partial 16S rRNA sequencing.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20080201

• Do fluoroquinolones predispose patients to Clostridium difficile associated disease? A review of the evidence.

  Current medical research and opinion 20080201

• Chronic bacterial prostatitis and relapsing Enterococcus faecalis bacteraemia successfully treated with moxifloxacin.

  The Journal of infection 20080201

• Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles.

  International journal of antimicrobial agents 20080201

• Intrinsic cytotoxic effects of fluoroquinolones on human corneal keratocytes and endothelial cells.

  Current medical research and opinion 20080201

• One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin.

  Helicobacter 20080201

• Late-onset interface inflammation associated with wearing cosmetic lenses 18 months after laser in situ keratomileusis.

  Cornea 20080201

• A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20080201

• Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess.

  Infection 20080201

• Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis.

  Journal of cataract and refractive surgery 20080201

• Endophthalmitis.

  Ophthalmology 20080201

• Early diagnosis of disseminated Mycobacterium genavense infection.

  Emerging infectious diseases 20080201

• Fluoroquinolone-resistant group B streptococci in acute exacerbation of chronic bronchitis.

  Emerging infectious diseases 20080201

• Stenotrophomonas maltophilia endocarditis treated with moxifloxacin-ceftazidime combination and annular wrapping technique.

  Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20080201

• In vitro antimicrobial susceptibility of Mycobacterium abscessus in Korea.

  Journal of Korean medical science 20080201

• Cigarette smoking-induced acute eosinophilic pneumonia: a case report including a provocation test.

  Journal of Korean medical science 20080201

• Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.

  Clinical therapeutics 20080201

• Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: can moxifloxacin activity be predicted by levofloxacin MIC results?

  Journal of chemotherapy (Florence, Italy) 20080201

• In vitro bactericidal activity of antibiotic combinations against clinical isolates of Mycobacterium chelonae.

  Journal of chemotherapy (Florence, Italy) 20080201

• Comparison of rifampicin and moxifloxacin efficacy in an experimental model of animal brucellosis.

  Journal of chemotherapy (Florence, Italy) 20080201

• Topical 0.5% moxifloxacin prevents endophthalmitis in an intravitreal injection rabbit model.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20080201

• In vitro activity of tigecycline, tetracycline and fluoroquinolones against Brucella melitensis.

  Journal of chemotherapy (Florence, Italy) 20080201

• Fluoroquinolones for treating tuberculosis.

  The Cochrane database of systematic reviews 20080123

• Ritonavir 100 mg does not cause QTc prolongation in healthy subjects: a possible role as CYP3A inhibitor in thorough QTc studies.

  Clinical pharmacology and therapeutics 20080101

• Mycobacterium fortuitum infection following total knee arthroplasty: a case report and literature review.

  The Knee 20080101

• Antimicrobial susceptibility of invasive group B streptococcal isolates from south-west Sweden 1988-2001.

  Scandinavian journal of infectious diseases 20080101

• Besifloxacin, a novel fluoroquinolone antimicrobial agent, exhibits potent inhibition of pro-inflammatory cytokines in human THP-1 monocytes.

  The Journal of antimicrobial chemotherapy 20080101

• Variation in the mutation frequency determining quinolone resistance in Chlamydia trachomatis serovars L2 and D.

  The Journal of antimicrobial chemotherapy 20080101

• Concentrations of moxifloxacin in plasma and urine, and penetration into prostatic fluid and ejaculate, following single oral administration of 400 mg to healthy volunteers.

  International journal of antimicrobial agents 20080101

• Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver.

  The Journal of pharmacy and pharmacology 20080101

• Randomized, double-blind, crossover study to investigate the effect of rivaroxaban on QT-interval prolongation.

  Drug safety 20080101

• Promising results for new tuberculosis therapy.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20080101

• Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients.

  Infection control and hospital epidemiology 20080101

• Comparison of the sterilising activities of the nitroimidazopyran PA-824 and moxifloxacin against persisting Mycobacterium tuberculosis.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20080101

• Antimicrobial efficacy of prophylactic gatifloxacin 0.3% and moxifloxacin 0.5% in patients undergoing phacoemulsification surgery.

  Eye & contact lens 20080101

• Comparing the protective effects of ciprofloxacin, moxifloxacin and levofloxacin in mice with lipopolysaccharide-induced acute lung injuries.

  Respirology (Carlton, Vic.) 20080101

• Primary photophysical properties of moxifloxacin--a fluoroquinolone antibiotic.

  Photochemistry and photobiology 20080101

• Pharmacokinetics and tissue penetration of moxifloxacin in intervention therapy for intra-abdominal abscess.

  Clinical drug investigation 20080101

• Immunomodulatory effect of gatifloxacin on mouse peritoneal macrophages in vitro and in models of endotoxin-induced rat conjunctivitis and rabbit bacterial keratitis.

  Ophthalmic research 20080101

• In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations.

  BMC microbiology 20080101

• Early bacterial keratitis after presbyopic LASIK.

  Cornea 20080101

• Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemia.

  APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 20080101

• Peripheral blood B lymphocytes derived from patients with idiopathic pulmonary arterial hypertension express a different RNA pattern compared with healthy controls: a cross sectional study.

  Respiratory research 20080101

• Bench-to-bedside review: Clostridium difficile colitis.

  Critical care (London, England) 20080101

• Fatal necrotizing pneumonia due to a Panton-Valentine leukocidin positive community-associated methicillin-sensitive Staphylococcus aureus and Influenza co-infection: a case report.

  Annals of clinical microbiology and antimicrobials 20080101

• Direct aspiration of capsular bag material in a case of sequestered endophthalmitis.

  Indian journal of ophthalmology 20080101

• Improving the detection of subtle I(Kr)-inhibition: assessing electrocardiographic abnormalities of repolarization induced by moxifloxacin.

  Drug safety 20080101

• Moxifloxacin-associated drug hypersensitivity syndrome with drug-induced hypersensitivity pneumonitis.

  Journal of investigational allergology & clinical immunology 20080101

• Pulmonary tuberculosis in a young pregnant female: challenges in diagnosis and management.

  Infectious diseases in obstetrics and gynecology 20080101

• Dental general anaesthetic receipt among Australians aged 15+ years, 1998-1999 to 2004-2005.

  BMC oral health 20080101

• Medical management approach to infectious keratitis.

  Indian journal of ophthalmology 20080101

• Acute orbital abscess complicating deep posterior subtenon triamcinolone injection.

  Indian journal of ophthalmology 20080101

• [Use of molecular-biological microchip TB-BIOCHIP-2 for detecting of Mycobacterium tuberculosis with multidrug resistance to fluoroquinolones in patients with new detected and chronic tuberculosis].

  Vestnik Rossiiskoi akademii meditsinskikh nauk 20080101

• Extensively drug resistant tuberculosis in a high income country: a report of four unrelated cases.

  BMC infectious diseases 20080101

• A statistical assessment of QT data following placebo and moxifloxacin dosing in thorough QT studies.

  Journal of biopharmaceutical statistics 20080101

• Validation testing in thorough QT/QTc clinical trials.

  Journal of biopharmaceutical statistics 20080101

• Statistical issues of QT prolongation assessment based on linear concentration modeling.

  Journal of biopharmaceutical statistics 20080101

• Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial.

  PloS one 20080101

• A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam.

  PloS one 20080101

• An overview of harms associated with beta-lactam antimicrobials: where do the carbapenems fit in?

  Critical care (London, England) 20080101

• Fluoroquinolone resistance during 2000-2005: an observational study.

  BMC infectious diseases 20080101

• Prevalence of putative virulence factors and antimicrobial susceptibility of Enterococcus faecalis isolates from patients with dental Diseases.

  BMC oral health 20080101

• Severe acute polyarthritis in a child after high doses of moxifloxacin.

  Scandinavian journal of infectious diseases 20080101

• Levofloxacin-induced delirium with psychotic features.

  General hospital psychiatry 20080101

• Novel gyrase mutations and characterization of ciprofloxacin-resistant clinical strains of Enterococcus faecalis isolated in Poland.

  Polish journal of microbiology 20080101

• Moxifloxacin-induced torsades de pointes.

  Cardiology journal 20080101

• A comparison of moxifloxacin and levofloxacin topical prophylaxis in a fluoroquinolone-resistant Staphylococcus aureus rabbit model.

  Japanese journal of ophthalmology 20080101

• Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: development and clinical application of two new immunoassays.

  Critical care (London, England) 20080101

• Improving antibiotic prescribing for adults with community acquired pneumonia: Does a computerised decision support system achieve more than academic detailing alone?--A time series analysis.

  BMC medical informatics and decision making 20080101

• Allergic reactions to oral drugs: A case/non-case study from an Italian spontaneous reporting database (GIF).

  Pharmacological research 20080101

• Pegaptanib combined with intravitreal injection of moxifloxacin as treatment of wet macular degeneration.

  Retina (Philadelphia, Pa.) 20080101

• Management of extensively drug-resistant tuberculosis in Peru: cure is possible.

  PloS one 20080101

• Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China.

  PloS one 20080101

• Evaluation of killing kinetics of anti-tuberculosis drugs on Mycobacterium tuberculosis using a bacteriophage-based assay.

  Chemotherapy 20080101

• [Treatment of cutaneous infections due to Mycobacterium fortuitum: two cases].

  Annales de dermatologie et de venereologie 20080101

• Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants.

  BMC microbiology 20080101

• Late development of esophageal stricture following radiation and chemotherapy for small cell carcinoma of the lung: A case report.

  Cases journal 20080101

• Diagnostic difficulties of Lactobacillus casei bacteraemia in immunocompetent patients: a case report.

  Journal of medical case reports 20080101

• [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].

  Pathologie-biologie 20080101

• The problems of meta-analysis for antibiotic treatment of chronic obstructive pulmonary disease, a heterogeneous disease: a commentary on Puhan et al.

  BMC medicine 20080101

• Persistence of Mycoplasma genitalium following azithromycin therapy.

  PloS one 20080101

• Spontaneous pneumomediastinum: diagnostic and therapeutic interventions.

  Journal of cardiothoracic surgery 20080101

• First isolation of Clostridium difficile PCR-ribotype 027/toxinotype III in Poland.

  Polish journal of microbiology 20080101

• [Culture proven bacterial endophthalmitis: a 6-year review].

  Arquivos brasileiros de oftalmologia 20080101

• Moxifloxacin versus polymyxin B/trimethoprim sulfate in pediatric bacterial conjunctivitis.

  Journal of pediatric ophthalmology and strabismus 20080101

• A multicenter comparison of polymyxin B sulfate/trimethoprim ophthalmic solution and moxifloxacin in the speed of clinical efficacy for the treatment of bacterial conjunctivitis.

  Journal of pediatric ophthalmology and strabismus 20080101

• The effects of moxifloxacin ophthalmic solution 0.5% or gatifloxacin ophthalmic solution 0.3% treatment on corneal wound healing in pigmented rabbits following anterior keratectomy.

  Veterinary ophthalmology 20080101

• [Unwanted side effects of antibacterials--a diagnostic challenge].

  Deutsche medizinische Wochenschrift (1946) 20080101

• Severe QT interval prolongation associated with moxifloxacin: a case report.

  Cases journal 20080101

• Medical management of genitourinary tuberculosis.

  Indian journal of urology : IJU : journal of the Urological Society of India 20080101

• Change in astigmatism after temporal clear corneal cataract extraction in the pediatric population.

  The open ophthalmology journal 20080101

• Mycobacterium fortuitum abdominal wall abscesses following liposuction.

  Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India 20080101

• Patch testing in non-immediate drug eruptions.

  Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20080101

• Transconjunctival Sutureless 23-gauge Vitrectomy for Vitreoretinal Diseases: Outcome of 30 Consecutive Cases.

  Middle East African journal of ophthalmology 20080101

• Mastoiditis secondary to mycobacterium abscessus imaged with gallium-67 scintigraphy.

  Biomedical imaging and intervention journal 20080101

• Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis.

  International journal of pharmaceutics 20071210

• Acute endophthalmitis after 25-gauge sutureless vitrectomy.

  International ophthalmology 20071201

• The influence of continuous venovenous haemodialysis on the pharmacokinetics of multiple oral moxifloxacin administration to patients with severe renal dysfunction.

  British journal of clinical pharmacology 20071201

• Ocular cysticercosis of the anterior segment.

  Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 20071201

• Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS).

  Rheumatology (Oxford, England) 20071201

• Efficacy and tolerability of a combined moxifloxacin/dexamethasone formulation for topical prophylaxis and reduction of inflammation in phacoemulsification: a comparative, double masked clinical trial.

  Current medical research and opinion 20071201

• Pharmacokinetic variables of moxifloxacin in healthy male camels following intravenous and intramuscular administration.

  Journal of veterinary pharmacology and therapeutics 20071201

• Anti-inflammatory effects of moxifloxacin and human beta-defensin 2 association in human lung epithelial cell line (A549) stimulated with lipopolysaccharide.

  Peptides 20071201

• Corneal wound healing in New Zealand White Rabbits following anterior keratectomy and treatment with moxifloxacin ophthalmic solution 0.5% or gatifloxacin ophthalmic solution 0.3%.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20071201

• Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy.

  Helicobacter 20071201

• A randomized study of sequential intravenous/oral moxifloxacin in comparison to sequential intravenous ceftriaxone/oral cefuroxime axetil in patients with hospital-acquired pneumonia.

  Infection 20071201

• Nosocomial pneumonia - are economical considerations important?

  Infection 20071201

• Late bacterial keratitis after intracorneal ring segments (Ferrara ring) insertion for keratoconus.

  Cornea 20071201

• Electroconvulsive therapy and antibiotics: a case report.

  The journal of ECT 20071201

• Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model.

  PLoS medicine 20071201

• [Antibacterial activity and pharmacological features of fluoroquinolones and considerations on their use in a nosocomial setting].

  Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20071201

• Comparative pharmacodynamics of garenoxacin, gemifloxacin, and moxifloxacin in community-acquired pneumonia caused by Streptococcus pneumoniae: a Monte Carlo simulation analysis.

  Clinical therapeutics 20071201

• Clinical applications of azithromycin microspheres in respiratory tract infections.

  International journal of nanomedicine 20071201

• Penetration of moxifloxacin and levofloxacin into cancellous and cortical bone in patients undergoing total hip arthroplasty.

  Journal of chemotherapy (Florence, Italy) 20071201

• Tissue concentrations of vancomycin and Moxifloxacin in periprosthetic infection in rats.

  Acta orthopaedica 20071201

• Rhodococcus equi infection after alemtuzumab therapy for T-cell prolymphocytic leukemia.

  Emerging infectious diseases 20071201

• Ototoxicity of topical moxifloxacin in a chinchilla animal model.

  The Laryngoscope 20071201

• Infectious keratitis secondary to Histoplasma capsulatum: the first case reports in humans.

  The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20071201

• [Prediction on the efficacy of fluoroquinolones for anaerobic infections using Monte Carlo simulation].

  The Japanese journal of antibiotics 20071201

• History and evolution of antibiotic resistance in coagulase-negative staphylococci: Susceptibility profiles of new anti-staphylococcal agents.

  Therapeutics and clinical risk management 20071201

• Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections.

  Therapeutics and clinical risk management 20071201

• Paliperidone ER: a review of the clinical trial data.

  Neuropsychiatric disease and treatment 20071201

• In the aftermath of the Fusarium keratitis outbreak: What have we learned?

  Clinical ophthalmology (Auckland, N.Z.) 20071201

• An assessment of the tolerability of moxifloxacin 0.5% compared to azithromycin 1.0% in DuraSite.

  Clinical ophthalmology (Auckland, N.Z.) 20071201

• Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations.

  The Journal of antimicrobial chemotherapy 20071101

• Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis.

  International journal of antimicrobial agents 20071101

• In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains.

  The Journal of antimicrobial chemotherapy 20071101

• Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro.

  The Journal of antimicrobial chemotherapy 20071101

• Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20071101

• Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study.

  European journal of clinical pharmacology 20071101

• [Interest of the disk diffusion method for screening Clostridium difficile isolates with decreased susceptibility to antibiotics].

  Pathologie-biologie 20071101

• [In vitro activity of moxifloxacin (8-methoxyquinolone) alone or in combination with cefotaxime against group B streptococci].

  Pathologie-biologie 20071101

• Population genetics and antibiotic susceptibility of invasive Haemophilus influenzae in Manitoba, Canada, from 2000 to 2006.

  FEMS immunology and medical microbiology 20071101

• The increasing problem of antibiotic resistance.

  Journal of cataract and refractive surgery 20071101

• Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.

  Journal of cataract and refractive surgery 20071101

• Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis.

  Journal of cataract and refractive surgery 20071101

• Building clinical trials capacity for tuberculosis drugs in high-burden countries.

  PLoS medicine 20071101

• Overview of anti-tuberculosis (TB) drugs and their resistance mechanisms.

  Mini reviews in medicinal chemistry 20071101

• In vitro permeation characteristics of moxifloxacin from oil drops through excised goat, sheep, buffalo and rabbit corneas.

  Die Pharmazie 20071101

• Doctors report breakthrough antibiotic treatment for TB.

  The AIDS reader 20071101

• Pulmonary disease caused by Mycobacterium xenopi: the first case in Korea.

  Yonsei medical journal 20071031

• Synthesis and antitubercular activity of lipophilic moxifloxacin and gatifloxacin derivatives.

  Bioorganic & medicinal chemistry letters 20071015

• Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20071015

• Validated spectrophotometric methods for the estimation of moxifloxacin in bulk and pharmaceutical formulations.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20071001

• [Tuberculosis treatment in 2007].

  Medecine et maladies infectieuses 20071001

• Emergency department drug orders: does drug storage location make a difference?

  Annals of emergency medicine 20071001

• Dose-related selection of fluoroquinolone-resistant Escherichia coli.

  The Journal of antimicrobial chemotherapy 20071001

• TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents.

  International journal of antimicrobial agents 20071001

• Low efficacy rate of moxifloxacin-containing Helicobacter pylori eradication treatment: in an observational study in a Turkish population.

  Helicobacter 20071001

• Susceptibility of oral obligate anaerobes to telithromycin, moxifloxacin and a number of commonly used antibacterials.

  Oral microbiology and immunology 20071001

• Allometric scaling of marbofloxacin, moxifloxacin, danofloxacin and difloxacin pharmacokinetics: a retrospective analysis.

  Journal of veterinary pharmacology and therapeutics 20071001

• Antimicrobial susceptibility and mechanism of resistance to fluoroquinolones in Staphylococcus intermedius and Staphylococcus schleiferi.

  Journal of veterinary pharmacology and therapeutics 20071001

• Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin.

  Journal of cataract and refractive surgery 20071001

• Patterns of perioperative prophylaxis for cataract surgery in Canada.

  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20071001

• Topical ophthalmic fourth-generation fluoroquinolones: Appropriate use and cost considerations.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20071001

• Drug combo speeds up TB treatment.

  AIDS patient care and STDs 20071001

• Generation of resistant mutants of Mycobacterium chelonae and Mycobacterium fortuitum after exposure to subinhibitory concentrations of clarithromycin and moxifloxacin.

  Journal of chemotherapy (Florence, Italy) 20071001

• Rapid increase of genetically diverse methicillin-resistant Staphylococcus aureus, Copenhagen, Denmark.

  Emerging infectious diseases 20071001

• Ciprofloxacin-resistant Neisseria meningitidis, Delhi, India.

  Emerging infectious diseases 20071001

• [Mycoplasma genitalium--aetiological agent of sexually transmitted infection].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20070906

• Antimicrobial phenotypes and molecular basis in clinical strains of Clostridium difficile.

  Diagnostic microbiology and infectious disease 20070901

• Antimicrobial resistance among invasive isolates of Streptococcus pneumoniae collected across Canada.

  Diagnostic microbiology and infectious disease 20070901

• Susceptibility of Bacillus anthracis, Bacillus cereus, Bacillus mycoides, Bacillus pseudomycoides and Bacillus thuringiensis to 24 antimicrobials using Sensititre automated microbroth dilution and Etest agar gradient diffusion methods.

  The Journal of antimicrobial chemotherapy 20070901

• [Modification of the histopathologic degree of inflammation in asymptomatic prostatitis (NIH IV) by moxifloxacin].

  Der Urologe. Ausg. A 20070901

• What are the most appropriate antibiotics for the treatment of acute exacerbation of chronic obstructive pulmonary disease? A therapeutic outcomes model.

  The Journal of antimicrobial chemotherapy 20070901

• Antistaphylococcal activities of CG400549, a new bacterial enoyl-acyl carrier protein reductase (FabI) inhibitor.

  The Journal of antimicrobial chemotherapy 20070901

• In vitro efficacy of imipenem in combination with six antimicrobial agents against Mycobacterium abscessus.

  International journal of antimicrobial agents 20070901

• Vitreous and aqueous penetration of orally administered moxifloxacin in humans.

  Eye (London, England) 20070901

• Treatment of respiratory tract infections with moxifloxacin: results of postmarketing surveillance in China.

  International journal of clinical practice 20070901

• Comparison of azithromycin and moxifloxacin against bacterial isolates causing conjunctivitis.

  Current medical research and opinion 20070901

• Bilateral peripheral infiltrative keratitis after LASIK.

  Korean journal of ophthalmology : KJO 20070901

• Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.

  Ophthalmology 20070901

• Torsade de pointes associated with moxifloxacin: a rare but potentially fatal adverse event.

  The Canadian journal of cardiology 20070901

• Validated polarographic methods for the determination of certain antibacterial drugs.

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20070901

• Activity of ulifloxacin against clinical hospital isolates.

  Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20070901

• Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD.

  International journal of chronic obstructive pulmonary disease 20070901

• Failure of isoniazid chemoprophylaxis during infliximab therapy.

  Emerging infectious diseases 20070901

• Delayed intraocular foreign body removal without endophthalmitis during Operations Iraqi Freedom and Enduring Freedom.

  Ophthalmology 20070801

• Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate.

  The Journal of antimicrobial chemotherapy 20070801

• Dexamethasone as adjuvant therapy to moxifloxacin attenuates valve destruction in experimental aortic valve endocarditis due to Staphylococcus aureus.

  Antimicrobial agents and chemotherapy 20070801

• Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile.

  Infection control and hospital epidemiology 20070801

• Acute appendicitis in the setting of Clostridium difficile colitis: case report and review of the literature.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20070801

• Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy.

  American journal of ophthalmology 20070801

• Fourth-generation fluoroquinolone-resistant bacterial keratitis.

  Journal of cataract and refractive surgery 20070801

• Antimicrobial resistance and the management of anaerobic infections.

  Expert review of anti-infective therapy 20070801

• Ocular toxicity of fluoroquinolones.

  Clinical & experimental ophthalmology 20070801

• A novel in vivo rabbit model that mimics human dosing to determine the distribution of antibiotics in ocular tissues.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20070801

• [Abstracts of the 6th Moxifloxacin Research Workshop, March 1-2, 2007, Leverkusen, Germany].

  Infection 20070801

• Drug forecast - the peptide deformylase inhibitors as antibacterial agents.

  Therapeutics and clinical risk management 20070801

• Aspiration pneumonia and primary lung abscess: diagnosis and therapy of an aerobic or an anaerobic infection?

  Expert review of respiratory medicine 20070801

• Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model.

  Eye (London, England) 20070701

• Cross-over assessment of serum bactericidal activity of moxifloxacin and levofloxacin versus penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae in healthy volunteers.

  Diagnostic microbiology and infectious disease 20070701

• Occurrence of enterotoxigenic and nonenterotoxigenic Bacteroides fragilis in calves and evaluation of their antimicrobial susceptibility.

  FEMS microbiology letters 20070701

• Nationwide surveillance of Streptococcus pneumoniae in Greece: patterns of resistance and serotype epidemiology.

  International journal of antimicrobial agents 20070701

• Molecular characterization and antimicrobial susceptibility patterns of Clostridium difficile strains isolated from hospitals in south-east Scotland.

  Journal of medical microbiology 20070701

• Comparison of antibiotic effect and corneal epithelial toxicity of levofloxacin and moxifloxacin in vitro.

  Cornea 20070701

• Update on the treatment of diabetic foot infections.

  Clinics in podiatric medicine and surgery 20070701

• [Brochiectasis (in the adult)].

  Praxis 20070613

• Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes.

  Journal of cardiovascular electrophysiology 20070601

• Effect of fourth-generation fluoroquinolones on the healing rate of corneal erosions in an animal model.

  Cornea 20070601

• Clinical response of contact lens-associated fungal keratitis to topical fluoroquinolone therapy.

  Cornea 20070601

• The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.

  Current medical research and opinion 20070601

• Nocardia farcinica brain abscess in a patient without immunocompromise.

  British journal of neurosurgery 20070601

• Mycobacterium tuberculosis DNA gyrase as a target for drug discovery.

  Infectious disorders drug targets 20070601

• Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin.

  Journal of health, population, and nutrition 20070601

• A brief review of moxifloxacin in the treatment of elderly patients with community-acquired pneumonia (CAP).

  Clinical interventions in aging 20070601

• Skin and skin structure infections: treatment with newer generation fluoroquinolones.

  Therapeutics and clinical risk management 20070601

• Treatment of community-acquired pneumonia, with special emphasis on gemifloxacin.

  Therapeutics and clinical risk management 20070601

• A randomized trial assessing the clinical efficacy and microbial eradication of 1% azithromycin ophthalmic solution vs tobramycin in adult and pediatric subjects with bacterial conjunctivitis.

  Clinical ophthalmology (Auckland, N.Z.) 20070601

• Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).

  Diagnostic microbiology and infectious disease 20070501

• In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004).

  Diagnostic microbiology and infectious disease 20070501

• In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates.

  Ophthalmology 20070501

• Cost-effectiveness of empirical prescribing of antimicrobials in community-acquired pneumonia in three countries in the presence of resistance.

  The Journal of antimicrobial chemotherapy 20070501

• Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values.

  Diagnostic microbiology and infectious disease 20070501

• Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure.

  The Journal of antimicrobial chemotherapy 20070501

• In vitro activity of amoxicillin, clindamycin, doxycycline, metronidazole, and moxifloxacin against oral Actinomyces.

  Journal of endodontics 20070501

• Central venous catheter-related Streptomyces septic thrombosis.

  Infection control and hospital epidemiology 20070501

• Comparative minimal inhibitory and mutant prevention drug concentrations of four fluoroquinolones against ocular isolates of Haemophilus influenzae.

  Eye & contact lens 20070501

• [Pharmacodynamic profile and clinical efficacy of moxifloxacin ophthalmic solution (Vegamox 0.5% ophthalmic solution].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20070501

• The influence of fluoroquinolone drugs on the bacterial growth of S. epidermidis utilizing the unique potential of vibrational spectroscopy.

  The journal of physical chemistry. A 20070419

• Increased polymorphonuclear leukocyte respiratory burst function in type 2 diabetes.

  Diabetes research and clinical practice 20070401

• Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series.

  Ophthalmology 20070401

• Arrhythmias associated with fluoroquinolone therapy.

  International journal of antimicrobial agents 20070401

• Type II topoisomerase mutations in clinical isolates of Enterobacter cloacae and other enterobacterial species harbouring the qnrA gene.

  International journal of antimicrobial agents 20070401

• Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.

  International journal of antimicrobial agents 20070401

• Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070401

• Factors compromising the activity of moxifloxacin against intracellular Staphylococcus aureus.

  The Journal of antimicrobial chemotherapy 20070401

• Antimicrobial efficacy of gatifloxacin and moxifloxacin with and without benzalkonium chloride compared with ciprofloxacin and levofloxacin against methicillin-resistant Staphylococcus aureus.

  Journal of chemotherapy (Florence, Italy) 20070401

• Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis.

  Current eye research 20070401

• The effect of moxifloxacin and gatifloxacin on long-term visual outcomes following photorefractive keratectomy.

  Journal of refractive surgery (Thorofare, N.J. : 1995) 20070401

• XDR-TB in South Africa: theory and practice.

  PLoS medicine 20070401

• Treatment of ankylosing spondylitis with moxifloxacin.

  Southern medical journal 20070401

• [Antibacterial activity of tosufloxacin against major organisms detected from patients with respiratory infections].

  The Japanese journal of antibiotics 20070401

• Antibiotic resistance testing of the total implant-associated micro-flora and its pure isolates.

  European journal of medical research 20070326

• Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats.

  Veterinary journal (London, England : 1997) 20070301

• Comparative in vitro and bactericidal activities of telithromycin against penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant Streptococcus pneumoniae by time-kill methodology.

  International journal of antimicrobial agents 20070301

• Concentration of moxifloxacin in serum and human aqueous humor following a single 400 mg oral dose.

  Journal of cataract and refractive surgery 20070301

• Validation of the agar proportion and 2 liquid systems for testing the susceptibility of Mycobacterium tuberculosis to moxifloxacin.

  Diagnostic microbiology and infectious disease 20070301

• Thorough QT study with recommended and supratherapeutic doses of tolterodine.

  Clinical pharmacology and therapeutics 20070301

• QT effects of duloxetine at supratherapeutic doses: a placebo and positive controlled study.

  Journal of cardiovascular pharmacology 20070301

• Worldwide emergence of extensively drug-resistant tuberculosis.

  Emerging infectious diseases 20070301

• gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027.

  Emerging infectious diseases 20070301

• Drug management in chronic rhinosinusitis: identification of the needs.

  Therapeutics and clinical risk management 20070301

• Clinical development of 1% azithromycin in DuraSite, a topical azalide anti-infective for ocular surface therapy.

  Clinical ophthalmology (Auckland, N.Z.) 20070301

• Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy.

  Antimicrobial agents and chemotherapy 20070201

• Influence of structural factors on the enhanced activity of moxifloxacin: a fluorescence and EPR spectroscopic study.

  Analytical and bioanalytical chemistry 20070201

• parE mutations in Streptococcus pneumoniae may reduce bactericidal activity of respiratory fluoroquinolones.

  International journal of antimicrobial agents 20070201

• In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.

  Cornea 20070201

• A case of vancomycin-resistant enterococcus conjunctivitis and its clinically successful topical treatment.

  Cornea 20070201

• Vitreal penetration of oral and topical moxifloxacin in humans.

  American journal of ophthalmology 20070201

• Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain.

  Infection control and hospital epidemiology 20070201

• Dysglycemia and fluoroquinolones: are you putting patients at risk?

  The Journal of family practice 20070201

• Moxifloxacin and torsade de pointes.

  The Annals of pharmacotherapy 20070201

• Moxifloxacin in the treatment of hospitalised community acquired pneumonia in HIV-infected subjects.

  Journal of chemotherapy (Florence, Italy) 20070201

• [In-vitro and in-vivo activities of moxifloxacin and garenoxacin against Mycobacterium leprae].

  Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association 20070201

• [Susceptibility of clinical isolates from primary care clinics to oral antibacterial agents].

  The Japanese journal of antibiotics 20070201

• Successful treatment of pulmonary hemorrhage associated with leptospirosis and scrub typhus coinfection by early plasma exchange.

  Journal of the Formosan Medical Association = Taiwan yi zhi 20070201

• Isothiazoloquinolones with enhanced antistaphylococcal activities against multidrug-resistant strains: effects of structural modifications at the 6-, 7-, and 8-positions.

  Journal of medicinal chemistry 20070125

• Pneumopericardium masquerading as an acute myocardial infarction.

  International journal of cardiology 20070118

• Application of a validated stability-indicating densitometric thin-layer chromatographic method to stress degradation studies on moxifloxacin.

  Analytica chimica acta 20070116

• High-performance liquid chromatography assay for moxifloxacin: pharmacokinetics in human plasma.

  Journal of pharmaceutical and biomedical analysis 20070104

• Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-kappaB activation in a cystic fibrosis epithelial cell line.

  American journal of physiology. Lung cellular and molecular physiology 20070101

• Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria.

  The Journal of antimicrobial chemotherapy 20070101

• Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin.

  Journal of pharmacological and toxicological methods 20070101

• [The effectiveness of the new fluoroquinolones against the normal bacterial flora of the conjunctiva].

  Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20070101

• Collagen shields as a drug delivery system for the fourth-generation fluoroquinolones.

  Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20070101

• Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.

  International journal of antimicrobial agents 20070101

• Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery.

  Journal of cataract and refractive surgery 20070101

• Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients.

  Journal of cataract and refractive surgery 20070101

• Activity of newer fluoroquinolones against gram-positive and gram-negative bacteria isolated from ocular infections: an in vitro comparison.

  Indian journal of ophthalmology 20070101

• Moxifloxacin-induced arthropathy.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20070101

• Determining factors in the prescription of moxifloxacin in exacerbations of chronic bronchitis in the primary-care setting.

  Clinical drug investigation 20070101

• [Clinical efficacy of moxifloxacin in the treatment of exacerbations of chronic bronchitis: a systematic review and meta-analysis].

  Archivos de bronconeumologia 20070101

• Antibacterial effects of moxifloxacin and levofloxacin simulating epithelial lining fluid concentrations against community-acquired methicillin-resistant Staphylococcus aureus.

  Drugs in R&D 20070101

• ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.

  Drugs in R&D 20070101

• Mycobacterium avium-intracellulare cellulitis occurring with septic arthritis after joint injection: a case report.

  BMC infectious diseases 20070101

• An unusual cause of granulomatous disease.

  BMC clinical pathology 20070101

• Moxifloxacin vs amoxicillin/clavulanate in the treatment of acute sinusitis.

  American journal of otolaryngology 20070101

• Antimicrobial susceptibility of invasive pneumococcal isolates from a region in south-west Sweden 1998-2001.

  Scandinavian journal of infectious diseases 20070101

• Methicillin-resistant Staphylococcus aureus caruncle abscess.

  Ophthalmic plastic and reconstructive surgery 20070101

• Effectiveness of topical antibiotics on Staphylococcus aureus biofilm in vitro.

  American journal of rhinology 20070101

• [Nongonococcal urethritis treatment in men with avelox (moxifloxacin)].

  Urologiia (Moscow, Russia : 1999) 20070101

• Molecular characterization and antimicrobial susceptibilities of extra-intestinal Clostridium difficile isolates.

  Anaerobe 20070101

• Intravenous conivaptan: effects on the QTc interval and other electrocardiographic parameters in healthy volunteers.

  Advances in therapy 20070101

• Comparative activities of antibiotics against intracellular non-typeable Haemophilus influenzae.

  Wiener klinische Wochenschrift 20070101

• Fluoroquinolone susceptibilities to methicillin-resistant and susceptible coagulase-negative Staphylococcus isolated from eye infection.

  Arquivos brasileiros de oftalmologia 20070101

• High eradication rate of H. pylori with moxifloxacin-based treatment: a randomized controlled trial.

  Wiener klinische Wochenschrift 20070101

• A highly sensitive canine telemetry model for detection of QT interval prolongation: studies with moxifloxacin, haloperidol and MK-499.

  Journal of pharmacological and toxicological methods 20070101

• Bilateral hilar lymphadenopathy in a young female: a case report.

  Journal of medical case reports 20070101

• Comparison of the QT interval response during sinus and paced rhythm in conscious and anesthetized beagle dogs.

  Journal of pharmacological and toxicological methods 20070101

• Novel agents in the management of Mycobacterium tuberculosis disease.

  Current medicinal chemistry 20070101

• Incidence of allergic reactions associated with antibacterial use in a large, managed care organisation.

  Drug safety 20070101

• A cluster of Candida krusei infections in a haematological unit.

  BMC infectious diseases 20070101

• Burkholderia pseudomallei: in vitro susceptibility to some new and old antimicrobials.

  Scandinavian journal of infectious diseases 20070101

• Fluoroquinolones for the treatment of pulmonary tuberculosis.

  Drugs 20070101

• Laboratory detection methods for methicillin resistance in coagulase negative Staphylococcus isolated from ophthalmic infections.

  Arquivos brasileiros de oftalmologia 20070101

• Acute cholecystitis - early laparoskopic surgery versus antibiotic therapy and delayed elective cholecystectomy: ACDC-study.

  Trials 20070101

• [Avelox efficacy in the treatment of acute purulent rhinosinusitis].

  Terapevticheskii arkhiv 20070101

• [Survey of susceptibility of clinical Clostridium diffiicile strains isolated from patients hospitalised in different departments of paediatric hospital to antimicrobial agents].

  Medycyna doswiadczalna i mikrobiologia 20070101

• Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid.

  Chemotherapy 20070101

• Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up.

  BMC ear, nose, and throat disorders 20070101

• [Pulmonary fibrosis induced by amiodarone--a pitfall of antiarrhytmic treatment].

  Pneumologia (Bucharest, Romania) 20070101

• Infections caused by mycobacterium tuberculosis in patients with hematological disorders and in recipients of hematopoietic stem cell transplant, a twelve year retrospective study.

  Annals of clinical microbiology and antimicrobials 20070101

• Speed of bacterial kill with a fluoroquinolone compared with nonfluoroquinolones: clinical implications and a review of kinetics of kill studies.

  Advances in therapy 20070101

• The cardiovascular safety profile of renzapride, a novel treatment for irritable bowel syndrome.

  The Journal of international medical research 20070101

• Acute hepatitis associated with Q fever in a man in Greece: a case report.

  Journal of medical case reports 20070101

• Endophthalmitis caused by staphylococcus epidermidis: in vitro antibiotic susceptibilities and clinical outcomes.

  Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 20070101

• Therapy-refractory Panton Valentine Leukocidin-positive community-acquired methicillin-sensitive Staphylococcus aureus sepsis with progressive metastatic soft tissue infection: a case report.

  Journal of medical case reports 20070101

• Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria.

  PloS one 20070101

• Analysis of an SIR epidemic model with pulse vaccination and distributed time delay.

  Journal of biomedicine & biotechnology 20070101

• [Genetical conditioning of fluoroquinolone resistance mechanisms of clinical enterococcus faecalis strains. II. The mutations present in the qrdrs of gyrA, gyrB, parC and parE genes].

  Medycyna doswiadczalna i mikrobiologia 20070101

• [MALDI-ToF mass-spectrometry in analysis of genetically determined resistance of Streptococcus pneumoniae to fluoroquinolones].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20070101

• [Investigation of moxifloxacin, a new antimicrobial of the fluoroquinolone group in Russia].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20070101

• Extensively drug-resistant tuberculosis (XDR-TB) - a potential threat in Ireland.

  The open respiratory medicine journal 20070101

• Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial.

  Sexually transmitted infections 20061201

• Design, synthesis and activity against Toxoplasma gondii, Plasmodium spp., and Mycobacterium tuberculosis of new 6-fluoroquinolones.

  European journal of medicinal chemistry 20061201

• High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile.

  The Journal of antimicrobial chemotherapy 20061201

• In vitro development of resistance to DX-619 and other quinolones in enterococci.

  The Journal of antimicrobial chemotherapy 20061201

• No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic-AV block.

  British journal of pharmacology 20061201

• Bilateral simultaneous Achromobacter xylosoxidans keratitis following penetrating keratoplasty.

  Journal of cataract and refractive surgery 20061201

• Stability indicating methods for the determination of some fluoroquinolones in the presence of their decarboxylated degrades.

  Chemical & pharmaceutical bulletin 20061201

• Evaluation of the penetration of fluoroquinolones in human conjunctival tissue.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20061201

• In vitro antifungal activity of the fourth generation fluoroquinolones against Candida isolates from human ocular infections.

  Ocular immunology and inflammation 20061201

• Stability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36% and Dianeal PD1 3.86%).

  Journal of clinical pharmacy and therapeutics 20061201

• Control of rapid heart rate changes for electrocardiographic analysis: implications for thorough QT studies.

  Clinical cardiology 20061201

• [Study investigating the activity of several fluoroquinolones against Pseudomonas aeruginosa using the mutant prevention concentration].

  Enfermedades infecciosas y microbiologia clinica 20061201

• [Development of antituberculous drugs: current status and future prospects].

  Kekkaku : [Tuberculosis] 20061201

• Moxifloxacin and gatifloxacin in an acid model of persistent Mycobacterium tuberculosis.

  Journal of chemotherapy (Florence, Italy) 20061201

• The first steps towards fluoroquinolone resistance in Hungarian pneumococci.

  Journal of chemotherapy (Florence, Italy) 20061201

• Editorial foreword.

  Therapeutics and clinical risk management 20061201

• Moxifloxacin in the treatment of skin and skin structure infections.

  Therapeutics and clinical risk management 20061201

• Optimization and validation of the direct HPLC method for the determination of moxifloxacin in plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061121

• Vitreous and aqueous penetration of orally administered moxifloxacin in humans.

  Eye (London, England) 20061101

• Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study.

  The European respiratory journal 20061101

• Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.

  The Journal of antimicrobial chemotherapy 20061101

• Penetration of moxifloxacin into the human pancreas following a single intravenous or oral dose.

  The Journal of antimicrobial chemotherapy 20061101

• The in vitro impact of moxifloxacin and gatifloxacin concentration (0.5% vs 0.3%) and the addition of benzalkonium chloride on antibacterial efficacy.

  American journal of ophthalmology 20061101

• Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin.

  American journal of ophthalmology 20061101

• Penetration of moxifloxacin into sternal bone of patients undergoing routine cardiopulmonary bypass surgery.

  International journal of antimicrobial agents 20061101

• In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates.

  American journal of ophthalmology 20061101

• Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis.

  Clinical journal of the American Society of Nephrology : CJASN 20061101

• Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-1 and Jurkat cells.

  British journal of cancer 20061023

• Simultaneous separation of five fluoroquinolone antibiotics by capillary zone electrophoresis.

  Analytica chimica acta 20061010

• Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents.

  Respiratory medicine 20061001

• Moxifloxacin prophylaxis in neutropenic patients.

  The Journal of antimicrobial chemotherapy 20061001

• In vitro susceptibility of Bartonella species to 17 antimicrobial compounds: comparison of Etest and agar dilution.

  The Journal of antimicrobial chemotherapy 20061001

• Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia.

  Stroke 20061001

• Evolution of resistance patterns and identification of risk factors for Streptococcus pneumoniae colonisation in daycare centre attendees in Athens, Greece.

  International journal of antimicrobial agents 20061001

• Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium.

  Helicobacter 20061001

• Hydrophilic acrylic intraocular lens as a drug-delivery system for fourth-generation fluoroquinolones.

  Journal of cataract and refractive surgery 20061001

• The effect of moxifloxacin on the normal human cornea.

  Current medical research and opinion 20061001

• [Cardiac tolerance of moxifloxacin: Clinical experience from a large observational French study in usual medical practice (IMMEDIAT study)].

  Medecine et maladies infectieuses 20061001

• Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate.

  Journal of chemotherapy (Florence, Italy) 20061001

• Efficacy and safety of moxifloxacin as an additive in Optisol-GS a preservation medium for corneal donor tissue.

  Cornea 20061001

• Effect of the fourth-generation fluoroquinolones on corneal reepithelialization after penetrating keratoplasty.

  Cornea 20061001

• Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats.

  Veterinary journal (London, England : 1997) 20060901

• Long-term moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugs.

  Respiratory medicine 20060901

• Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: the Latin American Cohort.

  Respiratory medicine 20060901

• The effect of treatment with moxifloxacin or azithromycin on acute bacterial rhinosinusitis in mice.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20060901

• Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.

  The Journal of antimicrobial chemotherapy 20060901

• Clinical significance of overexpression of multiple RND-family efflux pumps in Bacteroides fragilis isolates.

  The Journal of antimicrobial chemotherapy 20060901

• Evaluation of bacterial kill when modelling the bronchopulmonary pharmacokinetic profile of moxifloxacin and levofloxacin against parC-containing isolates of Streptococcus pneumoniae.

  The Journal of antimicrobial chemotherapy 20060901

• Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis.

  The Journal of antimicrobial chemotherapy 20060901

• Comparative elution of moxifloxacin from Norian skeletal repair system and acrylic bone cement: an in vitro study.

  International journal of antimicrobial agents 20060901

• Intracranial Nocardia recurrence during fluorinated quinolones therapy.

  Transplant infectious disease : an official journal of the Transplantation Society 20060901

• Selecting between gatifloxacin and moxifloxacin drops in ambulatory ophthalmic surgery.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20060901

• Institutional difference of antibiotic resistance of Helicobacter pylori strains in Korea.

  Journal of clinical gastroenterology 20060901

• Susceptibility testing of clinical isolates of pseudomonas aeruginosa to levofloxacin, moxifloxacin, and gatifloxacin as a guide to treating pseudomonas ocular infections.

  Eye & contact lens 20060901

• Patterns of Helicobacter pylori isolate resistance to fluoroquinolones, amoxicillin, clarithromycin and metronidazoles.

  The Southeast Asian journal of tropical medicine and public health 20060901

• Newer fluoroquinolones in the treatment of acute exacerbations of COPD.

  International journal of chronic obstructive pulmonary disease 20060901

• Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis.

  American journal of respiratory and critical care medicine 20060801

• European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe.

  The Journal of antimicrobial chemotherapy 20060801

• A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumonia.

  The Journal of antimicrobial chemotherapy 20060801

• Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections.

  Annals of surgery 20060801

• Prospects for advancing tuberculosis control efforts through novel therapies.

  PLoS medicine 20060801

• Permeability of pig urinary bladder wall: time and concentration dependent effect of chitosan.

  Biological & pharmaceutical bulletin 20060801

• Moxifloxacinium chloride-water-methanol (2/1/1), a novel antibacterial agent.

  Acta crystallographica. Section C, Crystal structure communications 20060801

• Moxifloxacin versus standard therapy in patients with pneumonia hospitalized after failure of preclinical anti-infective treatment.

  Infection 20060801

• In vitro antimicrobial activity of moxifloxacin against bacterial strains isolated from blood of neutropenic cancer patients.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20060801

• Pharmacokinetics of moxifloxacin in rabbits after intravenous, subcutaneous and a long-acting poloxamer 407 gel formulation administration.

  Journal of veterinary medicine. A, Physiology, pathology, clinical medicine 20060801

• In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.

  Pathology 20060801

• Relation between induction of the mar operon and cyclohexane tolerance and reduction in fluoroquinolone susceptibility in Salmonella spp.

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20060801

• Application of two methods to determine killing of Streptococcus pneumoniae by various fluoroquinolones.

  Journal of chemotherapy (Florence, Italy) 20060801

• Relative potential for selection of quinolone-resistance-determining-region mutations in Streptococcus pneumoniae by gemifloxacin, gatifloxacin and moxifloxacin.

  Journal of chemotherapy (Florence, Italy) 20060801

• Severe corneal toxicity after topical fluoroquinolone therapy: report of two cases.

  Cornea 20060801

• Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.

  American journal of respiratory and critical care medicine 20060701

• Differentiation of arrhythmia risk of the antibacterials moxifloxacin, erythromycin, and telithromycin based on analysis of monophasic action potential duration alternans and cardiac instability.

  The Journal of pharmacology and experimental therapeutics 20060701

• Comparative in vitro activity of PGE 9262932 and fluoroquinolones against Canadian clinical Streptococcus pneumoniae isolates, including molecularly characterized ciprofloxacin-resistant isolates.

  The Journal of antimicrobial chemotherapy 20060701

• Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients.

  International journal of antimicrobial agents 20060701

• Treatment of hospitalized patients with community-acquired pneumonia.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060701

• Treatment with moxifloxacin versus standard therapy for community-acquired pneumonia.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060701

• [New antibiotics for the therapy of respiratory tract infections].

  Pneumologie (Stuttgart, Germany) 20060701

• Azithromycin failure in Mycoplasma genitalium urethritis.

  Emerging infectious diseases 20060701

• Confocal assessment of the effects of fourth-generation fluoroquinolones on the cornea.

  Eye & contact lens 20060701

• Validation of a levofloxacin HPLC assay in plasma and dialysate for pharmacokinetic studies.

  Journal of pharmaceutical and biomedical analysis 20060616

• Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).

  Diagnostic microbiology and infectious disease 20060601

• Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.

  Ophthalmology 20060601

• Determination of ofloxacin and moxifloxacin and their penetration in human aqueous and vitreous humor by using high-performance liquid chromatography fluorescence detection.

  Analytical biochemistry 20060601

• Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season.

  Emerging infectious diseases 20060601

• Man versus machine: is there an optimal method for QT measurements in thorough QT studies?

  Journal of clinical pharmacology 20060601

• Controversies in antibiotic choices for odontogenic infections.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20060601

• Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20060601

• New trends in development of antimycobacterial compounds.

  Infectious disorders drug targets 20060601

• Penetration of moxifloxacin into bone in patients undergoing total knee arthroplasty.

  The Journal of antimicrobial chemotherapy 20060501

• Screening for drug-induced spoliation of the hydrogel optic of the AlphaCor artificial cornea.

  Contact lens & anterior eye : the journal of the British Contact Lens Association 20060501

• Recent advances in the medical and surgical treatment of multi-drug resistant tuberculosis.

  Current opinion in pulmonary medicine 20060501

• [Pathogenesis, diagnosis and therapy of Legionella infections].

  Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 20060501

• Treatment of murine pneumonic Francisella tularensis infection with gatifloxacin, moxifloxacin or ciprofloxacin.

  International journal of antimicrobial agents 20060501

• Treatment of implant-associated infections with moxifloxacin: an animal study.

  International journal of antimicrobial agents 20060501

• Correlation of quinolone resistance levels and differences in basal and quinolone-induced expression from three qnrA-containing plasmids.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20060501

• Antibiotic consumption and generation of resistance in Streptococcus pneumoniae: the paradoxical impact of quinolones in a complex selective landscape.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20060501

• Phakic status affects vitreous penetration of topical moxifloxacin.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20060501

• [Antibiotic resistance of Helicobacter pylori isolated from Korean patients].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20060501

• Vigamox: how good is its self-preservation?

  Journal of cataract and refractive surgery 20060501

• Mutagenesis induced by 12 quinolone antibacterial agents in Escherichia coli WP2uvrA/pKM101.

  Toxicology in vitro : an international journal published in association with BIBRA 20060401

• First successful treatment of Nocardia farcinica brain abscess with moxifloxacin.

  The Journal of infection 20060401

• Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis.

  Thorax 20060401

• Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotic moxifloxacin.

  British journal of pharmacology 20060401

• Concentration of moxifloxacin in plasma and tonsillar tissue after multiple administration in adult patients.

  The Journal of antimicrobial chemotherapy 20060401

• Correlation between in vitro and in vivo activity of levofloxacin and moxifloxacin against pneumococcal strains with different susceptibilities to fluoroquinolones.

  International journal of antimicrobial agents 20060401

• Drug interactions during therapy with three major groups of antimicrobial agents.

  Expert opinion on pharmacotherapy 20060401

• Antimicrobial susceptibilities of Pasteurella strains isolated from humans.

  International journal of antimicrobial agents 20060401

• Intracameral Vigamox (moxifloxacin 0.5%) is not effective in preventing endophthalmitis in a rabbit model.

  American journal of ophthalmology 20060401

• Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models.

  Investigative ophthalmology & visual science 20060401

• Rapid microbiologic and pharmacologic evaluation of experimental compounds against Mycobacterium tuberculosis.

  Antimicrobial agents and chemotherapy 20060401

• In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20060401

• A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease.

  PLoS pathogens 20060401

• Determination of the newer quinolones levofloxacin and moxifloxacin in plasma by high-performance liquid chromatography with fluorescence detection.

  Journal of chromatographic science 20060401

• Hydrophilic acrylic intraocular lens as a drug-delivery system: Pilot study.

  Journal of cataract and refractive surgery 20060401

• [Risk factors for increased cost of exacerbations of chronic bronchitis and chronic obstructive pulmonary disease].

  Archivos de bronconeumologia 20060401

• Moxifloxacin superior to vancomycin for treatment of bone infections--a study in rats.

  Acta orthopaedica 20060401

• Outpatient gatifloxacin therapy and dysglycemia in older adults.

  The New England journal of medicine 20060330

• Determination of the extent of protein binding of antibiotics by means of an automated continuous ultrafiltration method.

  International journal of pharmaceutics 20060327

• Glucose homeostasis abnormalities and gatifloxacin.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060315

• Biological evaluation of isothiazoloquinolones containing aromatic heterocycles at the 7-position: In vitro activity of a series of potent antibacterial agents that are effective against methicillin-resistant Staphylococcus aureus.

  Bioorganic & medicinal chemistry letters 20060301

• Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy.

  Scandinavian journal of gastroenterology 20060301

• Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas.

  AAPS PharmSciTech 20060301

• Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery.

  Journal of cataract and refractive surgery 20060301

• Urinary tract infections in patients with chronic renal insufficiency.

  Clinical journal of the American Society of Nephrology : CJASN 20060301

• Telithromycin in the treatment of acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and community-acquired pneumonia.

  Therapeutics and clinical risk management 20060301

• An increase in late sodium current potentiates the proarrhythmic activities of low-risk QT-prolonging drugs in female rabbit hearts.

  The Journal of pharmacology and experimental therapeutics 20060201

• Anti-inflammatory effects of moxifloxacin on IL-8, IL-1beta and TNF-alpha secretion and NFkappaB and MAP-kinase activation in human monocytes stimulated with Aspergillus fumigatus.

  The Journal of antimicrobial chemotherapy 20060201

• Intraocular concentrations of gatifloxacin and moxifloxacin in the anterior chamber via diffusion through the cornea using collagen shields.

  Cornea 20060201

• In vitro activity of sitafloxacin compared with several fluoroquinolones against Streptococcus anginosus and Streptococcus constellatus.

  International journal of antimicrobial agents 20060201

• Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection.

  Helicobacter 20060201

• Moxifloxacin versus levofloxacin for treatment of acute rhinosinusitis: a retrospective database analysis of treatment duration, outcomes, and charges.

  Current medical research and opinion 20060201

• Intravitreal toxicity of moxifloxacin.

  Retina (Philadelphia, Pa.) 20060201

• Vitreous penetration of topical moxifloxacin and gatifloxacin in humans.

  Retina (Philadelphia, Pa.) 20060201

• Vitreous and aqueous penetration of orally administered moxifloxacin in humans.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20060201

• Antimicrobial drug resistance, regulation, and research.

  Emerging infectious diseases 20060201

• [Rhinosinusitis: etiopathogenesis and antimicrobial therapy, an update].

  Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 20060201

• [Cervical spondylodiscitis: one pathogen may hide another].

  Medecine et maladies infectieuses 20060101

• Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060101

• [Antimicrobial resistance of Streptococcus pneumoniae strains isolated in the Reunion Island during 2004].

  Medecine et maladies infectieuses 20060101

• Clearance of intravitreal moxifloxacin.

  Investigative ophthalmology & visual science 20060101

• T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.

  Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20060101

• Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.

  Current eye research 20060101

• Do fluoroquinolones actually increase mortality in community-acquired pneumonia?

  Critical care (London, England) 20060101

• Effects of three fluoroquinolones on QT analysis after standard treatment courses.

  Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20060101

• Fluoroquinolones: an important class of antibiotics against tuberculosis.

  Current medicinal chemistry 20060101

• The pediatrician's dilemma.

  Journal of pediatric ophthalmology and strabismus 20060101

• Controlling contagious bacterial conjunctivitis.

  Journal of pediatric ophthalmology and strabismus 20060101

• Pharmacokinetic and pharmacodynamic aspects of oral moxifloxacin 400 mg/day in elderly patients with acute exacerbation of chronic bronchitis.

  Clinical pharmacokinetics 20060101

• Use of arterially perfused rabbit ventricular wedge in predicting arrhythmogenic potentials of drugs.

  Journal of pharmacological and toxicological methods 20060101

• Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility.

  Microbial drug resistance (Larchmont, N.Y.) 20060101

• Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647].

  BMC infectious diseases 20060101

• Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation.

  BMC health services research 20060101

• [A multicentre study on the pathogenic agents in 665 adult patients with community-acquired pneumonia in cities of China].

  Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20060101

• Eradication of common pathogens at days 2, 3 and 4 of moxifloxacin therapy in patients with acute bacterial sinusitis.

  BMC ear, nose, and throat disorders 20060101

• Cardiovascular monkey telemetry: sensitivity to detect QT interval prolongation.

  Journal of pharmacological and toxicological methods 20060101

• Susceptibility of Mycobacterium tuberculosis strains to gatifloxacin and moxifloxacin by different methods.

  Chemotherapy 20060101

• A preoperative mixture of anesthetic jelly, dilating drops, antibiotics, and anti-inflammatories for cataract surgery.

  Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 20060101

• In vitro activity of fluoroquinolones against common respiratory pathogens.

  The West Indian medical journal 20060101

• Surveillance of antibiotic resistance in non invasive clinical isolates of Streptococcus pneumoniae collected in Belgium during winters 2003 and 2004.

  Acta clinica Belgica 20060101

• Nursing home-acquired pneumonia: update on treatment options.

  Drugs & aging 20060101

• [Blood and respiratory diffusion of antibiotics. A critical analysis of predictive parameters for clinical effectiveness].

  Medecine et maladies infectieuses 20060101

• [Acute community-acquired pneumonia. A review of clinical trials].

  Medecine et maladies infectieuses 20060101

• Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan.

  Microbial drug resistance (Larchmont, N.Y.) 20060101

• Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans.

  Survey of ophthalmology 20060101

• Peritonitis - the Western experience.

  World journal of emergency surgery : WJES 20060101

• Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem.

  Annals of clinical microbiology and antimicrobials 20060101

• Tuberculosis chemotherapy: current drug delivery approaches.

  Respiratory research 20060101

• Moxifloxacin distribution in the interstitial space of infected decubitus ulcer tissue of patients with spinal cord injury measured by in vivo microdialysis.

  Scandinavian journal of infectious diseases 20060101

• In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics.

  Annals of clinical microbiology and antimicrobials 20060101

• Integrating iquix, vigamox, and zymar in the management of ocular infectious disease.

  International ophthalmology clinics 20060101

• Evidence-based review of moxifloxacin.

  International ophthalmology clinics 20060101

• Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use.

  Drug safety 20060101

• [Antibiotherapy for acute CAP in adults].

  Medecine et maladies infectieuses 20060101

• [Mutation window for the 'pneumococcus-fluoroquinolone' couple. Contribution of experimental models].

  Medecine et maladies infectieuses 20060101

• 13--Antibiotic therapy of community-acquired pneumonia (CAP) caused by atypical agents.

  Medecine et maladies infectieuses 20060101

• Efficacy and safety of intravenous moxifloxacin versus cefoperazone with azithromycin in the treatment of community acquired pneumonia.

  Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20060101

• Large B-cell lymphoma presenting as acute abdominal pain and spontaneous splenic rupture; a case report and review of relevant literature.

  World journal of emergency surgery : WJES 20060101

• Efficacy and tolerability of moxifloxacin in patients with respiratory tract infections treated in general practice: Results of a post-marketing surveillance study.

  Clinical drug investigation 20060101

• A comparative study on the cost of new antibiotics and drugs of other therapeutic categories.

  PloS one 20060101

• Real-life treatment of acute exacerbations of chronic bronchitis with moxifloxacin or macrolides: a comparative post-marketing surveillance study in general practice.

  Clinical drug investigation 20060101

• [Efficacy of moxifloxacin in the treatment of secondary peritonitis].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20060101

• Electrocardiographic method for identifying drug-induced repolarization abnormalities associated with a reduction of the rapidly activating delayed rectifier potassium current.

  Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 20060101

• [Moxifloxacin clinical and microbiological efficacy in therapy of infectious endocarditis].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20060101

• [Study of antituberculous activity of moxifloxacin conjugate with macrophage scavenger-receptor ligand].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20060101

• Tigecycline: an evidence-based review of its antibacterial activity and effectiveness in complicated skin and soft tissue and intraabdominal infections.

  Core evidence 20060101

• Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051215

• An epidemic, toxin gene-variant strain of Clostridium difficile.

  The New England journal of medicine 20051208

• Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosis.

  American journal of respiratory and critical care medicine 20051201

• Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model.

  American journal of respiratory and critical care medicine 20051201

• Successful moxifloxacin prophylaxis against experimental streptococcal aortic valve endocarditis.

  The Journal of antimicrobial chemotherapy 20051201

• In vitro activities of 11 fluoroquinolones against 226 Campylobacter jejuni strains isolated from Finnish patients, with special reference to ciprofloxacin resistance.

  The Journal of antimicrobial chemotherapy 20051201

• Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis.

  The Journal of antimicrobial chemotherapy 20051201

• In vivo efficacy of fluoroquinolones against systemic tularaemia infection in mice.

  The Journal of antimicrobial chemotherapy 20051201

• Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice.

  The Journal of antimicrobial chemotherapy 20051201

• Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.

  International journal of antimicrobial agents 20051201

• Activity of five quinolones, three macrolides and telithromycin against 12 Haemophilus influenzae strains with different resistance phenotypes.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20051201

• Hopkins scientist tunes in to treat tuberculosis.

  The Journal of clinical investigation 20051201

• Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20051201

• In vitro antimicrobial effect of cefazolin and cefotaxime combined with minocycline against Vibrio cholerae non-O1 non-O139.

  Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20051201

• Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery.

  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20051201

• Pharmacodynamics of moxifloxacin and levofloxacin simulating human serum and lung concentrations.

  Infection 20051201

• The integrated use of pharmacokinetic and pharmacodynamic models for the definition of breakpoints.

  Infection 20051201

• Effect of pH on the in vitro activity of and propensity for emergence of resistance to fluoroquinolones, macrolides, and a ketolide.

  Infection 20051201

• Contribution of immunocompetence to the antibacterial activities of ciprofloxacin and moxifloxacin in an in vitro pharmacodynamic model.

  Infection 20051201

• Moxifloxacin and ciprofloxacin protect human respiratory epithelial cells against Streptococcus pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa, and Haemophilus influenzae in vitro.

  Infection 20051201

• Immunomodulatory activities of fluoroquinolones.

  Infection 20051201

• Intravitreal clearance of moxifloxacin.

  Transactions of the American Ophthalmological Society 20051201

• QT prolongation and proarrhythmia by moxifloxacin: concordance of preclinical models in relation to clinical outcome.

  British journal of pharmacology 20051101

• Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients.

  The Journal of antimicrobial chemotherapy 20051101

• Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients.

  Ophthalmology 20051101

• An ophthalmologist's guide to understanding antibiotic susceptibility and minimum inhibitory concentration data.

  Ophthalmology 20051101

• Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.

  The Journal of antimicrobial chemotherapy 20051101

• Glucose homeostasis abnormalities associated with use of gatifloxacin.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051101

• Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa.

  International journal of antimicrobial agents 20051101

• Absorption of topical moxifloxacin ophthalmic solution into human aqueous humor.

  Cornea 20051101

• Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection.

  International journal of antimicrobial agents 20051101

• Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and multidrug-resistant Streptococcus pneumoniae in community-acquired pneumonia.

  International journal of clinical practice 20051101

• Changing patterns of fluoroquinolone resistance among Bacteroides fragilis group organisms over a 6-year period (1997-2002).

  Diagnostic microbiology and infectious disease 20051101

• Ophthalmic infections and their anti-infective challenges.

  Survey of ophthalmology 20051101

• In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone.

  Survey of ophthalmology 20051101

• Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans.

  Survey of ophthalmology 20051101

• Safety of moxifloxacin as shown in animal and in vitro studies.

  Survey of ophthalmology 20051101

• Clinical safety of moxifloxacin ophthalmic solution 0.5% (VIGAMOX) in pediatric and nonpediatric patients with bacterial conjunctivitis.

  Survey of ophthalmology 20051101

• Future of ophthalmic anti-infective therapy and the role of moxifloxacin ophthalmic solution 0.5% (VIGAMOX).

  Survey of ophthalmology 20051101

• Overview of the potency of moxifloxacin ophthalmic solution 0.5% (VIGAMOX).

  Survey of ophthalmology 20051101

• Q Fever pneumonia: are clarithromycin and moxifloxacin alternative treatments only?

  The American journal of tropical medicine and hygiene 20051101

• A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia.

  Chest 20051101

• Effect of gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions on human corneal epithelium following 2 dosing regimens.

  Journal of cataract and refractive surgery 20051101

• Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device.

  Journal of cataract and refractive surgery 20051101

• Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051015

• The effect of the fourth-generation fluoroquinolones on corneal reepithelialization after penetrating keratoplasty.

  Cornea 20051001

• How effective is moxifloxacin for the first-line treatment of patients with Helicobacter pylori infection?

  Nature clinical practice. Gastroenterology & hepatology 20051001

• Cost analyses of community-acquired pneumonia from the hospital perspective.

  Chest 20051001

• Nocardia keratitis after laser in situ keratomileusis: clinicopathologic correlation.

  Journal of cataract and refractive surgery 20051001

• [The basic and clinical studies of moxifloxacin: the profile as respiratory quinolones].

  The Japanese journal of antibiotics 20051001

• In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.

  The Medical journal of Malaysia 20051001

• Differential effects of three antibiotics on T helper cell cytokine expression.

  The Journal of antimicrobial chemotherapy 20050901

• Moxifloxacin is efficacious for treatment of community-acquired lung abscesses in adults.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050901

• Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.

  American journal of ophthalmology 20050901

• QT and QTc interval with standard and supratherapeutic doses of darifenacin, a muscarinic M3 selective receptor antagonist for the treatment of overactive bladder.

  Journal of clinical pharmacology 20050901

• The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20050901

• Nasopharyngeal carriage, antimicrobial susceptibility, serotype distribution and clonal relatedness of Streptococcus pneumoniae isolates in healthy children in Malatya, Turkey.

  International journal of antimicrobial agents 20050901

• Empirical antimicrobial therapy for odontogenic infections.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20050901

• Biliary secretion of moxifloxacin in obstructive cholangitis and the non-obstructed biliary tract.

  Alimentary pharmacology & therapeutics 20050901

• Evaluation of moxifloxacin, ciprofloxacin, gatifloxacin, ofloxacin, and levofloxacin concentrations in human conjunctival tissue.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20050901

• [Treatment of Helicobacter pylori infection].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20050901

• In-use study of potential bacterial contamination of ophthalmic moxifloxacin.

  Journal of cataract and refractive surgery 20050901

• Hospital-level rates of fluoroquinolone use and the risk of hospital-acquired infection with ciprofloxacin-nonsusceptible Pseudomonas aeruginosa.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050815

• A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus.

  Journal of medicinal chemistry 20050811

• Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.

  Respiratory medicine 20050801

• Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates.

  The Journal of antimicrobial chemotherapy 20050801

• Telavancin: in vitro activity against staphylococci in a biofilm model.

  The Journal of antimicrobial chemotherapy 20050801

• Clearance of moxifloxacin during continuous haemofiltration (CVVHF) in vitro.

  The Journal of antimicrobial chemotherapy 20050801

• Activity of moxifloxacin against Bacteroides fragilis and Escherichia coli in an in vitro pharmacokinetic/pharmacodynamic model employing pure and mixed cultures.

  Journal of medical microbiology 20050801

• In vitro activity of fluoroquinolones against Mycobacterium abscessus and Mycobacterium chelonae causing infectious keratitis after LASIK in Brazil.

  Cornea 20050801

• Pharmacokinetic-pharmacodynamic integration of moxifloxacin in rabbits after intravenous, intramuscular and oral administration.

  Journal of veterinary pharmacology and therapeutics 20050801

• Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use.

  Emerging infectious diseases 20050801

• Vancomycin-tolerance among clinical isolates of Streptococcus pneumoniae in Mississippi during 1999-2001.

  The American journal of the medical sciences 20050801

• Influence of human ascitic fluid on the in vitro antibacterial activity of moxifloxacin.

  Journal of chemotherapy (Florence, Italy) 20050801

• Telithromycin: the first ketolide antimicrobial.

  Clinical therapeutics 20050801

• Acute interstitial nephritis associated with moxifloxacin use.

  Clinical therapeutics 20050801

• Pharmacoeconomic considerations associated with the use of intravenous-to-oral moxifloxacin for community-acquired pneumonia.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050715

• Challenges in the management of community-acquired pneumonia: the role of quinolones and moxifloxacin.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050715

• Current management of acute bacterial rhinosinusitis and the role of moxifloxacin.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050715

• Moxifloxacin for the treatment of acute exacerbations of chronic obstructive pulmonary disease.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050715

• Susceptibility of European beta-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003.

  The Journal of antimicrobial chemotherapy 20050701

• Pharmacodynamic studies of moxifloxacin and erythromycin against intracellular Legionella pneumophila in an in vitro kinetic model.

  The Journal of antimicrobial chemotherapy 20050701

• Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.

  Journal of pharmaceutical sciences 20050701

• Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes.

  The Journal of antimicrobial chemotherapy 20050701

• The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy.

  American journal of ophthalmology 20050701

• Treating respiratory tract infections in ambulatory care in Belgium: fluoroquinolone consumption and resistance development.

  International journal of antimicrobial agents 20050701

• In vitro activity of telithromycin against respiratory tract pathogens in comparison with other antimicrobial agents.

  Chemotherapy 20050701

• Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting.

  The American journal of medicine 20050701

• Antimicrobial treatment of lower respiratory tract infections in the hospital setting.

  The American journal of medicine 20050701

• Treatment of rhinosinusitis in the outpatient setting.

  The American journal of medicine 20050701

• Facial bite wounds: management update.

  International journal of oral and maxillofacial surgery 20050701

• Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin.

  Cancer 20050615

• Prophylactic use of moxifloxacin in patients receiving bone marrow transplants was not associated with increased ciprofloxacin resistance in Escherichia coli and enterococci.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050615

• Acyl glucuronidation of fluoroquinolone antibiotics by the UDP-glucuronosyltransferase 1A subfamily in human liver microsomes.

  Drug metabolism and disposition: the biological fate of chemicals 20050601

• In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii.

  The Journal of antimicrobial chemotherapy 20050601

• Evaluation of the in vitro activity of NVP-LMB415 against clinical anaerobic isolates with emphasis on the Bacteroides fragilis group.

  The Journal of antimicrobial chemotherapy 20050601

• A double mutation in the gyrA gene is necessary to produce high levels of resistance to moxifloxacin in Campylobacter spp. clinical isolates.

  International journal of antimicrobial agents 20050601

• Effects of fluoroquinolones on the migration of human phagocytes through Chlamydia pneumoniae-infected and tumor necrosis factor alpha-stimulated endothelial cells.

  The Journal of urology 20050601

• Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003.

  International journal of antimicrobial agents 20050601

• Enantiomeric purity assay of moxifloxacin hydrochloride by capillary electrophoresis.

  Journal of pharmaceutical and biomedical analysis 20050601

• Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination.

  Antimicrobial agents and chemotherapy 20050601

• Moxifloxacin and warfarin: additional evidence for a clinically relevant interaction.

  Pharmacotherapy 20050601

• New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance.

  Infection 20050601

• Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20050601

• Effects of moxifloxacin on QT interval in conscious dogs.

  Journal of veterinary pharmacology and therapeutics 20050601

• Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.

  Diagnostic microbiology and infectious disease 20050601

• A comparison of therapeutic regimens containing moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% ophthalmic solution for surgical prophylaxis in patients undergoing LASIK or LASEK.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20050601

• Therapeutic options for pneumococcal pneumonia in Turkey.

  Clinical therapeutics 20050601

• [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].

  Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20050601

• Trospium chloride: an update on a quaternary anticholinergic for treatment of urge urinary incontinence.

  Therapeutics and clinical risk management 20050601

• Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders.

  Neuropsychiatric disease and treatment 20050601

• Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection.

  Alimentary pharmacology & therapeutics 20050515

• Vibrational spectroscopic characterization of fluoroquinolones.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20050501

• Penetration of moxifloxacin into the human aqueous humour after oral administration.

  The British journal of ophthalmology 20050501

• Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males.

  British journal of clinical pharmacology 20050501

• Susceptibility and resistance genes to fluoroquinolones in methicillin-resistant Staphylococcus aureus isolated in 2002.

  International journal of antimicrobial agents 20050501

• Permeability of pig urinary bladder wall: the effect of chitosan and the role of calcium.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20050501

• Susceptibilities of Neisseria gonorrhoeae and Ureaplasma urealyticum isolates from male patients with urethritis to several antibiotics including telithromycin.

  Chemotherapy 20050501

• The impact of mechanical ventilation on the moxifloxacin treatment of experimental pneumonia caused by Streptococcus pneumoniae.

  Critical care medicine 20050501

• Clostridium clostridioforme: a mixture of three clinically important species.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20050501

• Antimicrosporidial activity of (fluoro)quinolones in vitro and in vivo.

  Folia parasitologica 20050501

• Evaluation of phototoxic and photoallergic potentials of 13 compounds by different in vitro and in vivo methods.

  Journal of photochemistry and photobiology. B, Biology 20050404

• Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa.

  The Journal of antimicrobial chemotherapy 20050401

• Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages.

  The Journal of antimicrobial chemotherapy 20050401

• Comparison of gatifloxacin, moxifloxacin and ciprofloxacin for treatment of experimental Burkholderia pseudomallei infection.

  The Journal of antimicrobial chemotherapy 20050401

• Quinolones in 2005: an update.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20050401

• Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing.

  International journal of antimicrobial agents 20050401

• Antibiotic susceptibility of preoperative normal conjunctival bacteria.

  American journal of ophthalmology 20050401

• Antimicrobial-resistant invasive Escherichia coli, Spain.

  Emerging infectious diseases 20050401

• What's new in antibiotics?

  Dermatologic clinics 20050401

• Individual QT-R-R relationship: average stability over time does not rule out an individual residual variability: implication for the assessment of drug effect on the QT interval.

  Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20050401

• Infected cat-bite wound treated successfully with moxifloxacin after failure of parenteral cefuroxime and ciprofloxacin.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20050401

• Clinical assessment of drug-induced QT prolongation in association with heart rate changes.

  Clinical pharmacology and therapeutics 20050401

• In vitro selection of resistance to clarithromycin in Streptococcus pneumoniae clinical isolates.

  Journal of chemotherapy (Florence, Italy) 20050401

• In vitro activity of fluoroquinolones against Mycobacterium tuberculosis.

  Journal of chemotherapy (Florence, Italy) 20050401

• Microbiology and antimicrobial management of sinusitis.

  The Journal of laryngology and otology 20050401

• [Sensitivity of clinical strains of Neisseria gonorrhoeae circulating in Yekaterinburg and the Sverdlovsk region].

  Klinicheskaia laboratornaia diagnostika 20050401

• Moxifloxacin inhibits cytokine-induced MAP kinase and NF-kappaB activation as well as nitric oxide synthesis in a human respiratory epithelial cell line.

  The Journal of antimicrobial chemotherapy 20050301

• Treatment of Staphylococcus epidermidis endophthalmitis with intravitreal moxifloxacin in a rabbit model.

  The Tohoku journal of experimental medicine 20050301

• Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits.

  Cornea 20050301

• Usefulness of various antibiotics against Mycobacterium avium-intracellulare, measured by their mutant prevention concentration.

  International journal of antimicrobial agents 20050301

• Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor.

  Ophthalmology 20050301

• Antimicrobial drug prescribing for pneumonia in ambulatory care.

  Emerging infectious diseases 20050301

• [Pharmacokinetic/pharmacodynamic analysis of antibiotic therapy in dentistry and stomatology].

  Enfermedades infecciosas y microbiologia clinica 20050301

• Nonfermentative gram-negative bacilli in cancer patients: increasing frequency of infection and antimicrobial susceptibility of clinical isolates to fluoroquinolones.

  Diagnostic microbiology and infectious disease 20050301

• Reproducibility of gemifloxacin and comparison fluoroquinolone MIC results using Sensititre commercial dry-form panels.

  Diagnostic microbiology and infectious disease 20050301

• [In vitro susceptibility to antibiotics and the most common Streptococcus pneumoniae serotypes: a multicenter study].

  Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20050301

• Protonation equilibrium and lipophilicity of moxifloxacin.

  Journal of pharmaceutical and biomedical analysis 20050223

• Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studies.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050215

• In vitro comparison of agar and microbroth dilution methods for determination of MICs for Mycoplasma hominis.

  Journal of microbiological methods 20050201

• Moxifloxacin-warfarin interaction: a series of five case reports.

  The Annals of pharmacotherapy 20050201

• Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods.

  The Journal of antimicrobial chemotherapy 20050201

• In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point.

  International journal of antimicrobial agents 20050201

• A case of melioidosis presenting as migrating pulmonary infiltration: the first case in Korea.

  Journal of Korean medical science 20050201

• [Trial of moxifloxacin-containing triple therapy after initial and second-line treatment failures for Helicobacter pylori infection].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20050201

• Moxifloxacin in respiratory tract infections.

  Expert opinion on pharmacotherapy 20050201

• Antimicrobial resistance of nosocomial strains of Staphylococcus aureus in Russia: results of a prospective study.

  Journal of chemotherapy (Florence, Italy) 20050201

• [New fluoroquinolones: levofloxacin, moxifloxacin and gatifloxacin].

  Nederlands tijdschrift voor geneeskunde 20050108

• Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.

  The Journal of antimicrobial chemotherapy 20050101

• Comparison of corneal surface effects of gatifloxacin and moxifloxacin using intensive and prolonged dosing protocols.

  Cornea 20050101

• Enterococci spp. isolated from Cuba: species frequency of occurrence and antimicrobial susceptibility profile.

  Diagnostic microbiology and infectious disease 20050101

• Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20050101

• Activity of the new quinolone WCK 771 against pneumococci.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20050101

• Steroid-refractory ulcerative colitis treated with corticosteroids, metronidazole and vancomycin: a case report.

  BMC gastroenterology 20050101

• [Tendinitis in the Achilles in the elderly].

  Atencion primaria 20050101

• Demand for prophylaxis after bioterrorism-related anthrax cases, 2001.

  Emerging infectious diseases 20050101

• Kytococcus schroeteri endocarditis.

  Emerging infectious diseases 20050101

• Tolerability of moxifloxacin in patients with antibiotic hypersensitivity.

  Allergologia et immunopathologia 20050101

• Retrospective analysis of the safety profile of oral moxifloxacin in elderly patients enrolled in clinical trials.

  Drug safety 20050101

• Ocular penetration of moxifloxacin 0.5% and gatifloxacin 0.3% ophthalmic solutions into the aqueous humor following topical administration prior to routine cataract surgery.

  Current medical research and opinion 20050101

• [Comparative efficiency of treatment with moxyfloxacin and lomefloxacin for generalized murine tuberculosis caused by drug-resistant Mycobacterium strains].

  Problemy tuberkuleza i boleznei legkikh 20050101

• Guide to selection of fluoroquinolones in patients with lower respiratory tract infections.

  Drugs 20050101

• Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency.

  Annals of clinical microbiology and antimicrobials 20050101

• Campylobacter jejuni pancolitis mimicking idiopathic ulcerative colitis.

  Heart & lung : the journal of critical care 20050101

• Immediate hypersensitivity to quinolones: moxifloxacin cross-reactivity.

  Journal of investigational allergology & clinical immunology 20050101

• Effects of enteral feeding on the oral bioavailability of moxifloxacin in healthy volunteers.

  Clinical pharmacokinetics 20050101

• In vitro activities of 11 fluoroquinolones against 816 non-typhoidal strains of Salmonella enterica isolated from Finnish patients with special reference to reduced ciprofloxacin susceptibility.

  Annals of clinical microbiology and antimicrobials 20050101

• Evaluation of antibacterial in vitro activity of moxifloxacin and its effects on pulmonary clearance of Klebsiella pneumoniae in an animal experimental model.

  Arzneimittel-Forschung 20050101

• Biological assay and liquid chromatographic method for analysis of moxifloxacin in tablets.

  Journal of AOAC International 20050101

• Moxifloxacin in experimental Streptococcus pneumoniae cerebritis and meningitis.

  Neurocritical care 20050101

• [Treatment of community-acquired pneumonia in adults].

  Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 20050101

• [Flouroquinolone activity in clinical isolates of Streptococcus pneumoniae with different susceptibility to penicilline: an epidemiological study in five cities of Mexico].

  Gaceta medica de Mexico 20050101

• Cure of Q fever pneumonia with moxifloxacin: case report.

  Scandinavian journal of infectious diseases 20050101

• [Efficacy of moxifloxacin in the treatment of respiratory tract infections: the Croatian post-marketing study].

  Lijecnicki vjesnik 20050101

• In vitro activities of various antimicrobials against Brucella melitensis strains in the Aegean region in Turkey.

  Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20050101

• [A comparative analysis of antibiotics efficacy in acute ENT infections].

  Vestnik otorinolaringologii 20050101

• High carriage rate of high-level penicillin-resistant Streptococcus pneumoniae in a Taiwan kindergarten associated with a case of pneumococcal meningitis.

  BMC infectious diseases 20050101

• Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia.

  BMC infectious diseases 20050101

• Catheter-associated bacteremia by Mycobacterium senegalense in Korea.

  BMC infectious diseases 20050101

• [Moxifloxacin, a novel extended spectrum fluoroquinolone in the treatment of severe infectious inflammatory diseases].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20050101

• High prevalence of penicillin resistance and comparative in vitro activity of various antibiotics in clinical isolates of streptococcus pneumoniae isolated in the Province of Hainaut during winter 2004.

  Acta clinica Belgica 20050101

• [Characteristic of clinical fluoroquinolone resistant isolates E. faecalis].

  Medycyna doswiadczalna i mikrobiologia 20050101

• Fluoroquinolone therapy for uncomplicated skin and skin structure infections : a retrospective database comparison of treatment duration, failures and charges.

  Clinical drug investigation 20050101

• In vivo comparative pharmacokinetics and pharmacodynamics of moxifloxacin and levofloxacin in human neutrophils.

  Clinical drug investigation 20050101

• Efficacy and tolerability of sequential intravenous/oral moxifloxacin therapy in pneumonia: results of the first post-marketing surveillance study with intravenous moxifloxacin in hospital practice.

  Clinical drug investigation 20050101

• Place of newer quinolones and rifampicin in the treatment of Gram-positive bone and joint infections.

  The Journal of antimicrobial chemotherapy 20041201

• Efficacy of the latest fluoroquinolones against experimental Yersinia pestis.

  International journal of antimicrobial agents 20041201

• Moxifloxacin-associated drug hypersensitivity syndrome with toxic epidermal necrolysis and fulminant hepatic failure.

  Archives of dermatology 20041201

• Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration.

  Transactions of the American Ophthalmological Society 20041201

• [Mutant prevention concentrations of fluoroquinolones for Staphylococcus aureus].

  Zhonghua yi xue za zhi 20041117

• Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis.

  American journal of respiratory and critical care medicine 20041115

• [Antibiotic therapy of respiratory tract infections. Rapid and good effectiveness].

  MMW Fortschritte der Medizin 20041111

• [Moxifloxacin in general practice. Economical concept].

  MMW Fortschritte der Medizin 20041111

• Impact of plasma protein binding on antimicrobial activity using time-killing curves.

  The Journal of antimicrobial chemotherapy 20041101

• Resolution of symptoms in patients with community-acquired pneumonia treated on an ambulatory basis.

  The Journal of infection 20041101

• Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling.

  The Journal of infectious diseases 20041101

• Antimicrobial susceptibility of Enterococcus faecalis isolated from canals of root filled teeth with periapical lesions.

  International endodontic journal 20041101

• Safety and efficacy of sequential i.v. to p.o. moxifloxacin versus conventional combination therapies for the treatment of community-acquired pneumonia in patients requiring initial i.v. therapy.

  The Journal of emergency medicine 20041101

• Action of fluoroquinolones and Linezolid on logarithmic- and stationary-phase culture of Mycobacterium tuberculosis.

  Chemotherapy 20041101

• A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability.

  Current medical research and opinion 20041101

• MOSAIC acronym.

  Chest 20041101

• [Role of moxifloxacin in the treatment of community-acquired pneumonia].

  Orvosi hetilap 20041031

• [After stroke threatens pneumonia. Antibiotics to be given prophylactically?].

  MMW Fortschritte der Medizin 20041028

• [New fluoroquinolones: levofloxacin, moxifloxacin and gatifloxacin].

  Nederlands tijdschrift voor geneeskunde 20041023

• Synthesis and antibacterial activity of novel 6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-4-oxoquinoline-3-carboxylic acids bearing cyclopropane-fused 2-amino-8-azabicyclo[4.3.0]nonan-8-yl substituents at the C-7 position.

  Bioorganic & medicinal chemistry letters 20041018

• Simultaneous determination of levofloxacin, gatifloxacin and moxifloxacin in serum by liquid chromatography with column switching.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041015

• Effect of low-level resistance on subsequent enrichment of fluoroquinolone-resistant Streptococcus pneumoniae in rabbits.

  The Journal of infectious diseases 20041015

• In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in Spain.

  Oral microbiology and immunology 20041001

• Pharmacokinetics of moxifloxacin in patients undergoing continuous venovenous haemodiafiltration.

  The Journal of antimicrobial chemotherapy 20041001

• Bactericidal activity of moxifloxacin against multidrug-resistant Streptoccocus pneumoniae at clinically achievable serum and epithelial lining fluid concentrations compared with three other antimicrobials.

  International journal of antimicrobial agents 20041001

• Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing.

  Journal of cataract and refractive surgery 20041001

• The effect of cataract surgery on ocular levels of topical moxifloxacin.

  American journal of ophthalmology 20041001

• Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain.

  Emerging infectious diseases 20041001

• Efficacy of antibiotics against periodontopathogenic bacteria within epithelial cells: an in vitro study.

  Journal of periodontology 20041001

• Economic evaluation of the antibiotic treatment of exacerbations of chronic bronchitis and COPD in primary care.

  International journal of clinical practice 20041001

• Efficacy and safety of sequential moxifloxacin for treatment of community-acquired pneumonia associated with atypical pathogens.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20041001

• In vitro activity of moxifloxacin against community respiratory pathogens in Qatar.

  International journal of antimicrobial agents 20040901

• SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease.

  Antimicrobial agents and chemotherapy 20040901

• Penetration of newer quinolones in the empyema fluid.

  The European respiratory journal 20040901

• What is a MOSAIC study?

  Chest 20040901

• Efficacy and safety of oral telithromycin once daily for 5 days versus moxifloxacin once daily for 10 days in the treatment of acute bacterial rhinosinusitis.

  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20040901

• Selection of Bacillus anthracis isolates resistant to antibiotics.

  The Journal of antimicrobial chemotherapy 20040801

• In vitro antibacterial activity of fluoroquinolones against Porphyromonas gingivalis strains.

  The Journal of antimicrobial chemotherapy 20040801

• Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections.

  Current opinion in ophthalmology 20040801

• In vitro activities of mutant prevention concentration-targeted concentrations of fluoroquinolones against Staphylococcus aureus in a pharmacodynamic model.

  International journal of antimicrobial agents 20040801

• Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus.

  International journal of antimicrobial agents 20040801

• Urinary concentrations and bactericidal activities of newer fluoroquinolones in healthy volunteers.

  International journal of antimicrobial agents 20040801

• In vitro activity of older and newer fluoroquinolones against efflux-mediated high-level ciprofloxacin-resistant Streptococcus pneumoniae.

  International journal of antimicrobial agents 20040801

• A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.

  American journal of ophthalmology 20040801

• Moxifloxacin--a new fluoroquinolone antibacterial.

  Drug and therapeutics bulletin 20040801

• Evaluation of moxifloxacin activity in vitro against Mycobacterium tuberculosis, including resistant and multidrug-resistant strains.

  Journal of chemotherapy (Florence, Italy) 20040801

• Melioidosis in a traveller from Thailand: case report.

  Journal of chemotherapy (Florence, Italy) 20040801

• Vibrio vulnificus in Taiwan.

  Emerging infectious diseases 20040801

• Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin's disease.

  Annals of hematology 20040701

• Post-exposure prophylaxis of systemic anthrax in mice and treatment with fluoroquinolones.

  The Journal of antimicrobial chemotherapy 20040701

• Inhibition of TNF-alpha production in THP-1 macrophages by glatiramer acetate does not alter their susceptibility to infection by Listeria monocytogenes and does not impair the efficacy of ampicillin or moxifloxacin against intracellular bacteria.

  The Journal of antimicrobial chemotherapy 20040701

• Effects of a new antibacterial, telavancin, on cardiac repolarization (QTc interval duration) in healthy subjects.

  Journal of clinical pharmacology 20040701

• Antibiotic prescribing policy and Clostridium difficile diarrhoea.

  QJM : monthly journal of the Association of Physicians 20040701

• Invasive Streptococcus pneumoniae from Portugal: implications for vaccination and antimicrobial therapy.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20040701

• Antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Ireland.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20040701

• Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model.

  American journal of ophthalmology 20040701

• [Acute and bilateral uveitis secondary to moxifloxacin].

  Archivos de la Sociedad Espanola de Oftalmologia 20040701

• Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995-2001.

  Emerging infectious diseases 20040701

• Safety profile of oral and intravenous moxifloxacin: cumulative data from clinical trials and postmarketing studies.

  Clinical therapeutics 20040701

• Synthesis of new fluoroquinolones and evaluation of their in vitro activity on Toxoplasma gondii and Plasmodium spp.

  Bioorganic & medicinal chemistry letters 20040607

• Quinolone-resistant Haemophilus influenzae in a long-term care facility: clinical and molecular epidemiology.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040601

• Evaluation of vardenafil and sildenafil on cardiac repolarization.

  The American journal of cardiology 20040601

• New real-time PCR-based method for in vitro susceptibility testing of Anaplasma phagocytophilum against antimicrobial agents.

  International journal of antimicrobial agents 20040601

• Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.

  Chemotherapy 20040601

• Moxifloxacin and biofilm production by coagulase-negative staphylococci.

  Chemotherapy 20040601

• In vitro activity of ABT-492 against anaerobic bacteria.

  Journal of chemotherapy (Florence, Italy) 20040601

• The role of PK/PD parameters to avoid selection and increase of resistance: mutant prevention concentration.

  Journal of chemotherapy (Florence, Italy) 20040601

• Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040515

• Clinical experience with moxifloxacin in patients with respiratory tract infections.

  The Annals of pharmacotherapy 20040501

• Comparative in vitro activity of telavancin (TD-6424), a rapidly bactericidal, concentration-dependent anti-infective with multiple mechanisms of action against Gram-positive bacteria.

  The Journal of antimicrobial chemotherapy 20040501

• Moxifloxacin penetration into human gastrointestinal tissues.

  The Journal of antimicrobial chemotherapy 20040501

• Efficacy of antibiotics to strains of periodontopathogenic bacteria within a single species biofilm - an in vitro study.

  Journal of clinical periodontology 20040501

• Evaluation of the OSIRIS video reader as an automated measurement system for the agar disk diffusion technique.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20040501

• Prevention of the selection of resistant Staphylococcus aureus by moxifloxacin plus doxycycline in an in vitro dynamic model: an additive effect of the combination.

  International journal of antimicrobial agents 20040501

• In vitro selection of resistance in haemophilus influenzae by 4 quinolones and 5 beta-lactams.

  Diagnostic microbiology and infectious disease 20040501

• Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients.

  Emerging infectious diseases 20040501

• Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis.

  Current eye research 20040501

• Photophysical and phototoxic properties of the antibacterial fluoroquinolones levofloxacin and moxifloxacin.

  Chemistry & biodiversity 20040501

• In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.

  The Journal of antimicrobial chemotherapy 20040401

• Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040401

• Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity.

  Antimicrobial agents and chemotherapy 20040401

• Susceptibilities of Neisseria gonorrhoeae to fluoroquinolones and other antimicrobial agents in Hyogo and Osaka, Japan.

  Sexually transmitted infections 20040401

• Concentrations of moxifloxacin in serum and synovial fluid, and ex vivo bactericidal activity against arthritis-causing pathogens.

  Diagnostic microbiology and infectious disease 20040401

• Comparative in vitro activities of three new quinolones and azithromycin against aerobic pathogens causing respiratory tract and abdominal wound infections.

  Chemotherapy 20040401

• New therapies for pneumococcal meningitis.

  Expert opinion on investigational drugs 20040401

• Evaluation of the corneal effects of topical ophthalmic fluoroquinolones using in vivo confocal microscopy.

  Eye & contact lens 20040401

• Ophthalmic moxifloxacin (Vigamox) and gatifloxacin (Zymar).

  The Medical letter on drugs and therapeutics 20040329

• Structural identification and characterization of impurities in moxifloxacin.

  Journal of pharmaceutical and biomedical analysis 20040310

• [Gigantic study planned. 100,000 patients with COPD test general practice antibiotic].

  MMW Fortschritte der Medizin 20040304

• Voltammetric behaviour and determination of moxifloxacin in pharmaceutical products and human plasma.

  Analytical and bioanalytical chemistry 20040301

• Mutant prevention concentration: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis.

  The Journal of antimicrobial chemotherapy 20040301

• Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study.

  Antimicrobial agents and chemotherapy 20040301

• No more equivalence trials for antibiotics in exacerbations of COPD, please.

  Chest 20040301

• Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.

  Chest 20040301

• Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults.

  Chest 20040301

• Susceptibility testing of Singapore strains of Mycoplasma hominis to tetracycline, gatifloxacin, moxifloxacin, ciprofloxacin, clindamycin, and azithromycin by the Etest method.

  Diagnostic microbiology and infectious disease 20040301

• Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones.

  Survey of ophthalmology 20040301

• In vivo experimental approach for the risk assessment of fluoroquinolone antibacterial agents-induced long QT syndrome.

  European journal of pharmacology 20040220

• Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis.

  American journal of respiratory and critical care medicine 20040201

• In vitro susceptibility of Bacillus anthracis to various antibacterial agents and their time-kill activity.

  The Journal of antimicrobial chemotherapy 20040201

• Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli.

  The Journal of antimicrobial chemotherapy 20040201

• Pharmacologic considerations for cataract surgery.

  Current opinion in ophthalmology 20040201

• Sinus tissue concentration of moxifloxacin after a single oral dose.

  The Annals of otology, rhinology, and laryngology 20040201

• Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing.

  Journal of veterinary pharmacology and therapeutics 20040201

• Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.

  International journal of antimicrobial agents 20040201

• Effect of prophylactic antibiotics on antimicrobial resistance of viridans streptococci in the normal flora of cataract surgery patients.

  Journal of cataract and refractive surgery 20040201

• Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment.

  Clinical therapeutics 20040201

• Efficacy and tolerability of moxifloxacin in the treatment of acute bacterial sinusitis caused by penicillin-resistant Streptococcus pneumoniae: a pooled analysis.

  Clinical therapeutics 20040201

• Effect of moxifloxacin on bacterial pathogenicity factors in comparison with amoxicillin, clarithromycin and ceftriaxone.

  Journal of chemotherapy (Florence, Italy) 20040201

• New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method.

  The Journal of antimicrobial chemotherapy 20040101

• Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke.

  Stroke 20040101

• Pharmacokinetics of moxifloxacin are not influenced by a 7-day pretreatment with 200 mg oral itraconazole given once a day in healthy subjects.

  International journal of clinical pharmacology and therapeutics 20040101

• New developments in antibacterial choice for lower respiratory tract infections in elderly patients.

  Drugs & aging 20040101

• Potential role of moxifloxacin in methicillin-resistant Staphylococcus aureus (MRSA) infections.

  JPMA. The Journal of the Pakistan Medical Association 20040101

• Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan.

  Emerging infectious diseases 20040101

• Quinolone safety and efficacy more important than potency.

  Emerging infectious diseases 20040101

• Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study.

  Microbial drug resistance (Larchmont, N.Y.) 20040101

• Recurrent tendinitis after treatment with two different fluoroquinolones.

  Scandinavian journal of infectious diseases 20040101

• Moxifloxacin and glucose homeostasis: a pooled-analysis of the evidence from clinical and postmarketing studies.

  Drug safety 20040101

• Newer treatment options for skin and soft tissue infections.

  Drugs 20040101

• Activity of telithromycin and comparators against bacterial pathogens isolated from 1,336 patients with clinically diagnosed acute sinusitis.

  Annals of clinical microbiology and antimicrobials 20040101

• [Efficacy of moxifloxacin (Avelox) in prophylaxis of infection in patients with profound neutropenia].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20040101

• Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis.

  Scandinavian journal of infectious diseases 20040101

• Moxifloxacin: a review of its use in the management of bacterial infections.

  Drugs 20040101

• [Dynamics of Streptococcos pneumoniae antibiotic resistance extension in Moscow in 1998-2003].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20040101

• Fluoroquinolones as chemotherapeutics against mycobacterial infections.

  Current pharmaceutical design 20040101

• Effects of macrolides and ketolides on mycobacterial infections.

  Current pharmaceutical design 20040101

• Symptom resolution in patients with Mycoplasma pneumoniae pneumonia.

  Canadian respiratory journal 20040101

• [Optimization of tuberculosis complex chemotherapy with the use of moxifloxacin].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20040101

• Recently introduced antibiotics: a guide for the general physician.

  Clinical medicine (London, England) 20040101

• [Comparative assessment of fluoroquinolones efficacy in the treatment of patients with infectious exacerbation of chronic obstructive bronchitis].

  Likars'ka sprava 20040101

• Efficacy and tolerability of moxifloxacin in patients with sinusitis treated in general practice : results of a post-marketing surveillance study.

  Clinical drug investigation 20040101

• Once-daily moxifloxacin therapy for community-acquired pneumonia in general practice : evidence from a post-marketing surveillance study of 1467 patients.

  Clinical drug investigation 20040101

• Daily-practice treatment of acute exacerbations of chronic bronchitis with moxifloxacin in a large cohort in Germany.

  Clinical drug investigation 20040101

• The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.

  American journal of respiratory and critical care medicine 20031201

• Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England.

  The Journal of antimicrobial chemotherapy 20031201

• Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme.

  The Journal of antimicrobial chemotherapy 20031201

• In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.

  The Journal of antimicrobial chemotherapy 20031201

• Fluoroquinolone resistance in patients with newly diagnosed tuberculosis.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031201

• Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031201

• In vitro activities of nine peptide deformylase inhibitors and five comparator agents against respiratory and skin pathogens.

  International journal of antimicrobial agents 20031201

• Disposition and intracellular levels of moxifloxacin in human THP-1 monocytes in unstimulated and stimulated conditions.

  International journal of antimicrobial agents 20031201

• In vitro pharmacodynamic activity of gatifloxacin, gemifloxacin, moxifloxacin and levofloxacin against Streptococcus pneumoniae containing specific mutations in DNA gyrase and topoisomerase IV.

  Diagnostic microbiology and infectious disease 20031201

• Factors influencing fluoroquinolone resistance.

  Emerging infectious diseases 20031201

• Drawbacks of antibiotic susceptibility of Streptococcus pneumoniae.

  Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20031201

• Morphostructural damage and the inhibition of bacterial adhesiveness of Staphylococcus aureus and Moraxella catarrhalis induced by moxifloxacin.

  Journal of chemotherapy (Florence, Italy) 20031201

• Diffusion of oral and intravenous 400 mg once-daily moxifloxacin into lung tissue at pharmacokinetic steady-state.

  Journal of chemotherapy (Florence, Italy) 20031201

• Serum bactericidal activity of the methoxyfluoroquinolones gatifloxacin and moxifloxacin against clinical isolates of Staphylococcus species: are the susceptibility breakpoints too high?

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031115

• Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens.

  The Journal of antimicrobial chemotherapy 20031101

• Gatifloxacin, gemifloxacin, and moxifloxacin: the role of 3 newer fluoroquinolones.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031101

• In vitro activity of telithromycin compared with macrolides and fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.

  International journal of antimicrobial agents 20031101

• Moxifloxacin-induced Clostridium difficile-associated diarrhea.

  Pharmacotherapy 20031101

• Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients.

  Emerging infectious diseases 20031101

• Invasive Mycobacterium marinum infections.

  Emerging infectious diseases 20031101

• Effects of moxifloxacin in zymogen A or S. aureus stimulated human THP-1 monocytes on the inflammatory process and the spread of infection.

  Life sciences 20031010

• [Acute exacerbated chronic bronchitis. Antibiotics in comparison].

  MMW Fortschritte der Medizin 20031002

• Frequencies and mechanisms of resistance to moxifloxacin in nosocomial isolates of Acinetobacter baumannii.

  The Journal of antimicrobial chemotherapy 20031001

• Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones.

  The Journal of antimicrobial chemotherapy 20031001

• Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing.

  The Journal of antimicrobial chemotherapy 20031001

• Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora.

  The Journal of antimicrobial chemotherapy 20031001

• Fluoroquinolone-containing third-line regimen against Mycobacterium tuberculosis in vivo.

  Antimicrobial agents and chemotherapy 20031001

• Penicillin enhances the toll-like receptor 2-mediated proinflammatory activity of Streptococcus pneumoniae.

  The Journal of infectious diseases 20031001

• In vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer patients.

  Diagnostic microbiology and infectious disease 20031001

• Population pharmacokinetics of moxifloxacin in plasma and bronchial secretions in patients with severe bronchopneumonia.

  Clinical pharmacology and therapeutics 20031001

• Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumonia.

  Respiratory medicine 20031001

• In vitro activity of ertapenem against anaerobes isolated from the respiratory tract.

  Pathologie-biologie 20031001

• In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20031001

• Moxifloxacin (Avelox): a novel fluoroquinolone with a broad spectrum of activity.

  Expert review of anti-infective therapy 20031001

• Advances in the management of Chlamydia pneumoniae infections.

  Expert review of anti-infective therapy 20031001

• Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac risk.

  European journal of pharmacology 20030905

• Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 250 invasive Streptococcus pneumoniae isolates from France.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20030901

• Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.

  American journal of ophthalmology 20030901

• [A comparison of moxifloxacin and amoxicillin in the treatment of community-acquired pneumonia in Latin America: results of a multicenter clinical trial].

  Archivos de bronconeumologia 20030901

• Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.

  Bioorganic & medicinal chemistry letters 20030818

• Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000).

  The Journal of antimicrobial chemotherapy 20030801

• Emergence of fluoroquinolone resistance among Bacteroides species.

  The Journal of antimicrobial chemotherapy 20030801

• Treatment of bacterial skin and skin structure infections.

  Expert opinion on pharmacotherapy 20030801

• Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice.

  Antimicrobial agents and chemotherapy 20030801

• An economic evaluation of sequential i.v./po moxifloxacin therapy compared to i.v./po co-amoxiclav with or without clarithromycin in the treatment of community-acquired pneumonia.

  Chest 20030801

• In vitro susceptibility of 4903 bacterial isolates to gemifloxacin--an advanced fluoroquinolone.

  International journal of antimicrobial agents 20030801

• Therapeutic efficacy of moxifloxacin in a murine model of severe systemic mixed infection with Escherichia coli and Bacteroides fragilis.

  Anaerobe 20030801

• Intra-hospital dissemination of quinupristin/dalfopristin- and vancomycin-resistant Enterococcus faecium in a paediatric ward of a German hospital.

  The Journal of antimicrobial chemotherapy 20030701

• Effect of chloramphenicol, erythromycin, moxifloxacin, penicillin and tetracycline concentration on the recovery of resistant mutants of Mycobacterium smegmatis and Staphylococcus aureus.

  The Journal of antimicrobial chemotherapy 20030701

• In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene.

  International journal of antimicrobial agents 20030701

• A novel method of estimating cost of therapy by using patient population characteristics: analysis of fluoroquinolones in various populations with different distributions of renal function.

  Pharmacotherapy 20030701

• The penetration of moxifloxacin into the pancreas of male rats in experimental acute necrotizing pancreatitis.

  Chemotherapy 20030701

• Comparative in vitro activity of three fluoroquinolones against clinical isolates by E test.

  Chemotherapy 20030701

• Antimicrobial susceptibility breakpoints and first-step parC mutations in Streptococcus pneumoniae: redefining fluoroquinolone resistance.

  Emerging infectious diseases 20030701

• In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000-2001.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20030701

• Proceedings of the 99th meeting of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. May 29th and 30th, 2003.

  Circulation 20030617

• Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.

  The Journal of infectious diseases 20030615

• Selection of moxifloxacin-resistant Staphylococcus aureus compared with five other fluoroquinolones.

  The Journal of antimicrobial chemotherapy 20030601

• Immunomodulatory effects of quinolones.

  The Lancet. Infectious diseases 20030601

• Inhibitory and bactericidal activities of gemifloxacin and other antimicrobials against Mycoplasma pneumoniae.

  International journal of antimicrobial agents 20030601

• In vitro activity of garenoxacin against recent clinical isolates of Chlamydia pneumoniae.

  International journal of antimicrobial agents 20030601

• In vitro activity of new fluoroquinolones and linezolid against non-tuberculous mycobacteria.

  International journal of antimicrobial agents 20030601

• Re-evaluation of quality control guidelines for gatifloxacin and garenoxacin (BMS284756) when susceptibility testing Haemophilus influenzae and Streptococcus pneumoniae.

  Diagnostic microbiology and infectious disease 20030601

• New drugs and dosage forms.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030601

• Costs of broad-spectrum antibiotic use for acute sinusitis, chronic bronchitis, and pneumonia in a managed care population.

  Managed care interface 20030601

• Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20030601

• Antecedent use of fluoroquinolones is associated with resistance to moxifloxacin in Clostridium difficile.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20030601

• Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.

  Journal of chemotherapy (Florence, Italy) 20030601

• [Susceptibility of Campylobacter jejuni clinical isolates from children to eight antibiotics].

  Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20030601

• Development of the quinolones.

  The Journal of antimicrobial chemotherapy 20030501

• Maximizing efficacy and reducing the emergence of resistance.

  The Journal of antimicrobial chemotherapy 20030501

• Comparison of the bactericidal activity of moxifloxacin and levofloxacin against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli and Klebsiella pneumoniae.

  Chemotherapy 20030501

• In vitro synergy studies using aztreonam and fluoroquinolone combinations against six species of Gram-negative bacilli.

  Chemotherapy 20030501

• National surveillance programme on susceptibility patterns of respiratory pathogens in South Africa: moxifloxacin compared with eight other antimicrobial agents.

  Journal of clinical pathology 20030501

• Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance program.

  Diagnostic microbiology and infectious disease 20030501

• Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America (2000-2001): report from the SENTRY Antimicrobial Surveillance Program.

  Diagnostic microbiology and infectious disease 20030501

• [Unusual gram positive rods, causing pneumonia].

  Pneumologie (Stuttgart, Germany) 20030501

• [Playing it safe in bronchopulmonary infections].

  MMW Fortschritte der Medizin 20030501

• Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20030501

• Antibiotic susceptibility and serotypes of Streptococcus pneumoniae isolates from Hungary.

  The Journal of antimicrobial chemotherapy 20030401

• Activity of beta-lactams (ampicillin, meropenem), gentamicin, azithromycin and moxifloxacin against intracellular Listeria monocytogenes in a 24 h THP-1 human macrophage model.

  The Journal of antimicrobial chemotherapy 20030401

• AUC(0-t)/MIC is a continuous index of fluoroquinolone exposure and predictive of antibacterial response for Streptococcus pneumoniae in an in vitro infection model.

  The Journal of antimicrobial chemotherapy 20030401

• Synergic activity of fluoroquinolones and linezolid against Mycobacterium tuberculosis.

  International journal of antimicrobial agents 20030401

• In vitro antibacterial activity and pharmacodynamics of new quinolones.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20030401

• Effects of three fluoroquinolones on QT interval in healthy adults after single doses.

  Clinical pharmacology and therapeutics 20030401

• Antimicrobial susceptibility of community-acquired respiratory tract pathogens in North America in 1999-2000: findings of the PROTEKT surveillance study.

  Diagnostic microbiology and infectious disease 20030401

• Comparative activity of garenoxacin (BMS 284756), a novel desfluoroquinolone, tested against 8,331 isolates from community-acquired respiratory tract infections: North American results from the SENTRY Antimicrobial Surveillance Program (1999-2001).

  Diagnostic microbiology and infectious disease 20030401

• Comparative bactericidal activity of fluoroquinolones against clinical isolates resistant to fluoroquinolones.

  Journal of chemotherapy (Florence, Italy) 20030401

• Synthesis and structure-activity relationships of 5-amino-6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-8-methylquinolonecarboxylic acid antibacterials having fluorinated 7-[(3R)-3-(1-aminocyclopropan-1-yl)pyrrolidin-1-yl] substituents.

  Journal of medicinal chemistry 20030313

• Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile.

  The Journal of antimicrobial chemotherapy 20030301

• Experimental pneumococcal pleural empyema model: the effect of moxifloxacin.

  The Journal of antimicrobial chemotherapy 20030301

• [Pneumococcus and quinolone resistance].

  Archivos de bronconeumologia 20030301

• [Infection due to Mycobacterium kansasii in Elche, Spain].

  Medicina clinica 20030301

• Multidrug-resistant tuberculosis in pregnancy: case report and review of the literature.

  Chest 20030301

• Moxifloxacin-induced Clostridium difficile diarrhea.

  The Annals of pharmacotherapy 20030301

• New antibiotics for bacterial infections.

  Ophthalmology clinics of North America 20030301

• [New antibiotics in primary care].

  Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20030301

• Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.

  Pediatric pulmonology 20030201

• Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis.

  Antimicrobial agents and chemotherapy 20030201

• Rapid in vivo screening of experimental drugs for tuberculosis using gamma interferon gene-disrupted mice.

  Antimicrobial agents and chemotherapy 20030201

• Development and mechanism of fluoroquinolone resistance in Legionella pneumophila.

  The Journal of antimicrobial chemotherapy 20030201

• Long-term tolerance and effectiveness of moxifloxacin therapy for tuberculosis: preliminary results.

  Journal of chemotherapy (Florence, Italy) 20030201

• A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus.

  The Journal of antimicrobial chemotherapy 20030101

• Activities of 13 quinolones by three susceptibility testing methods against a collection of Haemophilus influenzae isolates with different levels of susceptibility to ciprofloxacin: evidence for cross-resistance.

  The Journal of antimicrobial chemotherapy 20030101

• Garenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci.

  Antimicrobial agents and chemotherapy 20030101

• Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice.

  Antimicrobial agents and chemotherapy 20030101

• Maintaining fluoroquinolone class efficacy: review of influencing factors.

  Emerging infectious diseases 20030101

• Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regions.

  Drug safety 20030101

• Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia.

  The European respiratory journal 20030101

• Molecular characterization of fluoroquinolone resistant Streptococcus pneumoniae clinical isolates obtained from across Canada.

  Diagnostic microbiology and infectious disease 20030101

• Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adults.

  The Journal of laryngology and otology 20030101

• Fluoroquinolones in the elderly: safety considerations.

  Drugs & aging 20030101

• Antimicrobial resistance in recent fecal enterococci from healthy volunteers and food handlers in Spain: genes and phenotypes.

  Microbial drug resistance (Larchmont, N.Y.) 20030101

• Antibiotic susceptibility and serotype distribution of 240 Streptococcus pneumoniae causing meningitis in Belgium 1997-2000.

  Acta clinica Belgica 20030101

• In vitro susceptibility of six fluoroquinolones against invasive Streptococcus pneumoniae isolated from 1996 to 2001 in Taiwan.

  Microbial drug resistance (Larchmont, N.Y.) 20030101

• Anaphylactoid reaction to ciprofloxacin.

  The Annals of pharmacotherapy 20030101

• [Experience in using the new drug moxifloxacin (Avelox, 'Bayer', Germaniia) in urologic practice].

  Urologiia (Moscow, Russia : 1999) 20030101

• [New approaches to antibacterial therapy of infections in the surgical practice].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20030101

• Beau's lines in a patient treated with moxifloxacin for anaerobic pulmonary infection.

  Scandinavian journal of infectious diseases 20030101

• Effect of topical fluoroquinolones on the expression of matrix metalloproteinases in the cornea.

  BMC ophthalmology 20030101

• Moxifloxacin in the treatment of acute maxillary sinusitis after first-line treatment failure and acute sinusitis with high risk of complications.

  The Journal of international medical research 20030101

• Pseudomonal infections in patients with COPD: epidemiology and management.

  American journal of respiratory medicine : drugs, devices, and other interventions 20030101

• Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens.

  Advances in therapy 20030101

• Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials : results of a two-year study.

  Clinical drug investigation 20030101

• Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections.

  International journal of antimicrobial agents 20021201

• In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis.

  International journal of antimicrobial agents 20021201

• Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus.

  The Journal of antimicrobial chemotherapy 20021201

• Synergic activity of cephalosporins plus fluoroquinolones against Pseudomonas aeruginosa with resistance to one or both drugs.

  The Journal of antimicrobial chemotherapy 20021201

• Moxifloxacin: new preparation. A me-too with more cardiac risks.

  Prescrire international 20021201

• In vitro activity of gemifloxacin against recent clinical isolates of bacteria in Korea.

  Journal of Korean medical science 20021201

• Efficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB).

  Journal of chemotherapy (Florence, Italy) 20021201

• [In vitro activity of moxifloxacin against respiratory pathogens in Latin America].

  Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20021201

• Determination of moxifloxacin in human plasma by liquid chromatography electrospray ionization tandem mass spectrometry.

  Journal of pharmaceutical and biomedical analysis 20021107

• Examination of single and multiple mutations involved in resistance to quinolones in Staphylococcus aureus by a combination of PCR and denaturing high-performance liquid chromatography (DHPLC).

  The Journal of antimicrobial chemotherapy 20021101

• Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams.

  International journal of antimicrobial agents 20021101

• [Diagnosis and treatment of legionella pneumonia].

  Pneumologie (Stuttgart, Germany) 20021101

• [Respiratory tract infections. Increasingly more established antibiotics fail].

  MMW Fortschritte der Medizin 20021017

• Simultaneous drug allergies.

  Allergy 20021001

• Comparison of the in vitro activities of several new fluoroquinolones against respiratory pathogens and their abilities to select fluoroquinolone resistance.

  The Journal of antimicrobial chemotherapy 20021001

• AUC/MIC relationships to different endpoints of the antimicrobial effect: multiple-dose in vitro simulations with moxifloxacin and levofloxacin.

  The Journal of antimicrobial chemotherapy 20021001

• Comparative in vitro activity of penicillin G, levofloxacin, moxifloxacin, telithromycin, pristinamycin, quinupristin-dalfopristin and linezolid against ofloxacin-intermediate and -resistant Streptococcus pneumoniae.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20021001

• Concurrent use of selected agents with moxifloxacin: an examination of labeling compliance within 1 year of marketing.

  Archives of internal medicine 20020923

• Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020901

• Alternative and rescue treatment regimens for Helicobacter pylori eradication.

  Expert opinion on pharmacotherapy 20020901

• The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia.

  Chest 20020901

• Clinical relevance of penicillin-resistant Streptococcus pneumoniae.

  Seminars in respiratory infections 20020901

• Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin.

  The Journal of antimicrobial chemotherapy 20020901

• In vitro activity of moxifloxacin against recent community-acquired respiratory tract pathogens isolated in France: a national survey.

  International journal of antimicrobial agents 20020901

• Moxifloxacin activity against clinical isolates compared with the activity of ciprofloxacin.

  International journal of antimicrobial agents 20020901

• Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan.

  Emerging infectious diseases 20020801

• In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method.

  Diagnostic microbiology and infectious disease 20020801

• Pharmacodynamic characterization of efflux and topoisomerase IV-mediated fluoroquinolone resistance in Streptococcus pneumoniae.

  The Journal of antimicrobial chemotherapy 20020801

• Calculation of composite recovery time: a new pharmacodynamic parameter.

  The Journal of antimicrobial chemotherapy 20020801

• [Prospects for development of new antituberculous drugs].

  Kekkaku : [Tuberculosis] 20020801

• Influence of moxifloxacin, comparator drugs and some fractions of pulmonary surfactant on adherence of some respiratory pathogens.

  Infection 20020801

• Single and multi-step resistance selection study in Streptococcus pneumoniae comparing ceftriaxone with levofloxacin, gatifloxacin and moxifloxacin.

  International journal of antimicrobial agents 20020801

• In vitro antimicrobial susceptibility of oral strains of Actinobacillus actinomycetemcomitans to seven antibiotics.

  Journal of clinical periodontology 20020801

• In vitro activity of linezolid, synercid and telithromycin against genetically defined high level fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus.

  International journal of antimicrobial agents 20020701

• Moxifloxacin-induced acute liver injury.

  The American journal of gastroenterology 20020701

• Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval.

  Expert opinion on drug safety 20020701

• Resistance among Streptococcus pneumoniae: Implications for drug selection.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020615

• Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020601

• Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis.

  Antimicrobial agents and chemotherapy 20020601

• Streptococcus pneumoniae, Brooklyn, New York: fluoroquinolone resistance at our doorstep.

  Emerging infectious diseases 20020601

• Single- and multistep selection study of the antipneumococcal activity of BMS-284756 compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacin.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20020601

• 'There's no such thing as a free meal'.

  Connecticut medicine 20020601

• In vitro photochemical clastogenicity of quinolone antibacterial agents studied by a chromosomal aberration test with light irradiation.

  Mutation research 20020527

• Separation of levofloxacin, ciprofloxacin, gatifloxacin, moxifloxacin, trovafloxacin and cinoxacin by high-performance liquid chromatography: application to levofloxacin determination in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020525

• Effect of antipyretic agents on uptake, transport, and release of antimicrobial agents by human polymorphonuclear leukocytes.

  The Journal of infectious diseases 20020501

• Serial passage of Chlamydia spp. in sub-inhibitory fluoroquinolone concentrations.

  The Journal of antimicrobial chemotherapy 20020501

• Pharmacodynamic activity of fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.

  The Journal of antimicrobial chemotherapy 20020501

• A prospective, multicentre study of moxifloxacin concentrations in the sinus mucosa tissue of patients undergoing elective surgery of the sinus.

  The Journal of antimicrobial chemotherapy 20020501

• Torsades de pointes associated with fluoroquinolones.

  Pharmacotherapy 20020501

• In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosis.

  Antimicrobial agents and chemotherapy 20020401

• Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics.

  American journal of ophthalmology 20020401

• Evaluation of survival and pharmacodynamic relationships for five fluoroquinolones in a neutropenic murine model of pneumococcal lung infection.

  Pharmacotherapy 20020401

• Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine.

  The Journal of infection 20020401

• In vitro antibacterial activities of DQ-113, a potent quinolone, against clinical isolates.

  Antimicrobial agents and chemotherapy 20020301

• Activity of clinafloxacin, compared with six other quinolones, against Acinetobacter baumannii clinical isolates.

  The Journal of antimicrobial chemotherapy 20020301

• Pharmacokinetics of moxifloxacin, a novel 8-methoxy-quinolone, in patients with renal dysfunction.

  British journal of clinical pharmacology 20020301

• Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication.

  Alimentary pharmacology & therapeutics 20020301

• Broth microdilution and E-test for determining fluoroquinolone activity against Streptococcus pneumoniae.

  The Annals of pharmacotherapy 20020301

• Levofloxacin treatment failure in a patient with fluoroquinolone-resistant Streptococcus pneumoniae pneumonia.

  Pharmacotherapy 20020301

• Avelox. Respiratory antibiotic now in i.v. form.

  Nursing 20020301

• In-vitro activity of moxifloxacin and other fluoroquinolones against Chlamydia species.

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20020301

• Increased in vitro activity of the novel des-fluoro(6) quinolone BMS-284756 against genetically defined clinical isolates of Staphylococcus aureus.

  The Journal of antimicrobial chemotherapy 20020201

• Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates.

  International journal of antimicrobial agents 20020201

• Apparent plateau in beta-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the LIBRA Surveillance initiative.

  International journal of antimicrobial agents 20020201

• Quinolones: a comprehensive review.

  American family physician 20020201

• In vitro activity of clinafloxacin in comparison with other quinolones against Stenotrophomonas maltophilia clinical isolates in the presence and absence of reserpine.

  Diagnostic microbiology and infectious disease 20020201

• Moxifloxacin sensitivity of respiratory pathogens in the United Kingdom.

  Journal of chemotherapy (Florence, Italy) 20020201

• Pharmacokinetic and pharmacodynamic predictors of antimicrobial efficacy: moxifloxacin and Streptococcus pneumoniae.

  Journal of chemotherapy (Florence, Italy) 20020201

• Improving care for patients with respiratory tract infections.

  Journal of chemotherapy (Florence, Italy) 20020201

• An updated safety profile of moxifloxacin.

  Journal of chemotherapy (Florence, Italy) 20020201

• A critical review of the fluoroquinolones: focus on respiratory infections.

  Drugs 20020101

• Comparative in vitro activity of gemifloxacin to other fluoroquinolones and non-quinolone agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the United States in 1999-2000.

  International journal of antimicrobial agents 20020101

• Susceptibility to moxifloxacin and other antimicrobial agents of major pathogens responsible for community acquired respiratory tract infection in Poland.

  International journal of antimicrobial agents 20020101

• The role of fluoroquinolones in skin and skin structure infections.

  American journal of clinical dermatology 20020101

• Influence of CO(2) incubation on quinolone activity against Streptococcus pneumoniae and Haemophilus influenzae.

  Diagnostic microbiology and infectious disease 20020101

• Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20020101

• E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20020101

• Moxifloxacin in uncomplicated skin and skin structure infections.

  Drugs 20020101

• [Perspectives of use of moxifloxacin for treatment of urogenital infections].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20020101

• Anaphylactoid reaction caused by moxifloxacin.

  Journal of investigational allergology & clinical immunology 20020101

• Clinical role of protein binding of quinolones.

  Clinical pharmacokinetics 20020101

• Levofloxacin: an updated review of its use in the treatment of bacterial infections.

  Drugs 20020101

• [Moxifloxacin--antimicrobial activity and pharmacokinetic properties].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20020101

• [Use of avelox in treating urogenital infections in men].

  Urologiia (Moscow, Russia : 1999) 20020101

• Demonstration of in vitro antagonism between fusidic acid and quinolones.

  The Journal of international medical research 20020101

• [Effectiveness of a new fluoroquinolone antibiotic avelox in the treatment of suppurative sinusitis].

  Vestnik otorinolaringologii 20020101

• Single- and multiple-dose pharmacokinetics of oral moxifloxacin and clarithromycin, and concentrations in serum, saliva and faeces.

  Scandinavian journal of infectious diseases 20020101

• Simulated in vitro quinolone pharmacodynamics at clinically achievable AUC/MIC ratios: advantage of I E over other integral parameters.

  Chemotherapy 20020101

• [Moxifloxacin: results of clinical use].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20020101

• Safety of fluoroquinolones: An update.

  The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses 20020101

• Oral fluoroquinolones in the treatment of pneumonia, bronchitis and sinusitis.

  The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses 20020101

• Quinolones and false-positive urine screening for opiates by immunoassay technology.

  JAMA 20011226

• Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice.

  Antimicrobial agents and chemotherapy 20011201

• Accumulation of five fluoroquinolones by Mycobacterium tuberculosis H37Rv.

  The Journal of antimicrobial chemotherapy 20011201

• Influence of the decrease in ciprofloxacin susceptibility and the presence of human serum on the in vitro susceptibility of Streptococcus pneumoniae to five new quinolones.

  The Journal of antimicrobial chemotherapy 20011201

• Comparative activity of linezolid and other new agents against methicillin-resistant Staphylococcus aureus and teicoplanin-intermediate coagulase-negative staphylococci.

  The Journal of antimicrobial chemotherapy 20011201

• Human aqueous humor levels of oral ciprofloxacin, levofloxacin, and moxifloxacin.

  Journal of cataract and refractive surgery 20011201

• Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin.

  Pharmacotherapy 20011201

• Activity of telithromycin against 26 quinolone-resistant pneumococci with known quinolone-resistance mechanisms.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20011201

• [Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].

  Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20011201

• [In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin].

  Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20011201

• Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.

  Antimicrobial agents and chemotherapy 20011101

• Comparison of antimicrobial in vitro activities against Streptococcus pneumoniae independent of MIC susceptibility breakpoints using MIC frequency distribution curves, scattergrams and linear regression analyses.

  The Journal of antimicrobial chemotherapy 20011101

• Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000.

  The Journal of antimicrobial chemotherapy 20011101

• [The safety of new quinolone treatment--levoflaxacin (tavanic) and moxiflocacin (megaxin)-- in the community].

  Harefuah 20011101

• In vitro activity of moxifloxacin against local bacterial isolates.

  Annals of the Academy of Medicine, Singapore 20011101

• A comparative study of the fluoroquinolone antibacterial agents on the action potential duration in guinea pig ventricular myocardia.

  Japanese journal of pharmacology 20011101

• Moxifloxacin does increase the corrected QT interval.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20011015

• Fluoroquinolone susceptibilities of efflux-mediated multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia.

  The Journal of antimicrobial chemotherapy 20011001

• Pharmacokinetics and pharmacodynamics of fluoroquinolones.

  Pharmacotherapy 20011001

• Clinical isolates of Streptococcus pneumoniae resistant to levofloxacin contain mutations in both gyrA and parC genes.

  International journal of antimicrobial agents 20011001

• Multicentre study of the in vitro evaluation of moxifloxacin and other quinolones against community acquired respiratory pathogens.

  International journal of antimicrobial agents 20011001

• [Diagnosis and therapy of abscess forming pneumonia].

  Therapeutische Umschau. Revue therapeutique 20011001

• Moxifloxacin (Avelox) for the treatment of bacterial skin infections.

  Skin therapy letter 20011001

• [Third and fourth generation fluoroquinolones].

  Revue medicale de Bruxelles 20011001

• Pharmacokinetics and pharmacodynamics of the new fluoroquinolones: focus on respiratory infections.

  Current opinion in pharmacology 20011001

• Assessment of chronic toxicity and carcinogenicity in an accelerated cancer bioassay in rats of moxifloxacin, a quinolone antibiotic.

  Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20011001

• Resistance of Streptococcus pneumoniae to fluoroquinolones--United States, 1995-1999.

  MMWR. Morbidity and mortality weekly report 20010921

• Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy.

  The Journal of infectious diseases 20010915

• Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae.

  The Journal of antimicrobial chemotherapy 20010901

• Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolone exposure.

  The Journal of antimicrobial chemotherapy 20010901

• Comparison of the in vitro activities of BMS-284756 and four fluoroquinolones against Streptococcus pneumoniae.

  The Journal of antimicrobial chemotherapy 20010901

• Future of the quinolones.

  Seminars in respiratory infections 20010901

• Is more than one quinolone needed in clinical practice?

  The Annals of pharmacotherapy 20010901

• The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis: a Spanish physician and patient experience.

  International journal of clinical practice 20010901

• In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.

  Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20010901

• A nosocomial outbreak of fluoroquinolone-resistant Streptococcus pneumoniae.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010815

• The inhibition and selectivity of bacterial topoisomerases by BMS-284756 and its analogues.

  The Journal of antimicrobial chemotherapy 20010801

• In vitro activity of fosfomycin in combination with various antistaphylococcal substances.

  The Journal of antimicrobial chemotherapy 20010801

• Treatment of Staphylococcus aureus endocarditis using moxifloxacin.

  International journal of medical microbiology : IJMM 20010801

• Fluoroquinolone susceptibility, resistance, and pharmacodynamics versus clinical isolates of Streptococcus pneumoniae from Indiana.

  Diagnostic microbiology and infectious disease 20010801

• [Hypertensive crisis and transitory left brunch block with QT interval prolongation associated to moxifloxacin].

  Medicina clinica 20010707

• Comparative in vitro study of the activity of moxifloxacin and other antibiotics against 150 strains of penicillin non-susceptible Streptococcus pneumoniae and against 110 strains of ampicillin-resistant Haemophilus influenzae isolated in 1999-2000 in Spain.

  The Journal of antimicrobial chemotherapy 20010701

• The use of fluoroquinolones as antiinfective transition-therapy agents in community-acquired pneumonia.

  Pharmacotherapy 20010701

• The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia.

  Respiratory medicine 20010701

• Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp.

  International journal of antimicrobial agents 20010701

• Ciprofloxacin- and methicillin-resistant staphylococcus aureus susceptible to moxifloxacin, levofloxacin, teicoplanin, vancomycin and linezolid.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20010701

• Clinical microbiology and infectious diseases - 11th European Congress. 1-4 April 2001, Istanbul, Turkey.

  IDrugs : the investigational drugs journal 20010701

• Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniae.

  The Journal of antimicrobial chemotherapy 20010601

• Antimicrobial activity of moxifloxacin, gatifloxacin and six fluoroquinolones against Streptococcus pneumoniae.

  The Journal of antimicrobial chemotherapy 20010601

• Conventional dogma applied to quinolones? Time for a change.

  The Journal of antimicrobial chemotherapy 20010601

• A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model.

  Journal of medical microbiology 20010601

• Microbial drug resistance and the roles of the new antibiotics.

  Cleveland Clinic journal of medicine 20010601

• Moxifloxacin versus amoxicillin clavulanate in the treatment of acute maxillary sinusitis: a primary care experience.

  International journal of clinical practice 20010601

• Newer drugs in leprosy.

  International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 20010601

• The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis.

  Journal of cardiovascular pharmacology 20010501

• Activity of moxifloxacin and other quinolones against pneumococci resistant to first-line agents, or with high-level ciprofloxacin resistance.

  International journal of antimicrobial agents 20010501

• Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopenia.

  European journal of haematology 20010501

• A whole blood bactericidal assay for tuberculosis.

  The Journal of infectious diseases 20010415

• Determination of moxifloxacin in growth media by high-performance liquid chromatography.

  Journal of chromatography. B, Biomedical sciences and applications 20010415

• Reassuring safety profile of moxifloxacin.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010401

• Activity of moxifloxacin against clinical isolates of Streptococcus pneumoniae from England and Wales.

  The Journal of antimicrobial chemotherapy 20010401

• Activity of BMS284756 against 2,681 recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis: Report from The SENTRY Antimicrobial Surveillance Program (2000) in Europe, Canada and the United States.

  Diagnostic microbiology and infectious disease 20010401

• Comparative in vitro and in vivo activity of the C-8 methoxy quinolone moxifloxacin and the C-8 chlorine quinolone BAY y 3118.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315

• Penicillin-resistant streptococcus pneumoniae: review of moxifloxacin activity.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315

• Comparative in vitro activity of moxifloxacin by E-test against Streptococcus pyogenes.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315

• Pharmacodynamics of moxifloxacin and levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis in an in vitro pharmacodynamic model.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315

• Profile of moxifloxacin drug interactions.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315

• Evaluation of the clinical microbiology profile of moxifloxacin.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315

• Clinical perspectives on new antimicrobials: focus on fluoroquinolones.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315

• Adverse reactions to fluoroquinolones. an overview on mechanistic aspects.

  Current medicinal chemistry 20010301

• Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotics.

  The Journal of pharmacology and experimental therapeutics 20010301

• Antimicrobial activity of fluoroquinolone photodegradation products determined by parallel-line bioassay and high performance liquid chromatography.

  The Journal of antimicrobial chemotherapy 20010301

• Moxifloxacin: clinical efficacy and safety.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010301

• What do the new antimicrobials offer? Weighing the advantages and disadvantages compared with traditional agents.

  Postgraduate medicine 20010301

• In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis.

  International journal of antimicrobial agents 20010301

• Bactericidal activity of moxifloxacin against Staphylococcus aureus.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20010301

• Activity of oral agents against pediatric isolates of Streptococcus pneumoniae.

  Diagnostic microbiology and infectious disease 20010301

• [One year moxifloxacin. Still effective in the respiratory tract].

  MMW Fortschritte der Medizin 20010215

• Efficacy of moxifloxacin, trovafloxacin, clinafloxacin and levofloxacin against intracellular Legionella pneumophila.

  The Journal of antimicrobial chemotherapy 20010201

• Advances in DNA gyrase inhibitors.

  Expert opinion on investigational drugs 20010201

• Workplace costs associated with acute exacerbation of chronic bronchitis: a comparison of moxifloxacin and levofloxacin.

  Managed care interface 20010201

• Moxifloxacin: a review of the microbiological, pharmacological, clinical and safety features.

  Expert opinion on pharmacotherapy 20010201

• Drug Points: tachycardia associated with moxifloxacin.

  BMJ (Clinical research ed.) 20010106

• Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.

  Antimicrobial agents and chemotherapy 20010101

• Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG.

  Molecular pharmacology 20010101

• In vitro development of resistance to three quinolones in Streptococcus pneumoniae.

  Chemotherapy 20010101

• Measurement of the bactericidal activity of fluoroquinolones against Streptococcus pneumoniae using the bactericidal index method.

  International journal of antimicrobial agents 20010101

• Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults.

  Chest 20010101

• Activity of moxifloxacin and twelve other antimicrobial agents against 216 clinical isolates of Streptococcus pneumoniae.

  Chemotherapy 20010101

• In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany.

  Chemotherapy 20010101

• Acute community-acquired pneumonia: current diagnosis and treatment.

  Journal of the South Carolina Medical Association (1975) 20010101

• In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood isolates from patients with hematologic malignancies.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20010101

• Bactericidal activity of moxifloxacin against pneumococci.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20010101

• Pharmacokinetics, safety and tolerability of moxifloxacin, a novel 8-methoxyfluoroquinolone, after repeated oral administration.

  Clinical pharmacokinetics 20010101

• The influence of age and gender on the pharmacokinetics of moxifloxacin.

  Clinical pharmacokinetics 20010101

• Effect of food on the pharmacokinetics of a single oral dose of moxifloxacin 400mg in healthy male volunteers.

  Clinical pharmacokinetics 20010101

• Effect of calcium supplements on the oral bioavailability of moxifloxacin in healthy male volunteers.

  Clinical pharmacokinetics 20010101

• Effects of dairy products on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers.

  Clinical pharmacokinetics 20010101

• Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.

  Clinical pharmacokinetics 20010101

• Effects of sucralfate on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers.

  Clinical pharmacokinetics 20010101

• Effects of iron supplements on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in humans.

  Clinical pharmacokinetics 20010101

• Lack of pharmacokinetic interaction between moxifloxacin, a novel 8-methoxyfluoroquinolone, and theophylline.

  Clinical pharmacokinetics 20010101

• Effect of probenecid on the kinetics of a single oral 400mg dose of moxifloxacin in healthy male volunteers.

  Clinical pharmacokinetics 20010101

• Chronic obstructive pulmonary disease.

  The Journal of international medical research 20010101

• Clinical experience in Germany of treating community-acquired respiratory infections with the new 8-methoxyfluoroquinolone, moxifloxacin.

  The Journal of international medical research 20010101

• Moxifloxacin in acute exacerbations of chronic bronchitis: clinical evaluation and assessment by patients.

  The Journal of international medical research 20010101

• Treatment outcomes in acute exacerbations of chronic bronchitis: comparison of macrolides and moxifloxacin from the patient perspective.

  The Journal of international medical research 20010101

• In vitro activity of ABT-773 versus macrolides and quinolones against resistant respiratory tract pathogens.

  Diagnostic microbiology and infectious disease 20010101

• Comparison of side effects of levofloxacin versus other fluoroquinolones.

  Chemotherapy 20010101

• Evidence of different profiles of side effects and drug-drug interactions among the quinolones--the pharmacokinetic standpoint.

  Chemotherapy 20010101

• In vitro activity of novel fluoroquinolones against Streptococcus pneumoniae isolated from children with acute otitis media.

  Chemotherapy 20010101

• A multinational, multicentre, non-blinded, randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis.

  The Journal of international medical research 20010101

• In vitro susceptibility study of BMS-284756 against Legionella species.

  Diagnostic microbiology and infectious disease 20010101

• Streptococcus pneumoniae as an agent of nosocomial infection: treatment in the era of penicillin-resistant strains.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20010101

• In vitro susceptibility and eradication of Chlamydia pneumoniae cardiovascular strains from coronary artery endothelium and smooth muscle cells.

  Cardiovascular drugs and therapy 20010101

• Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.

  Microbial drug resistance (Larchmont, N.Y.) 20010101

• [Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections].

  Terapevticheskii arkhiv 20010101

• [Flouroquinolones of the third and fourth generations].

  Journal de pharmacie de Belgique 20010101

• Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756.

  Antimicrobial agents and chemotherapy 20001201

• Prediction of quinolone activity against Mycobacterium avium by molecular topology and virtual computational screening.

  Antimicrobial agents and chemotherapy 20001001

• Anti-toxoplasma activities of 24 quinolones and fluoroquinolones in vitro: prediction of activity by molecular topology and virtual computational techniques.

  Antimicrobial agents and chemotherapy 20001001

• Mutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosis.

  Antimicrobial agents and chemotherapy 20000901

• Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones.

  The Journal of antimicrobial chemotherapy 20000501

• Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections.

  Drugs 20000101

• Activity of moxifloxacin against mycobacteria.

  The Journal of antimicrobial chemotherapy 19990901

• Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis.

  Antimicrobial agents and chemotherapy 19990101

• In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.

  Antimicrobial agents and chemotherapy 19980801

• In vitro activity of BAY 12-8039, a new fluoroquinolone.

  Antimicrobial agents and chemotherapy 19970101